id	sid	tid	token	lemma	pos
dti-3060	1	1	dti	dti	PROPN
dti-3060	1	2	drug	drug	PROPN
dti-3060	1	3	target	target	NOUN
dti-3060	1	4	insights	insight	NOUN
dti-3060	1	5	2024	2024	NUM
dti-3060	1	6	;	;	PUNCT
dti-3060	1	7	18	18	NUM
dti-3060	1	8	:	:	SYM
dti-3060	1	9	78	78	NUM
dti-3060	1	10	-	-	SYM
dti-3060	1	11	83	83	NUM
dti-3060	1	12	issn	issn	PROPN
dti-3060	1	13	1177	1177	NUM
dti-3060	1	14	-	-	SYM
dti-3060	1	15	3928	3928	NUM
dti-3060	1	16	|	|	ADV
dti-3060	1	17	doi	doi	NOUN
dti-3060	1	18	:	:	PUNCT
dti-3060	1	19	10.33393	10.33393	NUM
dti-3060	1	20	/	/	SYM
dti-3060	1	21	dti.2024.3060	dti.2024.3060	NOUN
dti-3060	1	22	original	original	ADJ
dti-3060	1	23	research	research	NOUN
dti-3060	1	24	article	article	NOUN
dti-3060	1	25	drug	drug	NOUN
dti-3060	1	26	target	target	NOUN
dti-3060	1	27	insights	insight	NOUN
dti-3060	1	28	issn	issn	VERB
dti-3060	1	29	1177	1177	NUM
dti-3060	1	30	-	-	SYM
dti-3060	1	31	3928	3928	NUM
dti-3060	1	32	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-3060	1	33	©	©	PROPN
dti-3060	1	34	2024	2024	NUM
dti-3060	1	35	the	the	DET
dti-3060	1	36	authors	author	NOUN
dti-3060	1	37	.	.	PUNCT
dti-3060	2	1	this	this	DET
dti-3060	2	2	article	article	NOUN
dti-3060	2	3	is	be	AUX
dti-3060	2	4	published	publish	VERB
dti-3060	2	5	by	by	ADP
dti-3060	2	6	aboutscience	aboutscience	NOUN
dti-3060	2	7	and	and	CCONJ
dti-3060	2	8	licensed	license	VERB
dti-3060	2	9	under	under	ADP
dti-3060	2	10	creative	creative	ADJ
dti-3060	2	11	commons	common	NOUN
dti-3060	2	12	attribution	attribution	NOUN
dti-3060	2	13	-	-	PUNCT
dti-3060	2	14	noncommercial	noncommercial	ADJ
dti-3060	2	15	4.0	4.0	NUM
dti-3060	2	16	international	international	NOUN
dti-3060	2	17	(	(	PUNCT
dti-3060	2	18	cc	cc	NOUN
dti-3060	2	19	by	by	ADP
dti-3060	2	20	-	-	PUNCT
dti-3060	2	21	nc	nc	PROPN
dti-3060	2	22	4.0	4.0	NUM
dti-3060	2	23	)	)	PUNCT
dti-3060	2	24	.	.	PUNCT
dti-3060	3	1	commercial	commercial	ADJ
dti-3060	3	2	use	use	NOUN
dti-3060	3	3	is	be	AUX
dti-3060	3	4	not	not	PART
dti-3060	3	5	permitted	permit	VERB
dti-3060	3	6	and	and	CCONJ
dti-3060	3	7	is	be	AUX
dti-3060	3	8	subject	subject	ADJ
dti-3060	3	9	to	to	ADP
dti-3060	3	10	publisher	publisher	NOUN
dti-3060	3	11	’s	’s	PART
dti-3060	3	12	permissions	permission	NOUN
dti-3060	3	13	.	.	PUNCT
dti-3060	4	1	full	full	ADJ
dti-3060	4	2	information	information	NOUN
dti-3060	4	3	is	be	AUX
dti-3060	4	4	available	available	ADJ
dti-3060	4	5	at	at	ADP
dti-3060	4	6	www.aboutscience.eu	www.aboutscience.eu	PROPN
dti-3060	4	7	levofloxacin	levofloxacin	NOUN
dti-3060	4	8	induces	induce	VERB
dti-3060	4	9	erythrocyte	erythrocyte	ADJ
dti-3060	4	10	contraction	contraction	NOUN
dti-3060	4	11	leading	lead	VERB
dti-3060	4	12	to	to	ADP
dti-3060	4	13	red	red	ADJ
dti-3060	4	14	cell	cell	NOUN
dti-3060	4	15	death	death	NOUN
dti-3060	4	16	hafiz	hafiz	PROPN
dti-3060	4	17	muhammad	muhammad	PROPN
dti-3060	4	18	aslam	aslam	PROPN
dti-3060	4	19	¹	¹	PROPN
dti-3060	4	20	,	,	PUNCT
dti-3060	4	21	azka	azka	PROPN
dti-3060	4	22	sohail¹	sohail¹	PROPN
dti-3060	4	23	,	,	PUNCT
dti-3060	4	24	ammara	ammara	ADV
dti-3060	4	25	shahid²	shahid²	NOUN
dti-3060	4	26	,	,	PUNCT
dti-3060	4	27	maham	maham	PROPN
dti-3060	4	28	abdul	abdul	PROPN
dti-3060	4	29	bari	bari	PROPN
dti-3060	4	30	khan	khan	PROPN
dti-3060	4	31	¹	¹	PROPN
dti-3060	4	32	,	,	PUNCT
dti-3060	4	33	muhammad	muhammad	PROPN
dti-3060	4	34	umar	umar	PROPN
dti-3060	4	35	sharif³	sharif³	PROPN
dti-3060	4	36	,	,	PUNCT
dti-3060	4	37	razia	razia	PROPN
dti-3060	4	38	kausar³	kausar³	PROPN
dti-3060	4	39	,	,	PUNCT
dti-3060	4	40	samia	samia	PROPN
dti-3060	4	41	nawab⁴	nawab⁴	PROPN
dti-3060	4	42	,	,	PUNCT
dti-3060	4	43	waqas	waqas	PROPN
dti-3060	4	44	farooq⁵	farooq⁵	PROPN
dti-3060	4	45	,	,	PUNCT
dti-3060	4	46	kashif	kashif	PROPN
dti-3060	4	47	jilani¹	jilani¹	PROPN
dti-3060	4	48	,	,	PUNCT
dti-3060	4	49	majeeda	majeeda	PROPN
dti-3060	4	50	rasheed	rashee	VERB
dti-3060	4	51	⁶	⁶	PROPN
dti-3060	4	52	1department	1department	NUM
dti-3060	4	53	of	of	ADP
dti-3060	4	54	biochemistry	biochemistry	NOUN
dti-3060	4	55	,	,	PUNCT
dti-3060	4	56	university	university	NOUN
dti-3060	4	57	of	of	ADP
dti-3060	4	58	agriculture	agriculture	PROPN
dti-3060	4	59	,	,	PUNCT
dti-3060	5	1	faisalabad	faisalabad	PROPN
dti-3060	5	2	pakistan	pakistan	PROPN
dti-3060	5	3	2department	2department	NUM
dti-3060	5	4	of	of	ADP
dti-3060	5	5	internal	internal	ADJ
dti-3060	5	6	medicine	medicine	NOUN
dti-3060	5	7	,	,	PUNCT
dti-3060	5	8	amna	amna	PROPN
dti-3060	5	9	anayat	anayat	PROPN
dti-3060	5	10	medical	medical	PROPN
dti-3060	5	11	college	college	PROPN
dti-3060	5	12	,	,	PUNCT
dti-3060	5	13	sheikhupura	sheikhupura	AUX
dti-3060	5	14	pakistan	pakistan	PROPN
dti-3060	5	15	3department	3department	NUM
dti-3060	5	16	of	of	ADP
dti-3060	5	17	anatomy	anatomy	NOUN
dti-3060	5	18	,	,	PUNCT
dti-3060	5	19	faculty	faculty	NOUN
dti-3060	5	20	of	of	ADP
dti-3060	5	21	veterinary	veterinary	ADJ
dti-3060	5	22	science	science	NOUN
dti-3060	5	23	.	.	PUNCT
dti-3060	6	1	university	university	NOUN
dti-3060	6	2	of	of	ADP
dti-3060	6	3	agriculture	agriculture	PROPN
dti-3060	6	4	,	,	PUNCT
dti-3060	6	5	faisalabad	faisalabad	PROPN
dti-3060	6	6	pakistan	pakistan	PROPN
dti-3060	6	7	4department	4department	NUM
dti-3060	6	8	of	of	ADP
dti-3060	6	9	chemistry	chemistry	NOUN
dti-3060	6	10	,	,	PUNCT
dti-3060	6	11	government	government	NOUN
dti-3060	6	12	graduate	graduate	NOUN
dti-3060	6	13	college	college	NOUN
dti-3060	6	14	for	for	ADP
dti-3060	6	15	women	woman	NOUN
dti-3060	6	16	,	,	PUNCT
dti-3060	6	17	township	township	NOUN
dti-3060	6	18	lahore	lahore	NOUN
dti-3060	6	19	5institute	5institute	NUM
dti-3060	6	20	of	of	ADP
dti-3060	6	21	biomedical	biomedical	ADJ
dti-3060	6	22	sciences	sciences	PROPN
dti-3060	6	23	,	,	PUNCT
dti-3060	6	24	shanxi	shanxi	PROPN
dti-3060	6	25	university	university	PROPN
dti-3060	6	26	,	,	PUNCT
dti-3060	6	27	taiyuan	taiyuan	PROPN
dti-3060	6	28	china	china	PROPN
dti-3060	6	29	6department	6department	NUM
dti-3060	6	30	of	of	ADP
dti-3060	6	31	life	life	NOUN
dti-3060	6	32	sciences	sciences	PROPN
dti-3060	6	33	,	,	PUNCT
dti-3060	6	34	khwaja	khwaja	PROPN
dti-3060	6	35	fareed	fareed	PROPN
dti-3060	6	36	university	university	PROPN
dti-3060	6	37	of	of	ADP
dti-3060	6	38	engineering	engineering	NOUN
dti-3060	6	39	and	and	CCONJ
dti-3060	6	40	information	information	NOUN
dti-3060	6	41	technology	technology	NOUN
dti-3060	6	42	rahimyar	rahimyar	PROPN
dti-3060	6	43	khan	khan	PROPN
dti-3060	6	44	,	,	PUNCT
dti-3060	6	45	punjab	punjab	PROPN
dti-3060	6	46	pakistan	pakistan	PROPN
dti-3060	6	47	abstract	abstract	ADJ
dti-3060	6	48	background	background	NOUN
dti-3060	6	49	:	:	PUNCT
dti-3060	6	50	levofloxacin	levofloxacin	PROPN
dti-3060	6	51	,	,	PUNCT
dti-3060	6	52	a	a	DET
dti-3060	6	53	fluoroquinolone	fluoroquinolone	NOUN
dti-3060	6	54	,	,	PUNCT
dti-3060	6	55	is	be	AUX
dti-3060	6	56	an	an	DET
dti-3060	6	57	extensively	extensively	ADV
dti-3060	6	58	used	use	VERB
dti-3060	6	59	antibiotic	antibiotic	ADJ
dti-3060	6	60	effective	effective	ADJ
dti-3060	6	61	against	against	ADP
dti-3060	6	62	both	both	DET
dti-3060	6	63	positively	positively	ADV
dti-3060	6	64	and	and	CCONJ
dti-3060	6	65	negatively	negatively	ADV
dti-3060	6	66	staining	stain	VERB
dti-3060	6	67	bacteria	bacteria	NOUN
dti-3060	6	68	.	.	PUNCT
dti-3060	7	1	it	it	PRON
dti-3060	7	2	works	work	VERB
dti-3060	7	3	by	by	ADP
dti-3060	7	4	inhibiting	inhibit	VERB
dti-3060	7	5	bacterial	bacterial	ADJ
dti-3060	7	6	topoisomerase	topoisomerase	ADJ
dti-3060	7	7	type	type	NOUN
dti-3060	7	8	ii	ii	NOUN
dti-3060	7	9	and	and	CCONJ
dti-3060	7	10	topoisomerase	topoisomerase	NOUN
dti-3060	7	11	type	type	NOUN
dti-3060	7	12	iv	iv	NOUN
dti-3060	7	13	,	,	PUNCT
dti-3060	7	14	resulting	result	VERB
dti-3060	7	15	in	in	ADP
dti-3060	7	16	impaired	impaired	ADJ
dti-3060	7	17	dna	dna	ADJ
dti-3060	7	18	synthesis	synthesis	NOUN
dti-3060	7	19	and	and	CCONJ
dti-3060	7	20	bacterial	bacterial	ADJ
dti-3060	7	21	cell	cell	NOUN
dti-3060	7	22	death	death	NOUN
dti-3060	7	23	.	.	PUNCT
dti-3060	8	1	eryptosis	eryptosis	NOUN
dti-3060	8	2	is	be	AUX
dti-3060	8	3	another	another	DET
dti-3060	8	4	term	term	NOUN
dti-3060	8	5	for	for	ADP
dti-3060	8	6	apoptotic	apoptotic	ADJ
dti-3060	8	7	cell	cell	NOUN
dti-3060	8	8	death	death	NOUN
dti-3060	8	9	of	of	ADP
dti-3060	8	10	erythrocyte	erythrocyte	NOUN
dti-3060	8	11	marked	mark	VERB
dti-3060	8	12	by	by	ADP
dti-3060	8	13	cell	cell	NOUN
dti-3060	8	14	shrinkage	shrinkage	NOUN
dti-3060	8	15	,	,	PUNCT
dti-3060	8	16	phosphatidylserine	phosphatidylserine	NOUN
dti-3060	8	17	(	(	PUNCT
dti-3060	8	18	ps	ps	NOUN
dti-3060	8	19	)	)	PUNCT
dti-3060	8	20	flipping	flipping	NOUN
dti-3060	8	21	,	,	PUNCT
dti-3060	8	22	and	and	CCONJ
dti-3060	8	23	membrane	membrane	NOUN
dti-3060	8	24	blebbing	blebbing	NOUN
dti-3060	8	25	.	.	PUNCT
dti-3060	9	1	methods	method	NOUN
dti-3060	9	2	:	:	PUNCT
dti-3060	9	3	the	the	DET
dti-3060	9	4	intent	intent	NOUN
dti-3060	9	5	of	of	ADP
dti-3060	9	6	the	the	DET
dti-3060	9	7	present	present	ADJ
dti-3060	9	8	research	research	NOUN
dti-3060	9	9	was	be	AUX
dti-3060	9	10	to	to	PART
dti-3060	9	11	look	look	VERB
dti-3060	9	12	at	at	ADP
dti-3060	9	13	the	the	DET
dti-3060	9	14	eryptotic	eryptotic	ADJ
dti-3060	9	15	effect	effect	NOUN
dti-3060	9	16	of	of	ADP
dti-3060	9	17	levofloxacin	levofloxacin	NOUN
dti-3060	9	18	by	by	ADP
dti-3060	9	19	exposing	expose	VERB
dti-3060	9	20	erythrocytes	erythrocyte	NOUN
dti-3060	9	21	to	to	ADP
dti-3060	9	22	therapeutical	therapeutical	ADJ
dti-3060	9	23	doses	dose	NOUN
dti-3060	9	24	(	(	PUNCT
dti-3060	9	25	7	7	NUM
dti-3060	9	26	,	,	PUNCT
dti-3060	9	27	14	14	NUM
dti-3060	9	28	µm	µm	NOUN
dti-3060	9	29	)	)	PUNCT
dti-3060	9	30	of	of	ADP
dti-3060	9	31	levofloxacin	levofloxacin	NOUN
dti-3060	9	32	for	for	ADP
dti-3060	9	33	48	48	NUM
dti-3060	9	34	hours	hour	NOUN
dti-3060	9	35	.	.	PUNCT
dti-3060	10	1	cell	cell	NOUN
dti-3060	10	2	size	size	NOUN
dti-3060	10	3	evaluation	evaluation	NOUN
dti-3060	10	4	,	,	PUNCT
dti-3060	10	5	ps	ps	NOUN
dti-3060	10	6	subjection	subjection	NOUN
dti-3060	10	7	to	to	ADP
dti-3060	10	8	outside	outside	NOUN
dti-3060	10	9	,	,	PUNCT
dti-3060	10	10	and	and	CCONJ
dti-3060	10	11	calcium	calcium	NOUN
dti-3060	10	12	channel	channel	NOUN
dti-3060	10	13	inhibition	inhibition	NOUN
dti-3060	10	14	were	be	AUX
dti-3060	10	15	carried	carry	VERB
dti-3060	10	16	out	out	ADP
dti-3060	10	17	to	to	PART
dti-3060	10	18	investigate	investigate	VERB
dti-3060	10	19	eryptosis	eryptosis	NOUN
dti-3060	10	20	.	.	PUNCT
dti-3060	11	1	oxidative	oxidative	ADJ
dti-3060	11	2	stress	stress	NOUN
dti-3060	11	3	generated	generate	VERB
dti-3060	11	4	by	by	ADP
dti-3060	11	5	levofloxacin	levofloxacin	PROPN
dti-3060	11	6	was	be	AUX
dti-3060	11	7	measured	measure	VERB
dti-3060	11	8	as	as	ADP
dti-3060	11	9	a	a	DET
dti-3060	11	10	putative	putative	ADJ
dti-3060	11	11	mechanism	mechanism	NOUN
dti-3060	11	12	of	of	ADP
dti-3060	11	13	eryptosis	eryptosis	NOUN
dti-3060	11	14	using	use	VERB
dti-3060	11	15	glutathione	glutathione	NOUN
dti-3060	11	16	peroxidase	peroxidase	NOUN
dti-3060	11	17	(	(	PUNCT
dti-3060	11	18	gpx	gpx	PROPN
dti-3060	11	19	)	)	PUNCT
dti-3060	11	20	,	,	PUNCT
dti-3060	11	21	superoxide	superoxide	NOUN
dti-3060	11	22	dismutase	dismutase	NOUN
dti-3060	11	23	(	(	PUNCT
dti-3060	11	24	sod	sod	NOUN
dti-3060	11	25	)	)	PUNCT
dti-3060	11	26	,	,	PUNCT
dti-3060	11	27	and	and	CCONJ
dti-3060	11	28	catalase	catalase	NOUN
dti-3060	11	29	activities	activity	NOUN
dti-3060	11	30	.	.	PUNCT
dti-3060	12	1	similarly	similarly	ADV
dti-3060	12	2	,	,	PUNCT
dti-3060	12	3	hemolysis	hemolysis	NOUN
dti-3060	12	4	measurements	measurement	NOUN
dti-3060	12	5	demonstrated	demonstrate	VERB
dti-3060	12	6	levofloxacin	levofloxacin	PROPN
dti-3060	12	7	’s	’s	PART
dti-3060	12	8	cytotoxic	cytotoxic	ADJ
dti-3060	12	9	effect	effect	NOUN
dti-3060	12	10	.	.	PUNCT
dti-3060	13	1	results	result	NOUN
dti-3060	13	2	:	:	PUNCT
dti-3060	13	3	our	our	PRON
dti-3060	13	4	findings	finding	NOUN
dti-3060	13	5	showed	show	VERB
dti-3060	13	6	that	that	SCONJ
dti-3060	13	7	therapeutic	therapeutic	ADJ
dti-3060	13	8	doses	dose	NOUN
dti-3060	13	9	of	of	ADP
dti-3060	13	10	levofloxacin	levofloxacin	NOUN
dti-3060	13	11	can	can	AUX
dti-3060	13	12	cause	cause	VERB
dti-3060	13	13	a	a	DET
dti-3060	13	14	considerable	considerable	ADJ
dti-3060	13	15	decline	decline	NOUN
dti-3060	13	16	in	in	ADP
dti-3060	13	17	antioxidant	antioxidant	ADJ
dti-3060	13	18	enzymes	enzyme	NOUN
dti-3060	13	19	activities	activity	NOUN
dti-3060	13	20	,	,	PUNCT
dti-3060	13	21	as	as	ADV
dti-3060	13	22	well	well	ADV
dti-3060	13	23	as	as	ADP
dti-3060	13	24	induce	induce	VERB
dti-3060	13	25	cell	cell	NOUN
dti-3060	13	26	shrinkage	shrinkage	NOUN
dti-3060	13	27	,	,	PUNCT
dti-3060	13	28	ps	ps	NOUN
dti-3060	13	29	externalization	externalization	NOUN
dti-3060	13	30	,	,	PUNCT
dti-3060	13	31	and	and	CCONJ
dti-3060	13	32	hemolysis	hemolysis	NOUN
dti-3060	13	33	in	in	ADP
dti-3060	13	34	erythrocytes	erythrocyte	NOUN
dti-3060	13	35	.	.	PUNCT
dti-3060	14	1	the	the	DET
dti-3060	14	2	role	role	NOUN
dti-3060	14	3	of	of	ADP
dti-3060	14	4	calcium	calcium	NOUN
dti-3060	14	5	in	in	ADP
dti-3060	14	6	triggering	trigger	VERB
dti-3060	14	7	erythrocyte	erythrocyte	NOUN
dti-3060	14	8	shrinkage	shrinkage	NOUN
dti-3060	14	9	was	be	AUX
dti-3060	14	10	also	also	ADV
dti-3060	14	11	confirmed	confirm	VERB
dti-3060	14	12	.	.	PUNCT
dti-3060	15	1	conclusion	conclusion	NOUN
dti-3060	15	2	:	:	PUNCT
dti-3060	15	3	in	in	ADP
dti-3060	15	4	conclusion	conclusion	NOUN
dti-3060	15	5	,	,	PUNCT
dti-3060	15	6	our	our	PRON
dti-3060	15	7	findings	finding	NOUN
dti-3060	15	8	showed	show	VERB
dti-3060	15	9	that	that	SCONJ
dti-3060	15	10	the	the	DET
dti-3060	15	11	indicated	indicate	VERB
dti-3060	15	12	levofloxacin	levofloxacin	NOUN
dti-3060	15	13	doses	dose	NOUN
dti-3060	15	14	caused	cause	VERB
dti-3060	15	15	oxidative	oxidative	ADJ
dti-3060	15	16	stress	stress	NOUN
dti-3060	15	17	,	,	PUNCT
dti-3060	15	18	which	which	PRON
dti-3060	15	19	leads	lead	VERB
dti-3060	15	20	to	to	ADP
dti-3060	15	21	erythrocyte	erythrocyte	NOUN
dti-3060	15	22	death	death	NOUN
dti-3060	15	23	via	via	ADP
dti-3060	15	24	eryptosis	eryptosis	NOUN
dti-3060	15	25	and	and	CCONJ
dti-3060	15	26	hemolysis	hemolysis	NOUN
dti-3060	15	27	.	.	PUNCT
dti-3060	16	1	these	these	DET
dti-3060	16	2	findings	finding	NOUN
dti-3060	16	3	emphasize	emphasize	VERB
dti-3060	16	4	the	the	DET
dti-3060	16	5	importance	importance	NOUN
dti-3060	16	6	of	of	ADP
dti-3060	16	7	using	use	VERB
dti-3060	16	8	levofloxacin	levofloxacin	NOUN
dti-3060	16	9	with	with	ADP
dti-3060	16	10	caution	caution	NOUN
dti-3060	16	11	and	and	CCONJ
dti-3060	16	12	the	the	DET
dti-3060	16	13	need	need	NOUN
dti-3060	16	14	for	for	ADP
dti-3060	16	15	additional	additional	ADJ
dti-3060	16	16	research	research	NOUN
dti-3060	16	17	to	to	PART
dti-3060	16	18	mitigate	mitigate	VERB
dti-3060	16	19	these	these	DET
dti-3060	16	20	side	side	NOUN
dti-3060	16	21	effects	effect	NOUN
dti-3060	16	22	.	.	PUNCT
dti-3060	17	1	keywords	keyword	NOUN
dti-3060	17	2	:	:	PUNCT
dti-3060	17	3	eryptosis	eryptosis	NOUN
dti-3060	17	4	,	,	PUNCT
dti-3060	17	5	erythrocyte	erythrocyte	NOUN
dti-3060	17	6	,	,	PUNCT
dti-3060	17	7	hemolysis	hemolysis	NOUN
dti-3060	17	8	,	,	PUNCT
dti-3060	17	9	levofloxacin	levofloxacin	PROPN
dti-3060	17	10	,	,	PUNCT
dti-3060	17	11	oxidative	oxidative	ADJ
dti-3060	17	12	stress	stress	NOUN
dti-3060	17	13	received	receive	VERB
dti-3060	17	14	:	:	PUNCT
dti-3060	17	15	march	march	PROPN
dti-3060	17	16	1	1	NUM
dti-3060	17	17	,	,	PUNCT
dti-3060	17	18	2024	2024	NUM
dti-3060	17	19	accepted	accept	VERB
dti-3060	17	20	:	:	PUNCT
dti-3060	17	21	july	july	PROPN
dti-3060	17	22	11	11	NUM
dti-3060	17	23	,	,	PUNCT
dti-3060	17	24	2024	2024	NUM
dti-3060	17	25	published	publish	VERB
dti-3060	17	26	online	online	ADV
dti-3060	17	27	:	:	PUNCT
dti-3060	17	28	october	october	PROPN
dti-3060	17	29	7	7	NUM
dti-3060	17	30	,	,	PUNCT
dti-3060	17	31	2024	2024	NUM
dti-3060	17	32	corresponding	correspond	VERB
dti-3060	17	33	author	author	NOUN
dti-3060	17	34	:	:	PUNCT
dti-3060	17	35	majeeda	majeeda	PROPN
dti-3060	17	36	rasheed	rasheed	PROPN
dti-3060	17	37	email	email	NOUN
dti-3060	17	38	:	:	PUNCT
dti-3060	17	39	majeeda.rasheed@kfueit.edu.pk	majeeda.rasheed@kfueit.edu.pk	ADJ
dti-3060	17	40	post	post	ADJ
dti-3060	17	41	-	-	ADJ
dti-3060	17	42	exposure	exposure	ADJ
dti-3060	17	43	inhalational	inhalational	ADJ
dti-3060	17	44	anthrax	anthrax	NOUN
dti-3060	17	45	,	,	PUNCT
dti-3060	17	46	hospital	hospital	NOUN
dti-3060	17	47	-	-	PUNCT
dti-3060	17	48	acquired	acquire	VERB
dti-3060	17	49	infections	infection	NOUN
dti-3060	17	50	and	and	CCONJ
dti-3060	17	51	pneumonitis	pneumonitis	NOUN
dti-3060	17	52	,	,	PUNCT
dti-3060	17	53	urinary	urinary	ADJ
dti-3060	17	54	tract	tract	NOUN
dti-3060	17	55	infections	infection	NOUN
dti-3060	17	56	,	,	PUNCT
dti-3060	17	57	inflammation	inflammation	NOUN
dti-3060	17	58	of	of	ADP
dti-3060	17	59	the	the	DET
dti-3060	17	60	prostate	prostate	NOUN
dti-3060	17	61	gland	gland	NOUN
dti-3060	17	62	,	,	PUNCT
dti-3060	17	63	and	and	CCONJ
dti-3060	17	64	soft	soft	ADJ
dti-3060	17	65	tissue	tissue	NOUN
dti-3060	17	66	or	or	CCONJ
dti-3060	17	67	skin	skin	NOUN
dti-3060	17	68	infection	infection	NOUN
dti-3060	17	69	.	.	PUNCT
dti-3060	18	1	the	the	DET
dti-3060	18	2	medicine	medicine	NOUN
dti-3060	18	3	levofloxacin	levofloxacin	NOUN
dti-3060	18	4	is	be	AUX
dti-3060	18	5	on	on	ADP
dti-3060	18	6	the	the	DET
dti-3060	18	7	world	world	PROPN
dti-3060	18	8	health	health	NOUN
dti-3060	18	9	organization	organization	NOUN
dti-3060	18	10	(	(	PUNCT
dti-3060	18	11	who	who	PRON
dti-3060	18	12	)	)	PUNCT
dti-3060	18	13	’s	’s	PART
dti-3060	18	14	list	list	NOUN
dti-3060	18	15	of	of	ADP
dti-3060	18	16	essential	essential	ADJ
dti-3060	18	17	medicines	medicine	NOUN
dti-3060	18	18	(	(	PUNCT
dti-3060	18	19	1,2	1,2	NUM
dti-3060	18	20	)	)	PUNCT
dti-3060	18	21	.	.	PUNCT
dti-3060	19	1	in	in	ADP
dti-3060	19	2	in	in	ADP
dti-3060	19	3	vivo	vivo	NOUN
dti-3060	19	4	and	and	CCONJ
dti-3060	19	5	in	in	ADP
dti-3060	19	6	vitro	vitro	X
dti-3060	19	7	conditions	condition	NOUN
dti-3060	19	8	levofloxacin	levofloxacin	PROPN
dti-3060	19	9	has	have	AUX
dti-3060	19	10	been	be	AUX
dti-3060	19	11	demonstrated	demonstrate	VERB
dti-3060	19	12	to	to	PART
dti-3060	19	13	have	have	VERB
dti-3060	19	14	immunomodulatory	immunomodulatory	ADJ
dti-3060	19	15	properties	property	NOUN
dti-3060	19	16	by	by	ADP
dti-3060	19	17	decreasing	decrease	VERB
dti-3060	19	18	the	the	DET
dti-3060	19	19	synthesis	synthesis	NOUN
dti-3060	19	20	and	and	CCONJ
dti-3060	19	21	secretion	secretion	NOUN
dti-3060	19	22	of	of	ADP
dti-3060	19	23	inflammatory	inflammatory	ADJ
dti-3060	19	24	cytokines	cytokine	NOUN
dti-3060	19	25	(	(	PUNCT
dti-3060	19	26	3	3	NUM
dti-3060	19	27	)	)	PUNCT
dti-3060	19	28	.	.	PUNCT
dti-3060	20	1	nausea	nausea	NOUN
dti-3060	20	2	,	,	PUNCT
dti-3060	20	3	vomiting	vomiting	NOUN
dti-3060	20	4	,	,	PUNCT
dti-3060	20	5	and	and	CCONJ
dti-3060	20	6	diarrhea	diarrhea	NOUN
dti-3060	20	7	are	be	AUX
dti-3060	20	8	among	among	ADP
dti-3060	20	9	the	the	DET
dti-3060	20	10	most	most	ADV
dti-3060	20	11	common	common	ADJ
dti-3060	20	12	side	side	NOUN
dti-3060	20	13	effects	effect	NOUN
dti-3060	20	14	associated	associate	VERB
dti-3060	20	15	with	with	ADP
dti-3060	20	16	levofloxacin	levofloxacin	PROPN
dti-3060	20	17	.	.	PUNCT
dti-3060	21	1	central	central	ADJ
dti-3060	21	2	nervous	nervous	ADJ
dti-3060	21	3	system	system	NOUN
dti-3060	21	4	complications	complication	NOUN
dti-3060	21	5	have	have	AUX
dti-3060	21	6	also	also	ADV
dti-3060	21	7	been	be	AUX
dti-3060	21	8	reported	report	VERB
dti-3060	21	9	from	from	ADP
dti-3060	21	10	mild	mild	ADJ
dti-3060	21	11	dizziness	dizziness	NOUN
dti-3060	21	12	and	and	CCONJ
dti-3060	21	13	headache	headache	NOUN
dti-3060	21	14	to	to	ADP
dti-3060	21	15	severe	severe	ADJ
dti-3060	21	16	depression	depression	NOUN
dti-3060	21	17	,	,	PUNCT
dti-3060	21	18	hallucination	hallucination	NOUN
dti-3060	21	19	,	,	PUNCT
dti-3060	21	20	and	and	CCONJ
dti-3060	21	21	seizures	seizure	NOUN
dti-3060	21	22	(	(	PUNCT
dti-3060	21	23	4	4	NUM
dti-3060	21	24	)	)	PUNCT
dti-3060	21	25	.	.	PUNCT
dti-3060	22	1	its	its	PRON
dti-3060	22	2	widespread	widespread	ADJ
dti-3060	22	3	usage	usage	NOUN
dti-3060	22	4	has	have	AUX
dti-3060	22	5	been	be	AUX
dti-3060	22	6	linked	link	VERB
dti-3060	22	7	to	to	ADP
dti-3060	22	8	several	several	ADJ
dti-3060	22	9	cases	case	NOUN
dti-3060	22	10	of	of	ADP
dti-3060	22	11	clinically	clinically	ADV
dti-3060	22	12	apparent	apparent	ADJ
dti-3060	22	13	liver	liver	NOUN
dti-3060	22	14	injury	injury	NOUN
dti-3060	22	15	.	.	PUNCT
dti-3060	23	1	it	it	PRON
dti-3060	23	2	has	have	AUX
dti-3060	23	3	been	be	AUX
dti-3060	23	4	proposed	propose	VERB
dti-3060	23	5	that	that	SCONJ
dti-3060	23	6	reactive	reactive	ADJ
dti-3060	23	7	oxygen	oxygen	NOUN
dti-3060	23	8	species	specie	NOUN
dti-3060	23	9	(	(	PUNCT
dti-3060	23	10	ros	ros	PROPN
dti-3060	23	11	)	)	PUNCT
dti-3060	23	12	produced	produce	VERB
dti-3060	23	13	by	by	ADP
dti-3060	23	14	the	the	DET
dti-3060	23	15	breakdown	breakdown	NOUN
dti-3060	23	16	of	of	ADP
dti-3060	23	17	vital	vital	ADJ
dti-3060	23	18	mitochondrial	mitochondrial	ADJ
dti-3060	23	19	enzymes	enzyme	NOUN
dti-3060	23	20	,	,	PUNCT
dti-3060	23	21	along	along	ADP
dti-3060	23	22	with	with	ADP
dti-3060	23	23	those	those	PRON
dti-3060	23	24	released	release	VERB
dti-3060	23	25	during	during	ADP
dti-3060	23	26	rna	rna	NOUN
dti-3060	23	27	processing	processing	NOUN
dti-3060	23	28	,	,	PUNCT
dti-3060	23	29	gene	gene	NOUN
dti-3060	23	30	transcription	transcription	NOUN
dti-3060	23	31	,	,	PUNCT
dti-3060	23	32	and	and	CCONJ
dti-3060	23	33	inflammatory	inflammatory	ADJ
dti-3060	23	34	processes	process	NOUN
dti-3060	23	35	,	,	PUNCT
dti-3060	23	36	causes	cause	VERB
dti-3060	23	37	liver	liver	NOUN
dti-3060	23	38	and	and	CCONJ
dti-3060	23	39	kidneys	kidney	NOUN
dti-3060	23	40	to	to	PART
dti-3060	23	41	suffer	suffer	VERB
dti-3060	23	42	from	from	ADP
dti-3060	23	43	oxidative	oxidative	ADJ
dti-3060	23	44	stress	stress	NOUN
dti-3060	23	45	and	and	CCONJ
dti-3060	23	46	cellular	cellular	ADJ
dti-3060	23	47	damage	damage	NOUN
dti-3060	23	48	(	(	PUNCT
dti-3060	23	49	5	5	NUM
dti-3060	23	50	)	)	PUNCT
dti-3060	23	51	.	.	PUNCT
dti-3060	24	1	introduction	introduction	NOUN
dti-3060	24	2	levofloxacin	levofloxacin	PROPN
dti-3060	24	3	is	be	AUX
dti-3060	24	4	a	a	DET
dti-3060	24	5	third	third	ADJ
dti-3060	24	6	-	-	PUNCT
dti-3060	24	7	generation	generation	NOUN
dti-3060	24	8	antibiotic	antibiotic	NOUN
dti-3060	24	9	that	that	PRON
dti-3060	24	10	belongs	belong	VERB
dti-3060	24	11	to	to	ADP
dti-3060	24	12	the	the	DET
dti-3060	24	13	class	class	NOUN
dti-3060	24	14	of	of	ADP
dti-3060	24	15	fluoroquinolones	fluoroquinolone	NOUN
dti-3060	24	16	.	.	PUNCT
dti-3060	25	1	it	it	PRON
dti-3060	25	2	has	have	VERB
dti-3060	25	3	more	more	ADJ
dti-3060	25	4	efficacy	efficacy	NOUN
dti-3060	25	5	against	against	ADP
dti-3060	25	6	positively	positively	ADV
dti-3060	25	7	staining	stain	VERB
dti-3060	25	8	bacteria	bacteria	NOUN
dti-3060	25	9	and	and	CCONJ
dti-3060	25	10	uncommon	uncommon	ADJ
dti-3060	25	11	intracellular	intracellular	ADJ
dti-3060	25	12	pathogens	pathogen	NOUN
dti-3060	25	13	than	than	ADP
dti-3060	25	14	prior	prior	ADJ
dti-3060	25	15	generations	generation	NOUN
dti-3060	25	16	of	of	ADP
dti-3060	25	17	fluoroquinolones	fluoroquinolone	NOUN
dti-3060	25	18	.	.	PUNCT
dti-3060	26	1	levofloxacin	levofloxacin	PROPN
dti-3060	26	2	works	work	VERB
dti-3060	26	3	by	by	ADP
dti-3060	26	4	inhibiting	inhibit	VERB
dti-3060	26	5	bacterial	bacterial	ADJ
dti-3060	26	6	type	type	NOUN
dti-3060	26	7	ii	ii	NOUN
dti-3060	26	8	topoisomerases	topoisomerase	NOUN
dti-3060	26	9	,	,	PUNCT
dti-3060	26	10	particularly	particularly	ADV
dti-3060	26	11	the	the	DET
dti-3060	26	12	enzymes	enzyme	NOUN
dti-3060	26	13	topoisomerase	topoisomerase	VERB
dti-3060	26	14	iv	iv	NUM
dti-3060	26	15	(	(	PUNCT
dti-3060	26	16	topo	topo	PROPN
dti-3060	26	17	iv	iv	NUM
dti-3060	26	18	)	)	PUNCT
dti-3060	26	19	and	and	CCONJ
dti-3060	26	20	bacterial	bacterial	ADJ
dti-3060	26	21	dna	dna	PROPN
dti-3060	26	22	gyrase	gyrase	NOUN
dti-3060	26	23	.	.	PUNCT
dti-3060	27	1	in	in	ADP
dti-3060	27	2	human	human	ADJ
dti-3060	27	3	medicine	medicine	NOUN
dti-3060	27	4	,	,	PUNCT
dti-3060	27	5	levofloxacin	levofloxacin	PROPN
dti-3060	27	6	is	be	AUX
dti-3060	27	7	used	use	VERB
dti-3060	27	8	to	to	PART
dti-3060	27	9	treat	treat	VERB
dti-3060	27	10	acute	acute	NOUN
dti-3060	27	11	rhinosinusitis	rhinosinusitis	NOUN
dti-3060	27	12	,	,	PUNCT
dti-3060	27	13	chronic	chronic	ADJ
dti-3060	27	14	bronchitis	bronchitis	NOUN
dti-3060	27	15	,	,	PUNCT
dti-3060	27	16	https://doi.org/10.33393/dti.2024.3060	https://doi.org/10.33393/dti.2024.3060	NOUN
dti-3060	27	17	https://doi.org/dti.2022.2522	https://doi.org/dti.2022.2522	PROPN
dti-3060	27	18	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NUM
dti-3060	27	19	https://orcid.org/0009-0002-5252-1214	https://orcid.org/0009-0002-5252-1214	ADJ
dti-3060	27	20	https://orcid.org/0009-0004-6520-5215	https://orcid.org/0009-0004-6520-5215	VERB
dti-3060	27	21	https://orcid.org/0000-0003-1400-9906	https://orcid.org/0000-0003-1400-9906	PROPN
dti-3060	27	22	mailto:majeeda.rasheed@kfueit.edu.pk	mailto:majeeda.rasheed@kfueit.edu.pk	PROPN
dti-3060	27	23	aslam	aslam	PROPN
dti-3060	27	24	et	et	PROPN
dti-3060	27	25	al	al	PROPN
dti-3060	27	26	drug	drug	PROPN
dti-3060	27	27	target	target	NOUN
dti-3060	27	28	insights	insight	NOUN
dti-3060	27	29	2024	2024	NUM
dti-3060	27	30	;	;	PUNCT
dti-3060	27	31	18	18	NUM
dti-3060	27	32	:	:	SYM
dti-3060	27	33	79	79	NUM
dti-3060	27	34	©	©	ADP
dti-3060	27	35	2024	2024	NUM
dti-3060	27	36	the	the	DET
dti-3060	27	37	authors	author	NOUN
dti-3060	27	38	.	.	PUNCT
dti-3060	28	1	published	publish	VERB
dti-3060	28	2	by	by	ADP
dti-3060	28	3	aboutscience	aboutscience	NOUN
dti-3060	28	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-3060	28	5	the	the	DET
dti-3060	28	6	prior	prior	ADJ
dti-3060	28	7	work	work	NOUN
dti-3060	28	8	using	use	VERB
dti-3060	28	9	animal	animal	NOUN
dti-3060	28	10	models	model	NOUN
dti-3060	28	11	demonstrated	demonstrate	VERB
dti-3060	28	12	that	that	SCONJ
dti-3060	28	13	fluoroquinolones	fluoroquinolone	NOUN
dti-3060	28	14	were	be	AUX
dti-3060	28	15	involved	involve	VERB
dti-3060	28	16	in	in	ADP
dti-3060	28	17	the	the	DET
dti-3060	28	18	formation	formation	NOUN
dti-3060	28	19	of	of	ADP
dti-3060	28	20	reactive	reactive	ADJ
dti-3060	28	21	oxygen	oxygen	NOUN
dti-3060	28	22	molecules	molecule	NOUN
dti-3060	28	23	,	,	PUNCT
dti-3060	28	24	which	which	PRON
dti-3060	28	25	is	be	AUX
dti-3060	28	26	what	what	PRON
dti-3060	28	27	causes	cause	VERB
dti-3060	28	28	oxidative	oxidative	ADJ
dti-3060	28	29	stress	stress	NOUN
dti-3060	28	30	(	(	PUNCT
dti-3060	28	31	4	4	NUM
dti-3060	28	32	)	)	PUNCT
dti-3060	28	33	.	.	PUNCT
dti-3060	29	1	oxidative	oxidative	ADJ
dti-3060	29	2	stress	stress	NOUN
dti-3060	29	3	is	be	AUX
dti-3060	29	4	a	a	DET
dti-3060	29	5	shift	shift	NOUN
dti-3060	29	6	in	in	ADP
dti-3060	29	7	pro	pro	ADJ
dti-3060	29	8	-	-	ADJ
dti-3060	29	9	oxidant	oxidant	ADJ
dti-3060	29	10	and	and	CCONJ
dti-3060	29	11	antioxidant	antioxidant	ADJ
dti-3060	29	12	balance	balance	NOUN
dti-3060	29	13	in	in	ADP
dti-3060	29	14	favor	favor	NOUN
dti-3060	29	15	of	of	ADP
dti-3060	29	16	oxidants	oxidant	NOUN
dti-3060	29	17	,	,	PUNCT
dti-3060	29	18	resulting	result	VERB
dti-3060	29	19	in	in	ADP
dti-3060	29	20	redox	redox	ADJ
dti-3060	29	21	signaling	signal	VERB
dti-3060	29	22	/	/	SYM
dti-3060	29	23	control	control	NOUN
dti-3060	29	24	disruption	disruption	NOUN
dti-3060	29	25	and	and	CCONJ
dti-3060	29	26	molecular	molecular	ADJ
dti-3060	29	27	damage	damage	NOUN
dti-3060	29	28	(	(	PUNCT
dti-3060	29	29	6	6	NUM
dti-3060	29	30	)	)	PUNCT
dti-3060	29	31	.	.	PUNCT
dti-3060	30	1	ros	ros	PROPN
dti-3060	30	2	can	can	AUX
dti-3060	30	3	be	be	AUX
dti-3060	30	4	produced	produce	VERB
dti-3060	30	5	either	either	CCONJ
dti-3060	30	6	exogenously	exogenously	ADV
dti-3060	30	7	by	by	ADP
dti-3060	30	8	ultraviolet	ultraviolet	NOUN
dti-3060	30	9	(	(	PUNCT
dti-3060	30	10	uv	uv	NOUN
dti-3060	30	11	)	)	PUNCT
dti-3060	30	12	light	light	NOUN
dti-3060	30	13	,	,	PUNCT
dti-3060	30	14	ionizing	ionize	VERB
dti-3060	30	15	radiation	radiation	NOUN
dti-3060	30	16	,	,	PUNCT
dti-3060	30	17	pollutants	pollutant	NOUN
dti-3060	30	18	,	,	PUNCT
dti-3060	30	19	and	and	CCONJ
dti-3060	30	20	nitroaromatics	nitroaromatic	NOUN
dti-3060	30	21	or	or	CCONJ
dti-3060	30	22	intracellularly	intracellularly	ADV
dti-3060	30	23	by	by	ADP
dti-3060	30	24	cytosolic	cytosolic	ADJ
dti-3060	30	25	enzyme	enzyme	NOUN
dti-3060	30	26	systems	system	NOUN
dti-3060	30	27	during	during	ADP
dti-3060	30	28	the	the	DET
dti-3060	30	29	course	course	NOUN
dti-3060	30	30	of	of	ADP
dti-3060	30	31	a	a	DET
dti-3060	30	32	variety	variety	NOUN
dti-3060	30	33	of	of	ADP
dti-3060	30	34	physiological	physiological	ADJ
dti-3060	30	35	and	and	CCONJ
dti-3060	30	36	biochemical	biochemical	ADJ
dti-3060	30	37	processes	process	NOUN
dti-3060	30	38	(	(	PUNCT
dti-3060	30	39	7	7	NUM
dti-3060	30	40	)	)	PUNCT
dti-3060	30	41	.	.	PUNCT
dti-3060	31	1	moreover	moreover	ADV
dti-3060	31	2	,	,	PUNCT
dti-3060	31	3	levofloxacin	levofloxacin	PROPN
dti-3060	31	4	was	be	AUX
dti-3060	31	5	shown	show	VERB
dti-3060	31	6	to	to	PART
dti-3060	31	7	increase	increase	VERB
dti-3060	31	8	lipid	lipid	ADJ
dti-3060	31	9	peroxidation	peroxidation	NOUN
dti-3060	31	10	,	,	PUNCT
dti-3060	31	11	no	no	DET
dti-3060	31	12	production	production	NOUN
dti-3060	31	13	,	,	PUNCT
dti-3060	31	14	and	and	CCONJ
dti-3060	31	15	superoxide	superoxide	NOUN
dti-3060	31	16	dismutase	dismutase	NOUN
dti-3060	31	17	(	(	PUNCT
dti-3060	31	18	sod	sod	NOUN
dti-3060	31	19	)	)	PUNCT
dti-3060	31	20	activity	activity	NOUN
dti-3060	31	21	in	in	ADP
dti-3060	31	22	cortex	cortex	NOUN
dti-3060	31	23	,	,	PUNCT
dti-3060	31	24	corpus	corpus	NOUN
dti-3060	31	25	striatum	striatum	NOUN
dti-3060	31	26	,	,	PUNCT
dti-3060	31	27	and	and	CCONJ
dti-3060	31	28	hippocampus	hippocampus	NOUN
dti-3060	31	29	(	(	PUNCT
dti-3060	31	30	8)	8)	NUM
dti-3060	31	31	.	.	PUNCT
dti-3060	32	1	the	the	DET
dti-3060	32	2	normal	normal	ADJ
dti-3060	32	3	lifespan	lifespan	NOUN
dti-3060	32	4	of	of	ADP
dti-3060	32	5	circulating	circulate	VERB
dti-3060	32	6	erythrocytes	erythrocyte	NOUN
dti-3060	32	7	is	be	AUX
dti-3060	32	8	100	100	NUM
dti-3060	32	9	–	–	SYM
dti-3060	32	10	120	120	NUM
dti-3060	32	11	days	day	NOUN
dti-3060	32	12	owing	owe	VERB
dti-3060	32	13	to	to	ADP
dti-3060	32	14	erythrocyte	erythrocyte	NOUN
dti-3060	32	15	aging	aging	NOUN
dti-3060	32	16	.	.	PUNCT
dti-3060	33	1	prior	prior	ADV
dti-3060	33	2	to	to	ADP
dti-3060	33	3	that	that	PRON
dti-3060	33	4	,	,	PUNCT
dti-3060	33	5	erythrocytes	erythrocyte	NOUN
dti-3060	33	6	are	be	AUX
dti-3060	33	7	rapidly	rapidly	ADV
dti-3060	33	8	removed	remove	VERB
dti-3060	33	9	from	from	ADP
dti-3060	33	10	circulation	circulation	NOUN
dti-3060	33	11	(	(	PUNCT
dti-3060	33	12	9	9	NUM
dti-3060	33	13	)	)	PUNCT
dti-3060	33	14	.	.	PUNCT
dti-3060	34	1	eryptosis	eryptosis	NOUN
dti-3060	34	2	is	be	AUX
dti-3060	34	3	the	the	DET
dti-3060	34	4	self	self	NOUN
dti-3060	34	5	-	-	PUNCT
dti-3060	34	6	destruction	destruction	NOUN
dti-3060	34	7	of	of	ADP
dti-3060	34	8	erythrocytes	erythrocyte	NOUN
dti-3060	34	9	that	that	PRON
dti-3060	34	10	eliminates	eliminate	VERB
dti-3060	34	11	old	old	ADJ
dti-3060	34	12	or	or	CCONJ
dti-3060	34	13	superfluous	superfluous	ADJ
dti-3060	34	14	erythrocytes	erythrocyte	NOUN
dti-3060	34	15	from	from	ADP
dti-3060	34	16	circulation	circulation	NOUN
dti-3060	34	17	,	,	PUNCT
dti-3060	34	18	characterized	characterize	VERB
dti-3060	34	19	by	by	ADP
dti-3060	34	20	erythrocyte	erythrocyte	ADJ
dti-3060	34	21	membrane	membrane	NOUN
dti-3060	34	22	perturbation	perturbation	NOUN
dti-3060	34	23	,	,	PUNCT
dti-3060	34	24	which	which	PRON
dti-3060	34	25	results	result	VERB
dti-3060	34	26	in	in	ADP
dti-3060	34	27	the	the	DET
dti-3060	34	28	dismantling	dismantling	NOUN
dti-3060	34	29	of	of	ADP
dti-3060	34	30	plasma	plasma	NOUN
dti-3060	34	31	membrane	membrane	NOUN
dti-3060	34	32	symmetry	symmetry	NOUN
dti-3060	34	33	and	and	CCONJ
dti-3060	34	34	the	the	DET
dti-3060	34	35	exposure	exposure	NOUN
dti-3060	34	36	of	of	ADP
dti-3060	34	37	phosphatidylserine	phosphatidylserine	NOUN
dti-3060	34	38	flipping	flip	VERB
dti-3060	34	39	from	from	ADP
dti-3060	34	40	the	the	DET
dti-3060	34	41	interior	interior	NOUN
dti-3060	34	42	to	to	ADP
dti-3060	34	43	the	the	DET
dti-3060	34	44	plasma	plasma	NOUN
dti-3060	34	45	membrane	membrane	NOUN
dti-3060	34	46	surface	surface	NOUN
dti-3060	34	47	(	(	PUNCT
dti-3060	34	48	10,11	10,11	NUM
dti-3060	34	49	)	)	PUNCT
dti-3060	34	50	.	.	PUNCT
dti-3060	35	1	oxidative	oxidative	ADJ
dti-3060	35	2	stress	stress	NOUN
dti-3060	35	3	activates	activate	VERB
dti-3060	35	4	several	several	ADJ
dti-3060	35	5	factors	factor	NOUN
dti-3060	35	6	that	that	PRON
dti-3060	35	7	cause	cause	VERB
dti-3060	35	8	erythrocyte	erythrocyte	NOUN
dti-3060	35	9	suicide	suicide	NOUN
dti-3060	35	10	,	,	PUNCT
dti-3060	35	11	including	include	VERB
dti-3060	35	12	opening	opening	NOUN
dti-3060	35	13	of	of	ADP
dti-3060	35	14	ca+2	ca+2	PROPN
dti-3060	35	15	channels	channel	NOUN
dti-3060	35	16	,	,	PUNCT
dti-3060	35	17	caspase	caspase	NOUN
dti-3060	35	18	activation	activation	NOUN
dti-3060	35	19	,	,	PUNCT
dti-3060	35	20	and	and	CCONJ
dti-3060	35	21	the	the	DET
dti-3060	35	22	formation	formation	NOUN
dti-3060	35	23	of	of	ADP
dti-3060	35	24	phospholipase	phospholipase	NOUN
dti-3060	35	25	a2	a2	PROPN
dti-3060	35	26	(	(	PUNCT
dti-3060	35	27	pla-2)-induced	pla-2)-induced	ADJ
dti-3060	35	28	platelet	platelet	NOUN
dti-3060	35	29	-	-	PUNCT
dti-3060	35	30	activating	activate	VERB
dti-3060	35	31	factor	factor	NOUN
dti-3060	35	32	(	(	PUNCT
dti-3060	35	33	paf	paf	PROPN
dti-3060	35	34	)	)	PUNCT
dti-3060	35	35	,	,	PUNCT
dti-3060	35	36	which	which	PRON
dti-3060	35	37	stimulate	stimulate	VERB
dti-3060	35	38	cellular	cellular	ADJ
dti-3060	35	39	ceramide	ceramide	NOUN
dti-3060	35	40	generation	generation	NOUN
dti-3060	35	41	through	through	ADP
dti-3060	35	42	stimulating	stimulate	VERB
dti-3060	35	43	sphingomyelinase	sphingomyelinase	PROPN
dti-3060	35	44	.	.	PUNCT
dti-3060	36	1	increased	increase	VERB
dti-3060	36	2	cytosolic	cytosolic	ADJ
dti-3060	36	3	ca++	ca++	NOUN
dti-3060	36	4	ions	ion	NOUN
dti-3060	36	5	and	and	CCONJ
dti-3060	36	6	ceramide	ceramide	NOUN
dti-3060	36	7	levels	level	NOUN
dti-3060	36	8	cause	cause	VERB
dti-3060	36	9	phosphatidylserine	phosphatidylserine	NOUN
dti-3060	36	10	exposure	exposure	NOUN
dti-3060	36	11	via	via	ADP
dti-3060	36	12	membrane	membrane	NOUN
dti-3060	36	13	scrambling	scrambling	NOUN
dti-3060	36	14	.	.	PUNCT
dti-3060	37	1	phosphatidylserine	phosphatidylserine	NOUN
dti-3060	37	2	(	(	PUNCT
dti-3060	37	3	ps)-exposed	ps)-expose	VERB
dti-3060	37	4	erythrocytes	erythrocyte	NOUN
dti-3060	37	5	apparently	apparently	ADV
dti-3060	37	6	attached	attach	VERB
dti-3060	37	7	to	to	ADP
dti-3060	37	8	thrombospondin	thrombospondin	VERB
dti-3060	37	9	(	(	PUNCT
dti-3060	37	10	tsp	tsp	NOUN
dti-3060	37	11	)	)	PUNCT
dti-3060	37	12	are	be	AUX
dti-3060	37	13	recognized	recognize	VERB
dti-3060	37	14	by	by	ADP
dti-3060	37	15	ps	ps	NOUN
dti-3060	37	16	receptors	receptor	NOUN
dti-3060	37	17	such	such	ADJ
dti-3060	37	18	as	as	ADP
dti-3060	37	19	psr-1	psr-1	VERB
dti-3060	37	20	,	,	PUNCT
dti-3060	37	21	and	and	CCONJ
dti-3060	37	22	are	be	AUX
dti-3060	37	23	removed	remove	VERB
dti-3060	37	24	from	from	ADP
dti-3060	37	25	circulating	circulate	VERB
dti-3060	37	26	blood	blood	NOUN
dti-3060	37	27	.	.	PUNCT
dti-3060	38	1	furthermore	furthermore	ADV
dti-3060	38	2	,	,	PUNCT
dti-3060	38	3	calcium	calcium	NOUN
dti-3060	38	4	stimulates	stimulate	NOUN
dti-3060	38	5	ca	ca	NOUN
dti-3060	38	6	-	-	PUNCT
dti-3060	38	7	sensitive	sensitive	ADJ
dti-3060	38	8	k+	k+	PROPN
dti-3060	38	9	channel	channel	PROPN
dti-3060	38	10	,	,	PUNCT
dti-3060	38	11	which	which	PRON
dti-3060	38	12	results	result	VERB
dti-3060	38	13	in	in	ADP
dti-3060	38	14	kcl	kcl	PROPN
dti-3060	38	15	loss	loss	NOUN
dti-3060	38	16	with	with	ADP
dti-3060	38	17	water	water	NOUN
dti-3060	38	18	that	that	PRON
dti-3060	38	19	leads	lead	VERB
dti-3060	38	20	to	to	ADP
dti-3060	38	21	cell	cell	NOUN
dti-3060	38	22	shrinkage	shrinkage	NOUN
dti-3060	38	23	,	,	PUNCT
dti-3060	38	24	and	and	CCONJ
dti-3060	38	25	activates	activate	VERB
dti-3060	38	26	calpain	calpain	NOUN
dti-3060	38	27	,	,	PUNCT
dti-3060	38	28	a	a	DET
dti-3060	38	29	protease	protease	NOUN
dti-3060	38	30	,	,	PUNCT
dti-3060	38	31	resulting	result	VERB
dti-3060	38	32	in	in	ADP
dti-3060	38	33	cytoskeleton	cytoskeleton	NOUN
dti-3060	38	34	destruction	destruction	NOUN
dti-3060	38	35	(	(	PUNCT
dti-3060	38	36	9,12	9,12	NUM
dti-3060	38	37	)	)	PUNCT
dti-3060	38	38	.	.	PUNCT
dti-3060	39	1	a	a	DET
dti-3060	39	2	number	number	NOUN
dti-3060	39	3	of	of	ADP
dti-3060	39	4	xenobiotics	xenobiotic	NOUN
dti-3060	39	5	have	have	AUX
dti-3060	39	6	been	be	AUX
dti-3060	39	7	reported	report	VERB
dti-3060	39	8	to	to	PART
dti-3060	39	9	induce	induce	VERB
dti-3060	39	10	eryptosis	eryptosis	NOUN
dti-3060	39	11	associated	associate	VERB
dti-3060	39	12	with	with	ADP
dti-3060	39	13	the	the	DET
dti-3060	39	14	conditions	condition	NOUN
dti-3060	39	15	such	such	ADJ
dti-3060	39	16	as	as	ADP
dti-3060	39	17	anemia	anemia	NOUN
dti-3060	39	18	,	,	PUNCT
dti-3060	39	19	diabetes	diabetes	NOUN
dti-3060	39	20	,	,	PUNCT
dti-3060	39	21	cancer	cancer	NOUN
dti-3060	39	22	,	,	PUNCT
dti-3060	39	23	cardiovascular	cardiovascular	ADJ
dti-3060	39	24	and	and	CCONJ
dti-3060	39	25	liver	liver	NOUN
dti-3060	39	26	complications	complication	NOUN
dti-3060	39	27	,	,	PUNCT
dti-3060	39	28	uremia	uremia	NOUN
dti-3060	39	29	,	,	PUNCT
dti-3060	39	30	and	and	CCONJ
dti-3060	39	31	chronic	chronic	ADJ
dti-3060	39	32	kidney	kidney	NOUN
dti-3060	39	33	disease	disease	NOUN
dti-3060	39	34	(	(	PUNCT
dti-3060	39	35	13,14	13,14	NUM
dti-3060	39	36	)	)	PUNCT
dti-3060	39	37	.	.	PUNCT
dti-3060	40	1	levofloxacin	levofloxacin	NOUN
dti-3060	40	2	-	-	PUNCT
dti-3060	40	3	induced	induce	VERB
dti-3060	40	4	oxidative	oxidative	ADJ
dti-3060	40	5	stress	stress	NOUN
dti-3060	40	6	and	and	CCONJ
dti-3060	40	7	anemia	anemia	NOUN
dti-3060	40	8	are	be	AUX
dti-3060	40	9	rarely	rarely	ADV
dti-3060	40	10	reported	report	VERB
dti-3060	40	11	in	in	ADP
dti-3060	40	12	the	the	DET
dti-3060	40	13	literature	literature	NOUN
dti-3060	40	14	.	.	PUNCT
dti-3060	41	1	this	this	DET
dti-3060	41	2	research	research	NOUN
dti-3060	41	3	was	be	AUX
dti-3060	41	4	designed	design	VERB
dti-3060	41	5	with	with	ADP
dti-3060	41	6	the	the	DET
dti-3060	41	7	intention	intention	NOUN
dti-3060	41	8	to	to	PART
dti-3060	41	9	look	look	VERB
dti-3060	41	10	into	into	ADP
dti-3060	41	11	the	the	DET
dti-3060	41	12	involvement	involvement	NOUN
dti-3060	41	13	of	of	ADP
dti-3060	41	14	levofloxacin	levofloxacin	NOUN
dti-3060	41	15	in	in	ADP
dti-3060	41	16	the	the	DET
dti-3060	41	17	induction	induction	NOUN
dti-3060	41	18	of	of	ADP
dti-3060	41	19	eryptosis	eryptosis	NOUN
dti-3060	41	20	by	by	ADP
dti-3060	41	21	oxidative	oxidative	ADJ
dti-3060	41	22	stress	stress	NOUN
dti-3060	41	23	.	.	PUNCT
dti-3060	42	1	isolated	isolate	VERB
dti-3060	42	2	human	human	ADJ
dti-3060	42	3	red	red	ADJ
dti-3060	42	4	cells	cell	NOUN
dti-3060	42	5	were	be	AUX
dti-3060	42	6	given	give	VERB
dti-3060	42	7	with	with	ADP
dti-3060	42	8	therapeutic	therapeutic	ADJ
dti-3060	42	9	dosages	dosage	NOUN
dti-3060	42	10	of	of	ADP
dti-3060	42	11	levofloxacin	levofloxacin	NOUN
dti-3060	42	12	in	in	ADP
dti-3060	42	13	order	order	NOUN
dti-3060	42	14	to	to	PART
dti-3060	42	15	evaluate	evaluate	VERB
dti-3060	42	16	its	its	PRON
dti-3060	42	17	eryptotic	eryptotic	ADJ
dti-3060	42	18	,	,	PUNCT
dti-3060	42	19	oxidizing	oxidizing	NOUN
dti-3060	42	20	,	,	PUNCT
dti-3060	42	21	and	and	CCONJ
dti-3060	42	22	hemolyzing	hemolyze	VERB
dti-3060	42	23	or	or	CCONJ
dti-3060	42	24	cytotoxic	cytotoxic	ADJ
dti-3060	42	25	effects	effect	NOUN
dti-3060	42	26	on	on	ADP
dti-3060	42	27	red	red	ADJ
dti-3060	42	28	cells	cell	NOUN
dti-3060	42	29	.	.	PUNCT
dti-3060	43	1	materials	material	NOUN
dti-3060	43	2	and	and	CCONJ
dti-3060	43	3	methods	method	NOUN
dti-3060	43	4	noninfectious	noninfectious	ADJ
dti-3060	43	5	screened	screen	VERB
dti-3060	43	6	blood	blood	NOUN
dti-3060	43	7	samples	sample	NOUN
dti-3060	43	8	in	in	ADP
dti-3060	43	9	heparin	heparin	ADJ
dti-3060	43	10	tubes	tube	NOUN
dti-3060	43	11	were	be	AUX
dti-3060	43	12	generously	generously	ADV
dti-3060	43	13	supplied	supply	VERB
dti-3060	43	14	by	by	ADP
dti-3060	43	15	the	the	DET
dti-3060	43	16	blood	blood	NOUN
dti-3060	43	17	bank	bank	NOUN
dti-3060	43	18	at	at	ADP
dti-3060	43	19	the	the	DET
dti-3060	43	20	allied	allied	ADJ
dti-3060	43	21	hospital	hospital	NOUN
dti-3060	43	22	,	,	PUNCT
dti-3060	43	23	faisalabad	faisalabad	PROPN
dti-3060	43	24	.	.	PUNCT
dti-3060	44	1	leukocyte	leukocyte	ADJ
dti-3060	44	2	-	-	PUNCT
dti-3060	44	3	free	free	ADJ
dti-3060	44	4	erythrocytes	erythrocyte	NOUN
dti-3060	44	5	were	be	AUX
dti-3060	44	6	isolated	isolate	VERB
dti-3060	44	7	by	by	ADP
dti-3060	44	8	depleting	deplete	VERB
dti-3060	44	9	the	the	DET
dti-3060	44	10	white	white	ADJ
dti-3060	44	11	cells	cell	NOUN
dti-3060	44	12	and	and	CCONJ
dti-3060	44	13	plasma	plasma	NOUN
dti-3060	44	14	from	from	ADP
dti-3060	44	15	the	the	DET
dti-3060	44	16	whole	whole	ADJ
dti-3060	44	17	blood	blood	NOUN
dti-3060	44	18	samples	sample	NOUN
dti-3060	44	19	following	follow	VERB
dti-3060	44	20	the	the	DET
dti-3060	44	21	protocol	protocol	NOUN
dti-3060	44	22	of	of	ADP
dti-3060	44	23	fink	fink	PROPN
dti-3060	44	24	et	et	PROPN
dti-3060	44	25	al	al	PROPN
dti-3060	44	26	.	.	PUNCT
dti-3060	45	1	the	the	DET
dti-3060	45	2	whole	whole	ADJ
dti-3060	45	3	blood	blood	NOUN
dti-3060	45	4	samples	sample	NOUN
dti-3060	45	5	were	be	AUX
dti-3060	45	6	spun	spin	VERB
dti-3060	45	7	up	up	ADP
dti-3060	45	8	at	at	ADP
dti-3060	45	9	1500	1500	NUM
dti-3060	45	10	rpm	rpm	NOUN
dti-3060	45	11	for	for	ADP
dti-3060	45	12	15	15	NUM
dti-3060	45	13	-	-	SYM
dti-3060	45	14	20	20	NUM
dti-3060	45	15	minutes	minute	NOUN
dti-3060	45	16	at	at	ADP
dti-3060	45	17	21	21	NUM
dti-3060	45	18	°	°	ADP
dti-3060	45	19	c	c	NOUN
dti-3060	45	20	and	and	CCONJ
dti-3060	45	21	the	the	DET
dti-3060	45	22	leukocyte	leukocyte	NOUN
dti-3060	45	23	and	and	CCONJ
dti-3060	45	24	platelet	platelet	ADJ
dti-3060	45	25	-	-	PUNCT
dti-3060	45	26	rich	rich	ADJ
dti-3060	45	27	afloat	afloat	ADJ
dti-3060	45	28	supernatant	supernatant	NOUN
dti-3060	45	29	was	be	AUX
dti-3060	45	30	discarded	discard	VERB
dti-3060	45	31	(	(	PUNCT
dti-3060	45	32	15	15	NUM
dti-3060	45	33	)	)	PUNCT
dti-3060	45	34	.	.	PUNCT
dti-3060	46	1	the	the	DET
dti-3060	46	2	sorted	sort	VERB
dti-3060	46	3	red	red	ADJ
dti-3060	46	4	blood	blood	NOUN
dti-3060	46	5	cells	cell	NOUN
dti-3060	46	6	were	be	AUX
dti-3060	46	7	put	put	VERB
dti-3060	46	8	into	into	ADP
dti-3060	46	9	microcentrifuge	microcentrifuge	ADJ
dti-3060	46	10	tubes	tube	NOUN
dti-3060	46	11	,	,	PUNCT
dti-3060	46	12	and	and	CCONJ
dti-3060	46	13	they	they	PRON
dti-3060	46	14	were	be	AUX
dti-3060	46	15	incubated	incubate	VERB
dti-3060	46	16	for	for	ADP
dti-3060	46	17	48	48	NUM
dti-3060	46	18	hours	hour	NOUN
dti-3060	46	19	at	at	ADP
dti-3060	46	20	37	37	NUM
dti-3060	46	21	°	°	NOUN
dti-3060	46	22	celsius	celsius	NOUN
dti-3060	46	23	and	and	CCONJ
dti-3060	46	24	ph	ph	NOUN
dti-3060	46	25	7.4	7.4	NUM
dti-3060	46	26	with	with	ADP
dti-3060	46	27	a	a	DET
dti-3060	46	28	0.4	0.4	NUM
dti-3060	46	29	%	%	NOUN
dti-3060	46	30	hematocrit	hematocrit	NOUN
dti-3060	46	31	volume	volume	NOUN
dti-3060	46	32	in	in	ADP
dti-3060	46	33	ringer	ringer	NOUN
dti-3060	46	34	solution	solution	NOUN
dti-3060	46	35	that	that	PRON
dti-3060	46	36	included	include	VERB
dti-3060	46	37	sodium	sodium	NOUN
dti-3060	46	38	chloride	chloride	NOUN
dti-3060	46	39	125	125	NUM
dti-3060	46	40	mm	mm	NOUN
dti-3060	46	41	,	,	PUNCT
dti-3060	46	42	potassium	potassium	NOUN
dti-3060	46	43	chloride	chloride	NOUN
dti-3060	46	44	5	5	NUM
dti-3060	46	45	mm	mm	NOUN
dti-3060	46	46	,	,	PUNCT
dti-3060	46	47	magnesium	magnesium	NOUN
dti-3060	46	48	silicate	silicate	NOUN
dti-3060	46	49	1	1	NUM
dti-3060	46	50	mm	mm	PROPN
dti-3060	46	51	,	,	PUNCT
dti-3060	46	52	hepes	hepe	NOUN
dti-3060	46	53	sodium	sodium	NOUN
dti-3060	46	54	salt	salt	NOUN
dti-3060	46	55	32	32	NUM
dti-3060	46	56	mm	mm	NOUN
dti-3060	46	57	,	,	PUNCT
dti-3060	46	58	glucose	glucose	NOUN
dti-3060	46	59	5	5	NUM
dti-3060	46	60	mm	mm	NOUN
dti-3060	46	61	,	,	PUNCT
dti-3060	46	62	and	and	CCONJ
dti-3060	46	63	calcium	calcium	NOUN
dti-3060	46	64	chloride	chloride	NOUN
dti-3060	46	65	1	1	NUM
dti-3060	46	66	mm	mm	NOUN
dti-3060	46	67	(	(	PUNCT
dti-3060	46	68	16	16	NUM
dti-3060	46	69	)	)	PUNCT
dti-3060	46	70	.	.	PUNCT
dti-3060	47	1	erythrocytes	erythrocyte	NOUN
dti-3060	47	2	were	be	AUX
dti-3060	47	3	exposed	expose	VERB
dti-3060	47	4	to	to	ADP
dti-3060	47	5	levofloxacin	levofloxacin	PROPN
dti-3060	47	6	(	(	PUNCT
dti-3060	47	7	getz	getz	ADJ
dti-3060	47	8	pharma	pharma	PROPN
dti-3060	47	9	pakistan	pakistan	PROPN
dti-3060	47	10	)	)	PUNCT
dti-3060	47	11	at	at	ADP
dti-3060	47	12	the	the	DET
dti-3060	47	13	physiological	physiological	ADJ
dti-3060	47	14	concentrations	concentration	NOUN
dti-3060	47	15	(	(	PUNCT
dti-3060	47	16	7	7	NUM
dti-3060	47	17	,	,	PUNCT
dti-3060	47	18	14	14	NUM
dti-3060	47	19	µm	µm	NOUN
dti-3060	47	20	)	)	PUNCT
dti-3060	47	21	.	.	PUNCT
dti-3060	48	1	levofloxacin	levofloxacin	PROPN
dti-3060	48	2	was	be	AUX
dti-3060	48	3	added	add	VERB
dti-3060	48	4	from	from	ADP
dti-3060	48	5	stock	stock	NOUN
dti-3060	48	6	solution	solution	NOUN
dti-3060	48	7	of	of	ADP
dti-3060	48	8	14	14	NUM
dti-3060	48	9	mm	mm	NOUN
dti-3060	48	10	prepared	prepare	VERB
dti-3060	48	11	by	by	ADP
dti-3060	48	12	dissolving	dissolve	VERB
dti-3060	48	13	levofloxacin	levofloxacin	NOUN
dti-3060	48	14	salt	salt	NOUN
dti-3060	48	15	in	in	ADP
dti-3060	48	16	dimethylsulfoxide	dimethylsulfoxide	ADV
dti-3060	48	17	(	(	PUNCT
dti-3060	48	18	dmso	dmso	NOUN
dti-3060	48	19	)	)	PUNCT
dti-3060	48	20	and	and	CCONJ
dti-3060	48	21	later	later	ADV
dti-3060	48	22	diluted	dilute	VERB
dti-3060	48	23	to	to	PART
dti-3060	48	24	get	get	VERB
dti-3060	48	25	the	the	DET
dti-3060	48	26	required	require	VERB
dti-3060	48	27	concentrations	concentration	NOUN
dti-3060	48	28	for	for	ADP
dti-3060	48	29	the	the	DET
dti-3060	48	30	experiments	experiment	NOUN
dti-3060	48	31	.	.	PUNCT
dti-3060	49	1	oxidative	oxidative	ADJ
dti-3060	49	2	stress	stress	NOUN
dti-3060	49	3	measurement	measurement	NOUN
dti-3060	49	4	antioxidant	antioxidant	NOUN
dti-3060	49	5	enzyme	enzyme	NOUN
dti-3060	49	6	assays	assay	NOUN
dti-3060	49	7	(	(	PUNCT
dti-3060	49	8	for	for	ADP
dti-3060	49	9	glutathione	glutathione	NOUN
dti-3060	49	10	peroxidase	peroxidase	NOUN
dti-3060	49	11	[	[	X
dti-3060	49	12	gpx	gpx	X
dti-3060	49	13	]	]	X
dti-3060	49	14	,	,	PUNCT
dti-3060	49	15	catalase	catalase	NOUN
dti-3060	49	16	,	,	PUNCT
dti-3060	49	17	and	and	CCONJ
dti-3060	49	18	sod	sod	NOUN
dti-3060	49	19	)	)	PUNCT
dti-3060	49	20	were	be	AUX
dti-3060	49	21	conducted	conduct	VERB
dti-3060	49	22	to	to	PART
dti-3060	49	23	assess	assess	VERB
dti-3060	49	24	the	the	DET
dti-3060	49	25	stress	stress	NOUN
dti-3060	49	26	levels	level	NOUN
dti-3060	49	27	of	of	ADP
dti-3060	49	28	erythrocytes	erythrocyte	NOUN
dti-3060	49	29	exposed	expose	VERB
dti-3060	49	30	to	to	ADP
dti-3060	49	31	levofloxacin	levofloxacin	PROPN
dti-3060	49	32	.	.	PUNCT
dti-3060	50	1	superoxide	superoxide	NOUN
dti-3060	50	2	dismutase	dismutase	NOUN
dti-3060	50	3	sod	sod	NOUN
dti-3060	50	4	activity	activity	NOUN
dti-3060	50	5	was	be	AUX
dti-3060	50	6	determined	determine	VERB
dti-3060	50	7	by	by	ADP
dti-3060	50	8	using	use	VERB
dti-3060	50	9	naveed	naveed	PROPN
dti-3060	50	10	et	et	PROPN
dti-3060	50	11	al	al	PROPN
dti-3060	50	12	’s	’s	PART
dti-3060	50	13	protocol	protocol	NOUN
dti-3060	50	14	(	(	PUNCT
dti-3060	50	15	17	17	NUM
dti-3060	50	16	)	)	PUNCT
dti-3060	50	17	.	.	PUNCT
dti-3060	51	1	the	the	DET
dti-3060	51	2	reaction	reaction	NOUN
dti-3060	51	3	mixture	mixture	NOUN
dti-3060	51	4	contained	contain	VERB
dti-3060	51	5	nitroblue	nitroblue	ADJ
dti-3060	51	6	tetrazolium	tetrazolium	NOUN
dti-3060	51	7	(	(	PUNCT
dti-3060	51	8	0.015	0.015	NUM
dti-3060	51	9	g	g	NOUN
dti-3060	51	10	in	in	ADP
dti-3060	51	11	17.5	17.5	NUM
dti-3060	51	12	ml	ml	NOUN
dti-3060	51	13	d	d	NOUN
dti-3060	51	14	-	-	PUNCT
dti-3060	51	15	h2o	h2o	NOUN
dti-3060	51	16	)	)	PUNCT
dti-3060	51	17	,	,	PUNCT
dti-3060	51	18	l	l	NOUN
dti-3060	51	19	-	-	NOUN
dti-3060	51	20	methionine	methionine	NOUN
dti-3060	51	21	(	(	PUNCT
dti-3060	51	22	0.222	0.222	NUM
dti-3060	51	23	g	g	NOUN
dti-3060	51	24	in	in	ADP
dti-3060	51	25	15	15	NUM
dti-3060	51	26	ml	ml	NOUN
dti-3060	51	27	d	d	PROPN
dti-3060	51	28	-	-	PUNCT
dti-3060	51	29	h2o	h2o	NOUN
dti-3060	51	30	)	)	PUNCT
dti-3060	51	31	,	,	PUNCT
dti-3060	51	32	triton	triton	PROPN
dti-3060	51	33	-	-	PROPN
dti-3060	51	34	x-100	x-100	PROPN
dti-3060	51	35	(	(	PUNCT
dti-3060	51	36	0.0375	0.0375	NUM
dti-3060	51	37	ml	ml	NOUN
dti-3060	51	38	in	in	ADP
dti-3060	51	39	17.5	17.5	NUM
dti-3060	51	40	ml	ml	NUM
dti-3060	51	41	h2o	h2o	PROPN
dti-3060	51	42	)	)	PUNCT
dti-3060	51	43	,	,	PUNCT
dti-3060	51	44	vitamin	vitamin	NOUN
dti-3060	51	45	b2	b2	NOUN
dti-3060	51	46	rib	rib	NOUN
dti-3060	51	47	(	(	PUNCT
dti-3060	51	48	0.0132	0.0132	NUM
dti-3060	51	49	g	g	NOUN
dti-3060	51	50	in	in	ADP
dti-3060	51	51	17.5	17.5	NUM
dti-3060	51	52	ml	ml	NOUN
dti-3060	51	53	d	d	NOUN
dti-3060	51	54	-	-	PUNCT
dti-3060	51	55	h2o	h2o	NOUN
dti-3060	51	56	)	)	PUNCT
dti-3060	51	57	,	,	PUNCT
dti-3060	51	58	and	and	CCONJ
dti-3060	51	59	phosphate	phosphate	ADJ
dti-3060	51	60	buffer	buffer	NOUN
dti-3060	51	61	of	of	ADP
dti-3060	51	62	ph	ph	ADJ
dti-3060	51	63	7.4	7.4	NUM
dti-3060	51	64	,	,	PUNCT
dti-3060	51	65	0.2	0.2	NUM
dti-3060	51	66	m.	m.	NOUN
dti-3060	51	67	the	the	DET
dti-3060	51	68	spectrophotometer	spectrophotometer	NOUN
dti-3060	51	69	value	value	NOUN
dti-3060	51	70	of	of	ADP
dti-3060	51	71	chromophore	chromophore	NOUN
dti-3060	51	72	was	be	AUX
dti-3060	51	73	taken	take	VERB
dti-3060	51	74	at	at	ADP
dti-3060	51	75	525	525	NUM
dti-3060	51	76	nm	nm	NOUN
dti-3060	51	77	.	.	PUNCT
dti-3060	52	1	glutathione	glutathione	NOUN
dti-3060	52	2	peroxidase	peroxidase	NOUN
dti-3060	52	3	using	use	VERB
dti-3060	52	4	the	the	DET
dti-3060	52	5	methodology	methodology	NOUN
dti-3060	52	6	described	describe	VERB
dti-3060	52	7	by	by	ADP
dti-3060	52	8	sattar	sattar	PROPN
dti-3060	52	9	et	et	PROPN
dti-3060	52	10	al	al	PROPN
dti-3060	52	11	(	(	PUNCT
dti-3060	52	12	18	18	NUM
dti-3060	52	13	)	)	PUNCT
dti-3060	52	14	,	,	PUNCT
dti-3060	52	15	gpx	gpx	NOUN
dti-3060	52	16	enzyme	enzyme	NOUN
dti-3060	52	17	activity	activity	NOUN
dti-3060	52	18	was	be	AUX
dti-3060	52	19	evaluated	evaluate	VERB
dti-3060	52	20	every	every	DET
dti-3060	52	21	20	20	NUM
dti-3060	52	22	seconds	second	NOUN
dti-3060	52	23	at	at	ADP
dti-3060	52	24	470	470	NUM
dti-3060	52	25	nm	nm	NOUN
dti-3060	52	26	using	use	VERB
dti-3060	52	27	spectrophotometer	spectrophotometer	NOUN
dti-3060	52	28	in	in	ADP
dti-3060	52	29	the	the	DET
dti-3060	52	30	reaction	reaction	NOUN
dti-3060	52	31	mixture	mixture	NOUN
dti-3060	52	32	containing	contain	VERB
dti-3060	52	33	guaiacol	guaiacol	NOUN
dti-3060	52	34	(	(	PUNCT
dti-3060	52	35	sigma	sigma	PROPN
dti-3060	52	36	-	-	PUNCT
dti-3060	52	37	aldrich	aldrich	NOUN
dti-3060	52	38	;	;	PUNCT
dti-3060	52	39	20	20	NUM
dti-3060	52	40	mm	mm	NOUN
dti-3060	52	41	)	)	PUNCT
dti-3060	52	42	,	,	PUNCT
dti-3060	52	43	phosphate	phosphate	ADJ
dti-3060	52	44	buffer	buffer	NOUN
dti-3060	52	45	of	of	ADP
dti-3060	52	46	ph	ph	ADJ
dti-3060	52	47	5	5	NUM
dti-3060	52	48	(	(	PUNCT
dti-3060	52	49	50	50	NUM
dti-3060	52	50	mm	mm	NOUN
dti-3060	52	51	)	)	PUNCT
dti-3060	52	52	,	,	PUNCT
dti-3060	52	53	hydrogen	hydrogen	NOUN
dti-3060	52	54	peroxide	peroxide	NOUN
dti-3060	52	55	(	(	PUNCT
dti-3060	52	56	40	40	NUM
dti-3060	52	57	mm	mm	NOUN
dti-3060	52	58	)	)	PUNCT
dti-3060	52	59	,	,	PUNCT
dti-3060	52	60	and	and	CCONJ
dti-3060	52	61	200	200	NUM
dti-3060	52	62	µl	µl	ADP
dti-3060	52	63	enzyme	enzyme	NOUN
dti-3060	52	64	extract	extract	NOUN
dti-3060	52	65	.	.	PUNCT
dti-3060	53	1	catalase	catalase	VERB
dti-3060	53	2	the	the	DET
dti-3060	53	3	assessment	assessment	NOUN
dti-3060	53	4	of	of	ADP
dti-3060	53	5	erythrocyte	erythrocyte	ADJ
dti-3060	53	6	catalase	catalase	NOUN
dti-3060	53	7	activity	activity	NOUN
dti-3060	53	8	followed	follow	VERB
dti-3060	53	9	the	the	DET
dti-3060	53	10	methodology	methodology	NOUN
dti-3060	53	11	outlined	outline	VERB
dti-3060	53	12	by	by	ADP
dti-3060	53	13	mukhtar	mukhtar	PROPN
dti-3060	53	14	et	et	PROPN
dti-3060	53	15	al	al	PROPN
dti-3060	53	16	(	(	PUNCT
dti-3060	53	17	19	19	NUM
dti-3060	53	18	)	)	PUNCT
dti-3060	53	19	.	.	PUNCT
dti-3060	54	1	the	the	DET
dti-3060	54	2	reaction	reaction	NOUN
dti-3060	54	3	cocktail	cocktail	NOUN
dti-3060	54	4	composed	compose	VERB
dti-3060	54	5	of	of	ADP
dti-3060	54	6	phosphate	phosphate	ADJ
dti-3060	54	7	buffer	buffer	NOUN
dti-3060	54	8	of	of	ADP
dti-3060	54	9	ph	ph	ADJ
dti-3060	54	10	7.4	7.4	NUM
dti-3060	54	11	(	(	PUNCT
dti-3060	54	12	50	50	NUM
dti-3060	54	13	mm	mm	NOUN
dti-3060	54	14	)	)	PUNCT
dti-3060	54	15	and	and	CCONJ
dti-3060	54	16	54	54	NUM
dti-3060	54	17	µl	µl	NOUN
dti-3060	54	18	of	of	ADP
dti-3060	54	19	5.9	5.9	NUM
dti-3060	54	20	nm	nm	ADJ
dti-3060	54	21	hydrogen	hydrogen	NOUN
dti-3060	54	22	peroxide	peroxide	NOUN
dti-3060	54	23	in	in	ADP
dti-3060	54	24	10	10	NUM
dti-3060	54	25	ml	ml	NOUN
dti-3060	54	26	water	water	NOUN
dti-3060	54	27	.	.	PUNCT
dti-3060	55	1	equal	equal	ADJ
dti-3060	55	2	proportions	proportion	NOUN
dti-3060	55	3	of	of	ADP
dti-3060	55	4	sample	sample	NOUN
dti-3060	55	5	and	and	CCONJ
dti-3060	55	6	reaction	reaction	NOUN
dti-3060	55	7	solution	solution	NOUN
dti-3060	55	8	were	be	AUX
dti-3060	55	9	placed	place	VERB
dti-3060	55	10	into	into	ADP
dti-3060	55	11	a	a	DET
dti-3060	55	12	multiwell	multiwell	ADJ
dti-3060	55	13	plate	plate	NOUN
dti-3060	55	14	(	(	PUNCT
dti-3060	55	15	96	96	NUM
dti-3060	55	16	wells	well	NOUN
dti-3060	55	17	)	)	PUNCT
dti-3060	55	18	,	,	PUNCT
dti-3060	55	19	and	and	CCONJ
dti-3060	55	20	the	the	DET
dti-3060	55	21	optical	optical	ADJ
dti-3060	55	22	density	density	NOUN
dti-3060	55	23	measured	measure	VERB
dti-3060	55	24	at	at	ADP
dti-3060	55	25	240	240	NUM
dti-3060	55	26	nm	nm	NOUN
dti-3060	55	27	using	use	VERB
dti-3060	55	28	biotek	biotek	NOUN
dti-3060	55	29	quant	quant	NOUN
dti-3060	55	30	.	.	PUNCT
dti-3060	56	1	cell	cell	NOUN
dti-3060	56	2	size	size	NOUN
dti-3060	56	3	measurements	measurement	VERB
dti-3060	56	4	variations	variation	NOUN
dti-3060	56	5	in	in	ADP
dti-3060	56	6	cell	cell	NOUN
dti-3060	56	7	dimensions	dimension	NOUN
dti-3060	56	8	were	be	AUX
dti-3060	56	9	ascertained	ascertain	VERB
dti-3060	56	10	by	by	ADP
dti-3060	56	11	calculating	calculate	VERB
dti-3060	56	12	the	the	DET
dti-3060	56	13	mean	mean	ADJ
dti-3060	56	14	cellular	cellular	ADJ
dti-3060	56	15	volume	volume	NOUN
dti-3060	56	16	(	(	PUNCT
dti-3060	56	17	mcv	mcv	PROPN
dti-3060	56	18	)	)	PUNCT
dti-3060	56	19	for	for	ADP
dti-3060	56	20	both	both	CCONJ
dti-3060	56	21	the	the	DET
dti-3060	56	22	controlled	control	VERB
dti-3060	56	23	and	and	CCONJ
dti-3060	56	24	levofloxacin	levofloxacin	NOUN
dti-3060	56	25	-	-	PUNCT
dti-3060	56	26	treated	treat	VERB
dti-3060	56	27	erythrocytes	erythrocyte	NOUN
dti-3060	56	28	.	.	PUNCT
dti-3060	57	1	the	the	DET
dti-3060	57	2	mcv	mcv	PROPN
dti-3060	57	3	was	be	AUX
dti-3060	57	4	calculated	calculate	VERB
dti-3060	57	5	using	use	VERB
dti-3060	57	6	an	an	DET
dti-3060	57	7	humacount	humacount	NOUN
dti-3060	57	8	5d	5d	NUM
dti-3060	57	9	hematology	hematology	NOUN
dti-3060	57	10	analyzer	analyzer	NOUN
dti-3060	57	11	(	(	PUNCT
dti-3060	57	12	human	human	PROPN
dti-3060	57	13	gmbh	gmbh	PROPN
dti-3060	57	14	,	,	PUNCT
dti-3060	57	15	wiesbaden	wiesbaden	PROPN
dti-3060	57	16	,	,	PUNCT
dti-3060	57	17	germany	germany	PROPN
dti-3060	57	18	)	)	PUNCT
dti-3060	57	19	,	,	PUNCT
dti-3060	57	20	which	which	PRON
dti-3060	57	21	provided	provide	VERB
dti-3060	57	22	estimated	estimate	VERB
dti-3060	57	23	information	information	NOUN
dti-3060	57	24	on	on	ADP
dti-3060	57	25	red	red	ADJ
dti-3060	57	26	blood	blood	NOUN
dti-3060	57	27	cell	cell	NOUN
dti-3060	57	28	volume	volume	NOUN
dti-3060	57	29	and	and	CCONJ
dti-3060	57	30	shape	shape	NOUN
dti-3060	57	31	and	and	CCONJ
dti-3060	57	32	size	size	NOUN
dti-3060	57	33	(	(	PUNCT
dti-3060	57	34	20	20	NUM
dti-3060	57	35	)	)	PUNCT
dti-3060	57	36	.	.	PUNCT
dti-3060	58	1	phosphatidylserine	phosphatidylserine	NOUN
dti-3060	58	2	content	content	NOUN
dti-3060	58	3	concentration	concentration	NOUN
dti-3060	58	4	of	of	ADP
dti-3060	58	5	externalized	externalized	ADJ
dti-3060	58	6	ps	ps	NOUN
dti-3060	58	7	in	in	ADP
dti-3060	58	8	levofloxacin	levofloxacin	NOUN
dti-3060	58	9	-	-	PUNCT
dti-3060	58	10	treated	treat	VERB
dti-3060	58	11	erythrocytes	erythrocyte	NOUN
dti-3060	58	12	was	be	AUX
dti-3060	58	13	measured	measure	VERB
dti-3060	58	14	using	use	VERB
dti-3060	58	15	a	a	DET
dti-3060	58	16	human	human	ADJ
dti-3060	58	17	ps	ps	NOUN
dti-3060	58	18	enzymelinked	enzymelinke	VERB
dti-3060	58	19	immunosorbent	immunosorbent	NOUN
dti-3060	58	20	assay	assay	PROPN
dti-3060	58	21	(	(	PUNCT
dti-3060	58	22	elisa	elisa	NOUN
dti-3060	58	23	)	)	PUNCT
dti-3060	58	24	kit	kit	NOUN
dti-3060	58	25	(	(	PUNCT
dti-3060	58	26	elabscience	elabscience	NOUN
dti-3060	58	27	,	,	PUNCT
dti-3060	58	28	beijing	beijing	PROPN
dti-3060	58	29	,	,	PUNCT
dti-3060	58	30	people	people	NOUN
dti-3060	58	31	’s	’s	PART
dti-3060	58	32	republic	republic	PROPN
dti-3060	58	33	of	of	ADP
dti-3060	58	34	china	china	PROPN
dti-3060	58	35	)	)	PUNCT
dti-3060	58	36	according	accord	VERB
dti-3060	58	37	to	to	ADP
dti-3060	58	38	the	the	DET
dti-3060	58	39	manufacturer	manufacturer	NOUN
dti-3060	58	40	’s	’s	PART
dti-3060	58	41	instructions	instruction	NOUN
dti-3060	58	42	.	.	PUNCT
dti-3060	59	1	absorbance	absorbance	NOUN
dti-3060	59	2	was	be	AUX
dti-3060	59	3	read	read	VERB
dti-3060	59	4	at	at	ADP
dti-3060	59	5	wavelength	wavelength	NOUN
dti-3060	59	6	of	of	ADP
dti-3060	59	7	450	450	NUM
dti-3060	59	8	nm	nm	NOUN
dti-3060	59	9	levofloxacin	levofloxacin	NOUN
dti-3060	59	10	triggers	trigger	VERB
dti-3060	59	11	eryptosis	eryptosis	NOUN
dti-3060	59	12	via	via	ADP
dti-3060	59	13	oxidative	oxidative	ADJ
dti-3060	59	14	stress	stress	NOUN
dti-3060	59	15	pathways80	pathways80	NOUN
dti-3060	59	16	©	©	ADP
dti-3060	59	17	2024	2024	NUM
dti-3060	59	18	the	the	DET
dti-3060	59	19	authors	author	NOUN
dti-3060	59	20	.	.	PUNCT
dti-3060	60	1	drug	drug	NOUN
dti-3060	60	2	target	target	NOUN
dti-3060	60	3	insights	insight	NOUN
dti-3060	60	4	issn	issn	VERB
dti-3060	60	5	1177	1177	NUM
dti-3060	60	6	-	-	SYM
dti-3060	60	7	3928	3928	NUM
dti-3060	60	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-3060	60	9	on	on	ADP
dti-3060	60	10	the	the	DET
dti-3060	60	11	biotek	biotek	NOUN
dti-3060	60	12	μ	μ	PROPN
dti-3060	60	13	quant	quant	ADJ
dti-3060	60	14	microplate	microplate	NOUN
dti-3060	60	15	reader	reader	NOUN
dti-3060	60	16	and	and	CCONJ
dti-3060	60	17	expressed	express	VERB
dti-3060	60	18	as	as	ADP
dti-3060	60	19	ps	ps	PROPN
dti-3060	60	20	equivalents	equivalent	NOUN
dti-3060	60	21	(	(	PUNCT
dti-3060	60	22	mg	mg	PROPN
dti-3060	60	23	/	/	SYM
dti-3060	60	24	ml	ml	NOUN
dti-3060	60	25	)	)	PUNCT
dti-3060	60	26	(	(	PUNCT
dti-3060	60	27	21	21	NUM
dti-3060	60	28	)	)	PUNCT
dti-3060	60	29	.	.	PUNCT
dti-3060	61	1	confirmation	confirmation	NOUN
dti-3060	61	2	of	of	ADP
dti-3060	61	3	the	the	DET
dti-3060	61	4	role	role	NOUN
dti-3060	61	5	of	of	ADP
dti-3060	61	6	ca++	ca++	PROPN
dti-3060	61	7	ions	ion	NOUN
dti-3060	61	8	to	to	PART
dti-3060	61	9	validate	validate	VERB
dti-3060	61	10	the	the	DET
dti-3060	61	11	functional	functional	ADJ
dti-3060	61	12	role	role	NOUN
dti-3060	61	13	of	of	ADP
dti-3060	61	14	ca++	ca++	NOUN
dti-3060	61	15	in	in	ADP
dti-3060	61	16	the	the	DET
dti-3060	61	17	initiation	initiation	NOUN
dti-3060	61	18	of	of	ADP
dti-3060	61	19	eryptosis	eryptosis	NOUN
dti-3060	61	20	,	,	PUNCT
dti-3060	61	21	the	the	DET
dti-3060	61	22	mcv	mcv	NOUN
dti-3060	61	23	of	of	ADP
dti-3060	61	24	erythrocytes	erythrocyte	NOUN
dti-3060	61	25	was	be	AUX
dti-3060	61	26	evaluated	evaluate	VERB
dti-3060	61	27	using	use	VERB
dti-3060	61	28	a	a	DET
dti-3060	61	29	hematology	hematology	NOUN
dti-3060	61	30	analyzer	analyzer	NOUN
dti-3060	61	31	.	.	PUNCT
dti-3060	62	1	erythrocytes	erythrocyte	NOUN
dti-3060	62	2	were	be	AUX
dti-3060	62	3	treated	treat	VERB
dti-3060	62	4	with	with	ADP
dti-3060	62	5	levofloxacin	levofloxacin	NOUN
dti-3060	62	6	doses	dose	NOUN
dti-3060	62	7	and	and	CCONJ
dti-3060	62	8	10	10	NUM
dti-3060	62	9	µm	µm	NOUN
dti-3060	62	10	of	of	ADP
dti-3060	62	11	a	a	DET
dti-3060	62	12	calcium	calcium	NOUN
dti-3060	62	13	entry	entry	NOUN
dti-3060	62	14	blocker	blocker	NOUN
dti-3060	62	15	(	(	PUNCT
dti-3060	62	16	amlodipine	amlodipine	NOUN
dti-3060	62	17	)	)	PUNCT
dti-3060	62	18	to	to	PART
dti-3060	62	19	ensure	ensure	VERB
dti-3060	62	20	the	the	DET
dti-3060	62	21	involvement	involvement	NOUN
dti-3060	62	22	of	of	ADP
dti-3060	62	23	calcium	calcium	NOUN
dti-3060	62	24	ions	ion	NOUN
dti-3060	62	25	in	in	ADP
dti-3060	62	26	levofloxacin	levofloxacin	NOUN
dti-3060	62	27	-	-	PUNCT
dti-3060	62	28	induced	induce	VERB
dti-3060	62	29	eryptosis	eryptosis	NOUN
dti-3060	62	30	(	(	PUNCT
dti-3060	62	31	22	22	NUM
dti-3060	62	32	)	)	PUNCT
dti-3060	62	33	.	.	PUNCT
dti-3060	63	1	measurement	measurement	NOUN
dti-3060	63	2	of	of	ADP
dti-3060	63	3	hemolysis	hemolysis	NOUN
dti-3060	63	4	percentage	percentage	NOUN
dti-3060	63	5	to	to	PART
dti-3060	63	6	validate	validate	VERB
dti-3060	63	7	levofloxacin	levofloxacin	PROPN
dti-3060	63	8	’s	’s	PART
dti-3060	63	9	hemolytic	hemolytic	ADJ
dti-3060	63	10	effect	effect	NOUN
dti-3060	63	11	on	on	ADP
dti-3060	63	12	erythrocytes	erythrocyte	NOUN
dti-3060	63	13	,	,	PUNCT
dti-3060	63	14	controlled	control	VERB
dti-3060	63	15	and	and	CCONJ
dti-3060	63	16	levofloxacin	levofloxacin	NOUN
dti-3060	63	17	-	-	PUNCT
dti-3060	63	18	treated	treat	VERB
dti-3060	63	19	red	red	ADJ
dti-3060	63	20	cell	cell	NOUN
dti-3060	63	21	samples	sample	NOUN
dti-3060	63	22	were	be	AUX
dti-3060	63	23	centrifuged	centrifuge	VERB
dti-3060	63	24	at	at	ADP
dti-3060	63	25	400	400	NUM
dti-3060	63	26	g	g	NOUN
dti-3060	63	27	for	for	ADP
dti-3060	63	28	3	3	NUM
dti-3060	63	29	minutes	minute	NOUN
dti-3060	63	30	at	at	ADP
dti-3060	63	31	25	25	NUM
dti-3060	63	32	°	°	NOUN
dti-3060	63	33	c	c	NOUN
dti-3060	63	34	to	to	PART
dti-3060	63	35	get	get	VERB
dti-3060	63	36	the	the	DET
dti-3060	63	37	supernatant	supernatant	NOUN
dti-3060	63	38	.	.	PUNCT
dti-3060	64	1	the	the	DET
dti-3060	64	2	concentration	concentration	NOUN
dti-3060	64	3	of	of	ADP
dti-3060	64	4	hemoglobin	hemoglobin	NOUN
dti-3060	64	5	in	in	ADP
dti-3060	64	6	supernatants	supernatant	NOUN
dti-3060	64	7	was	be	AUX
dti-3060	64	8	measured	measure	VERB
dti-3060	64	9	at	at	ADP
dti-3060	64	10	405	405	NUM
dti-3060	64	11	nm	nm	ADV
dti-3060	64	12	using	use	VERB
dti-3060	64	13	lmsp	lmsp	NOUN
dti-3060	64	14	-	-	PUNCT
dti-3060	64	15	v310	v310	PROPN
dti-3060	64	16	visible	visible	ADJ
dti-3060	64	17	spectrophotometer	spectrophotometer	NOUN
dti-3060	64	18	;	;	PUNCT
dti-3060	64	19	100	100	NUM
dti-3060	64	20	%	%	NOUN
dti-3060	64	21	hemolysis	hemolysis	NOUN
dti-3060	64	22	was	be	AUX
dti-3060	64	23	defined	define	VERB
dti-3060	64	24	as	as	ADP
dti-3060	64	25	the	the	DET
dti-3060	64	26	optical	optical	ADJ
dti-3060	64	27	density	density	NOUN
dti-3060	64	28	of	of	ADP
dti-3060	64	29	erythrocyte	erythrocyte	NOUN
dti-3060	64	30	supernatant	supernatant	NOUN
dti-3060	64	31	lysed	lyse	VERB
dti-3060	64	32	in	in	ADP
dti-3060	64	33	distilled	distil	VERB
dti-3060	64	34	water	water	NOUN
dti-3060	64	35	(	(	PUNCT
dti-3060	64	36	23	23	NUM
dti-3060	64	37	)	)	PUNCT
dti-3060	64	38	.	.	PUNCT
dti-3060	65	1	statistical	statistical	ADJ
dti-3060	65	2	analysis	analysis	NOUN
dti-3060	65	3	the	the	DET
dti-3060	65	4	findings	finding	NOUN
dti-3060	65	5	were	be	AUX
dti-3060	65	6	presented	present	VERB
dti-3060	65	7	with	with	ADP
dti-3060	65	8	a	a	DET
dti-3060	65	9	mean	mean	ADJ
dti-3060	65	10	standard	standard	ADJ
dti-3060	65	11	error	error	NOUN
dti-3060	65	12	of	of	ADP
dti-3060	65	13	mean	mean	PROPN
dti-3060	65	14	(	(	PUNCT
dti-3060	65	15	±	±	NUM
dti-3060	65	16	sem	sem	NOUN
dti-3060	65	17	)	)	PUNCT
dti-3060	65	18	.	.	PUNCT
dti-3060	66	1	analysis	analysis	NOUN
dti-3060	66	2	of	of	ADP
dti-3060	66	3	variance	variance	NOUN
dti-3060	66	4	(	(	PUNCT
dti-3060	66	5	anova	anova	PROPN
dti-3060	66	6	)	)	PUNCT
dti-3060	66	7	with	with	ADP
dti-3060	66	8	tukey	tukey	PROPN
dti-3060	66	9	’s	’s	PART
dti-3060	66	10	test	test	NOUN
dti-3060	66	11	as	as	ADP
dti-3060	66	12	a	a	DET
dti-3060	66	13	follow	follow	VERB
dti-3060	66	14	-	-	PUNCT
dti-3060	66	15	up	up	ADP
dti-3060	66	16	test	test	NOUN
dti-3060	66	17	was	be	AUX
dti-3060	66	18	used	use	VERB
dti-3060	66	19	for	for	ADP
dti-3060	66	20	the	the	DET
dti-3060	66	21	statistical	statistical	ADJ
dti-3060	66	22	study	study	NOUN
dti-3060	66	23	where	where	SCONJ
dti-3060	66	24	necessary	necessary	ADJ
dti-3060	66	25	(	(	PUNCT
dti-3060	66	26	24	24	NUM
dti-3060	66	27	)	)	PUNCT
dti-3060	66	28	.	.	PUNCT
dti-3060	67	1	statistical	statistical	ADJ
dti-3060	67	2	significance	significance	NOUN
dti-3060	67	3	was	be	AUX
dti-3060	67	4	considered	consider	VERB
dti-3060	67	5	as	as	ADP
dti-3060	67	6	p	p	NOUN
dti-3060	67	7	-	-	PUNCT
dti-3060	67	8	value	value	NOUN
dti-3060	67	9	<	<	NOUN
dti-3060	67	10	0.05	0.05	NUM
dti-3060	67	11	.	.	PUNCT
dti-3060	67	12	results	result	VERB
dti-3060	67	13	the	the	DET
dti-3060	67	14	purpose	purpose	NOUN
dti-3060	67	15	of	of	ADP
dti-3060	67	16	this	this	DET
dti-3060	67	17	study	study	NOUN
dti-3060	67	18	was	be	AUX
dti-3060	67	19	to	to	PART
dti-3060	67	20	analyze	analyze	VERB
dti-3060	67	21	levofloxacin	levofloxacin	PROPN
dti-3060	67	22	’s	’s	PART
dti-3060	67	23	eryptotic	eryptotic	ADJ
dti-3060	67	24	effects	effect	NOUN
dti-3060	67	25	by	by	ADP
dti-3060	67	26	implementing	implement	VERB
dti-3060	67	27	the	the	DET
dti-3060	67	28	oxidative	oxidative	ADJ
dti-3060	67	29	stress	stress	NOUN
dti-3060	67	30	induction	induction	NOUN
dti-3060	67	31	that	that	PRON
dti-3060	67	32	is	be	AUX
dti-3060	67	33	one	one	NUM
dti-3060	67	34	of	of	ADP
dti-3060	67	35	the	the	DET
dti-3060	67	36	eryptosis	eryptosis	NOUN
dti-3060	67	37	-	-	PUNCT
dti-3060	67	38	stimulating	stimulate	VERB
dti-3060	67	39	mechanisms	mechanism	NOUN
dti-3060	67	40	.	.	PUNCT
dti-3060	68	1	to	to	PART
dti-3060	68	2	validate	validate	VERB
dti-3060	68	3	this	this	PRON
dti-3060	68	4	,	,	PUNCT
dti-3060	68	5	the	the	DET
dti-3060	68	6	antioxidant	antioxidant	ADJ
dti-3060	68	7	enzymatic	enzymatic	ADJ
dti-3060	68	8	activities	activity	NOUN
dti-3060	68	9	,	,	PUNCT
dti-3060	68	10	erythrocyte	erythrocyte	NOUN
dti-3060	68	11	size	size	NOUN
dti-3060	68	12	,	,	PUNCT
dti-3060	68	13	exposing	expose	VERB
dti-3060	68	14	of	of	ADP
dti-3060	68	15	ps	ps	PROPN
dti-3060	68	16	at	at	ADP
dti-3060	68	17	the	the	DET
dti-3060	68	18	cell	cell	NOUN
dti-3060	68	19	exterior	exterior	NOUN
dti-3060	68	20	,	,	PUNCT
dti-3060	68	21	hemolytic	hemolytic	ADJ
dti-3060	68	22	activity	activity	NOUN
dti-3060	68	23	,	,	PUNCT
dti-3060	68	24	and	and	CCONJ
dti-3060	68	25	substantiating	substantiate	VERB
dti-3060	68	26	the	the	DET
dti-3060	68	27	involvement	involvement	NOUN
dti-3060	68	28	of	of	ADP
dti-3060	68	29	calcium	calcium	NOUN
dti-3060	68	30	in	in	ADP
dti-3060	68	31	triggering	trigger	VERB
dti-3060	68	32	the	the	DET
dti-3060	68	33	programmed	program	VERB
dti-3060	68	34	cell	cell	NOUN
dti-3060	68	35	death	death	NOUN
dti-3060	68	36	of	of	ADP
dti-3060	68	37	erythrocytes	erythrocyte	NOUN
dti-3060	68	38	were	be	AUX
dti-3060	68	39	all	all	PRON
dti-3060	68	40	evaluated	evaluate	VERB
dti-3060	68	41	.	.	PUNCT
dti-3060	69	1	the	the	DET
dti-3060	69	2	findings	finding	NOUN
dti-3060	69	3	of	of	ADP
dti-3060	69	4	the	the	DET
dti-3060	69	5	research	research	NOUN
dti-3060	69	6	are	be	AUX
dti-3060	69	7	showcased	showcase	VERB
dti-3060	69	8	in	in	ADP
dti-3060	69	9	graphs	graph	NOUN
dti-3060	69	10	,	,	PUNCT
dti-3060	69	11	featuring	feature	VERB
dti-3060	69	12	mean	mean	NOUN
dti-3060	69	13	values	value	NOUN
dti-3060	69	14	±sem	±sem	NOUN
dti-3060	69	15	with	with	ADP
dti-3060	69	16	clear	clear	ADJ
dti-3060	69	17	indications	indication	NOUN
dti-3060	69	18	of	of	ADP
dti-3060	69	19	statistical	statistical	ADJ
dti-3060	69	20	significance	significance	NOUN
dti-3060	69	21	.	.	PUNCT
dti-3060	70	1	the	the	DET
dti-3060	70	2	antioxidant	antioxidant	ADJ
dti-3060	70	3	enzyme	enzyme	NOUN
dti-3060	70	4	activities	activity	NOUN
dti-3060	70	5	in	in	ADP
dti-3060	70	6	levofloxacin	levofloxacin	NOUN
dti-3060	70	7	-	-	PUNCT
dti-3060	70	8	treated	treat	VERB
dti-3060	70	9	and	and	CCONJ
dti-3060	70	10	-nontreated	-nontreated	ADJ
dti-3060	70	11	cells	cell	NOUN
dti-3060	70	12	(	(	PUNCT
dti-3060	70	13	control	control	NOUN
dti-3060	70	14	group	group	NOUN
dti-3060	70	15	)	)	PUNCT
dti-3060	70	16	were	be	AUX
dti-3060	70	17	measured	measure	VERB
dti-3060	70	18	to	to	PART
dti-3060	70	19	see	see	VERB
dti-3060	70	20	if	if	SCONJ
dti-3060	70	21	levofloxacin	levofloxacin	NOUN
dti-3060	70	22	induces	induce	VERB
dti-3060	70	23	oxidative	oxidative	ADJ
dti-3060	70	24	stress	stress	NOUN
dti-3060	70	25	.	.	PUNCT
dti-3060	71	1	figure	figure	NOUN
dti-3060	71	2	1	1	NUM
dti-3060	71	3	shows	show	VERB
dti-3060	71	4	a	a	DET
dti-3060	71	5	notable	notable	ADJ
dti-3060	71	6	decrease	decrease	NOUN
dti-3060	71	7	in	in	ADP
dti-3060	71	8	sod	sod	NOUN
dti-3060	71	9	activity	activity	NOUN
dti-3060	71	10	at	at	ADP
dti-3060	71	11	7	7	NUM
dti-3060	71	12	and	and	CCONJ
dti-3060	71	13	14	14	NUM
dti-3060	71	14	μm	μm	NUM
dti-3060	71	15	levofloxacin	levofloxacin	NOUN
dti-3060	71	16	compared	compare	VERB
dti-3060	71	17	to	to	ADP
dti-3060	71	18	control	control	NOUN
dti-3060	71	19	cells	cell	NOUN
dti-3060	71	20	.	.	PUNCT
dti-3060	72	1	figure	figure	NOUN
dti-3060	72	2	2	2	NUM
dti-3060	72	3	shows	show	VERB
dti-3060	72	4	that	that	SCONJ
dti-3060	72	5	48	48	NUM
dti-3060	72	6	hours	hour	NOUN
dti-3060	72	7	treatment	treatment	NOUN
dti-3060	72	8	with	with	ADP
dti-3060	72	9	the	the	DET
dti-3060	72	10	mentioned	mention	VERB
dti-3060	72	11	drug	drug	NOUN
dti-3060	72	12	concentrations	concentration	NOUN
dti-3060	72	13	resulted	result	VERB
dti-3060	72	14	in	in	ADP
dti-3060	72	15	a	a	DET
dti-3060	72	16	statistically	statistically	ADV
dti-3060	72	17	substantial	substantial	ADJ
dti-3060	72	18	drop	drop	NOUN
dti-3060	72	19	in	in	ADP
dti-3060	72	20	gpx	gpx	NOUN
dti-3060	72	21	activity	activity	NOUN
dti-3060	72	22	at	at	ADP
dti-3060	72	23	7	7	NUM
dti-3060	72	24	and	and	CCONJ
dti-3060	72	25	14	14	NUM
dti-3060	72	26	μm	μm	NUM
dti-3060	72	27	doses	dose	NOUN
dti-3060	72	28	compared	compare	VERB
dti-3060	72	29	with	with	ADP
dti-3060	72	30	control	control	NOUN
dti-3060	72	31	groups	group	NOUN
dti-3060	72	32	.	.	PUNCT
dti-3060	73	1	similarly	similarly	ADV
dti-3060	73	2	,	,	PUNCT
dti-3060	73	3	figure	figure	VERB
dti-3060	73	4	3	3	NUM
dti-3060	73	5	shows	show	VERB
dti-3060	73	6	that	that	SCONJ
dti-3060	73	7	48	48	NUM
dti-3060	73	8	hours	hour	NOUN
dti-3060	73	9	of	of	ADP
dti-3060	73	10	treatment	treatment	NOUN
dti-3060	73	11	with	with	ADP
dti-3060	73	12	levofloxacin	levofloxacin	NOUN
dti-3060	73	13	results	result	NOUN
dti-3060	73	14	in	in	ADP
dti-3060	73	15	a	a	DET
dti-3060	73	16	relatively	relatively	ADV
dti-3060	73	17	moderate	moderate	ADJ
dti-3060	73	18	decline	decline	NOUN
dti-3060	73	19	at	at	ADP
dti-3060	73	20	7	7	NUM
dti-3060	73	21	µm	µm	ADP
dti-3060	73	22	and	and	CCONJ
dti-3060	73	23	highly	highly	ADV
dti-3060	73	24	significant	significant	ADJ
dti-3060	73	25	decline	decline	NOUN
dti-3060	73	26	at	at	ADP
dti-3060	73	27	14	14	NUM
dti-3060	73	28	µm	µm	NOUN
dti-3060	73	29	in	in	ADP
dti-3060	73	30	catalase	catalase	NOUN
dti-3060	73	31	activity	activity	NOUN
dti-3060	73	32	.	.	PUNCT
dti-3060	74	1	a	a	DET
dti-3060	74	2	substantial	substantial	ADJ
dti-3060	74	3	and	and	CCONJ
dti-3060	74	4	statistically	statistically	ADV
dti-3060	74	5	significant	significant	ADJ
dti-3060	74	6	decrease	decrease	NOUN
dti-3060	74	7	in	in	ADP
dti-3060	74	8	the	the	DET
dti-3060	74	9	mcv	mcv	PROPN
dti-3060	74	10	of	of	ADP
dti-3060	74	11	red	red	ADJ
dti-3060	74	12	blood	blood	NOUN
dti-3060	74	13	cells	cell	NOUN
dti-3060	74	14	was	be	AUX
dti-3060	74	15	observed	observe	VERB
dti-3060	74	16	after	after	ADP
dti-3060	74	17	treatment	treatment	NOUN
dti-3060	74	18	with	with	ADP
dti-3060	74	19	7	7	NUM
dti-3060	74	20	and	and	CCONJ
dti-3060	74	21	14	14	NUM
dti-3060	74	22	µm	µm	ADP
dti-3060	74	23	concentrations	concentration	NOUN
dti-3060	74	24	of	of	ADP
dti-3060	74	25	levofloxacin	levofloxacin	NOUN
dti-3060	74	26	for	for	ADP
dti-3060	74	27	48	48	NUM
dti-3060	74	28	hours	hour	NOUN
dti-3060	74	29	(	(	PUNCT
dti-3060	74	30	fig	fig	NOUN
dti-3060	74	31	.	.	PUNCT
dti-3060	75	1	4	4	NUM
dti-3060	75	2	)	)	PUNCT
dti-3060	75	3	.	.	PUNCT
dti-3060	76	1	increased	increase	VERB
dti-3060	76	2	mean	mean	ADJ
dti-3060	76	3	cell	cell	NOUN
dti-3060	76	4	volume	volume	NOUN
dti-3060	76	5	could	could	AUX
dti-3060	76	6	be	be	AUX
dti-3060	76	7	attributed	attribute	VERB
dti-3060	76	8	to	to	ADP
dti-3060	76	9	membrane	membrane	ADJ
dti-3060	76	10	bleb	bleb	NOUN
dti-3060	76	11	formation	formation	NOUN
dti-3060	76	12	caused	cause	VERB
dti-3060	76	13	by	by	ADP
dti-3060	76	14	levofloxacin	levofloxacin	NOUN
dti-3060	76	15	-	-	PUNCT
dti-3060	76	16	induced	induce	VERB
dti-3060	76	17	oxidative	oxidative	ADJ
dti-3060	76	18	damage	damage	NOUN
dti-3060	76	19	.	.	PUNCT
dti-3060	77	1	results	result	NOUN
dti-3060	77	2	of	of	ADP
dti-3060	77	3	ps	ps	PROPN
dti-3060	77	4	exposure	exposure	NOUN
dti-3060	77	5	assay	assay	PROPN
dti-3060	77	6	showed	show	VERB
dti-3060	77	7	least	least	ADJ
dti-3060	77	8	absorbance	absorbance	NOUN
dti-3060	77	9	in	in	ADP
dti-3060	77	10	the	the	DET
dti-3060	77	11	control	control	NOUN
dti-3060	77	12	group	group	NOUN
dti-3060	77	13	,	,	PUNCT
dti-3060	77	14	which	which	PRON
dti-3060	77	15	indicates	indicate	VERB
dti-3060	77	16	minor	minor	ADJ
dti-3060	77	17	ps	ps	NOUN
dti-3060	77	18	externalization	externalization	NOUN
dti-3060	77	19	,	,	PUNCT
dti-3060	77	20	while	while	SCONJ
dti-3060	77	21	levofloxacin	levofloxacin	NOUN
dti-3060	77	22	-	-	PUNCT
dti-3060	77	23	exposed	expose	VERB
dti-3060	77	24	treatment	treatment	NOUN
dti-3060	77	25	groups	group	NOUN
dti-3060	77	26	showed	show	VERB
dti-3060	77	27	increasing	increase	VERB
dti-3060	77	28	absorbance	absorbance	NOUN
dti-3060	77	29	(	(	PUNCT
dti-3060	77	30	p	p	X
dti-3060	77	31	<	<	X
dti-3060	77	32	0.001	0.001	NUM
dti-3060	77	33	)	)	PUNCT
dti-3060	77	34	in	in	ADP
dti-3060	77	35	both	both	PRON
dti-3060	77	36	7	7	NUM
dti-3060	77	37	and	and	CCONJ
dti-3060	77	38	14	14	NUM
dti-3060	77	39	µm	µm	ADP
dti-3060	77	40	concentrations	concentration	NOUN
dti-3060	77	41	,	,	PUNCT
dti-3060	77	42	reflecting	reflect	VERB
dti-3060	77	43	increased	increase	VERB
dti-3060	77	44	ps	ps	NOUN
dti-3060	77	45	exposure	exposure	NOUN
dti-3060	77	46	and	and	CCONJ
dti-3060	77	47	suggesting	suggest	VERB
dti-3060	77	48	higher	high	ADJ
dti-3060	77	49	levels	level	NOUN
dti-3060	77	50	of	of	ADP
dti-3060	77	51	eryptosis	eryptosis	NOUN
dti-3060	77	52	.	.	PUNCT
dti-3060	78	1	the	the	DET
dti-3060	78	2	standard	standard	ADJ
dti-3060	78	3	curve	curve	NOUN
dti-3060	78	4	was	be	AUX
dti-3060	78	5	generated	generate	VERB
dti-3060	78	6	using	use	VERB
dti-3060	78	7	the	the	DET
dti-3060	78	8	absorbance	absorbance	NOUN
dti-3060	78	9	values	value	NOUN
dti-3060	78	10	of	of	ADP
dti-3060	78	11	the	the	DET
dti-3060	78	12	known	know	VERB
dti-3060	78	13	ps	ps	NOUN
dti-3060	78	14	standards	standard	NOUN
dti-3060	78	15	,	,	PUNCT
dti-3060	78	16	which	which	PRON
dti-3060	78	17	showed	show	VERB
dti-3060	78	18	a	a	DET
dti-3060	78	19	linear	linear	ADJ
dti-3060	78	20	relationship	relationship	NOUN
dti-3060	78	21	between	between	ADP
dti-3060	78	22	absorbance	absorbance	NOUN
dti-3060	78	23	and	and	CCONJ
dti-3060	78	24	ps	ps	NOUN
dti-3060	78	25	concentration	concentration	NOUN
dti-3060	78	26	(	(	PUNCT
dti-3060	78	27	fig	fig	NOUN
dti-3060	78	28	.	.	PUNCT
dti-3060	79	1	5	5	NUM
dti-3060	79	2	)	)	PUNCT
dti-3060	79	3	.	.	PUNCT
dti-3060	80	1	the	the	DET
dti-3060	80	2	calcium	calcium	NOUN
dti-3060	80	3	channel	channel	NOUN
dti-3060	80	4	blocker	blocker	NOUN
dti-3060	80	5	amlodipine	amlodipine	NOUN
dti-3060	80	6	was	be	AUX
dti-3060	80	7	employed	employ	VERB
dti-3060	80	8	to	to	PART
dti-3060	80	9	verify	verify	VERB
dti-3060	80	10	the	the	DET
dti-3060	80	11	effect	effect	NOUN
dti-3060	80	12	of	of	ADP
dti-3060	80	13	ca++	ca++	NOUN
dti-3060	80	14	in	in	ADP
dti-3060	80	15	the	the	DET
dti-3060	80	16	elicitation	elicitation	NOUN
dti-3060	80	17	of	of	ADP
dti-3060	80	18	oxidative	oxidative	ADJ
dti-3060	80	19	stress	stress	NOUN
dti-3060	80	20	initiated	initiate	VERB
dti-3060	80	21	by	by	ADP
dti-3060	80	22	eryptosis	eryptosis	NOUN
dti-3060	80	23	in	in	ADP
dti-3060	80	24	triggering	trigger	VERB
dti-3060	80	25	the	the	DET
dti-3060	80	26	formation	formation	NOUN
dti-3060	80	27	of	of	ADP
dti-3060	80	28	figure	figure	NOUN
dti-3060	80	29	1	1	NUM
dti-3060	80	30	the	the	DET
dti-3060	80	31	effect	effect	NOUN
dti-3060	80	32	of	of	ADP
dti-3060	80	33	levofloxacin	levofloxacin	NOUN
dti-3060	80	34	on	on	ADP
dti-3060	80	35	superoxide	superoxide	NOUN
dti-3060	80	36	dismutase	dismutase	NOUN
dti-3060	80	37	activity	activity	NOUN
dti-3060	80	38	in	in	ADP
dti-3060	80	39	erythrocytes	erythrocyte	NOUN
dti-3060	80	40	exposed	expose	VERB
dti-3060	80	41	to	to	ADP
dti-3060	80	42	levofloxacin	levofloxacin	PROPN
dti-3060	80	43	(	(	PUNCT
dti-3060	80	44	measured	measure	VERB
dti-3060	80	45	in	in	ADP
dti-3060	80	46	u	u	PROPN
dti-3060	80	47	/	/	SYM
dti-3060	80	48	g	g	PROPN
dti-3060	80	49	hb	hb	PROPN
dti-3060	80	50	)	)	PUNCT
dti-3060	80	51	.	.	PUNCT
dti-3060	81	1	variations	variation	NOUN
dti-3060	81	2	in	in	ADP
dti-3060	81	3	erythrocyte	erythrocyte	ADJ
dti-3060	81	4	responses	response	NOUN
dti-3060	81	5	(	(	PUNCT
dti-3060	81	6	n	n	NOUN
dti-3060	81	7	=	=	SYM
dti-3060	81	8	15	15	NUM
dti-3060	81	9	)	)	PUNCT
dti-3060	81	10	are	be	AUX
dti-3060	81	11	visible	visible	ADJ
dti-3060	81	12	after	after	ADP
dti-3060	81	13	48	48	NUM
dti-3060	81	14	hours	hour	NOUN
dti-3060	81	15	of	of	ADP
dti-3060	81	16	incubation	incubation	NOUN
dti-3060	81	17	in	in	ADP
dti-3060	81	18	ringers	ringer	NOUN
dti-3060	81	19	’	’	PART
dti-3060	81	20	solution	solution	NOUN
dti-3060	81	21	with	with	ADP
dti-3060	81	22	varying	vary	VERB
dti-3060	81	23	concentrations	concentration	NOUN
dti-3060	81	24	of	of	ADP
dti-3060	81	25	levofloxacin	levofloxacin	NOUN
dti-3060	81	26	in	in	ADP
dti-3060	81	27	black	black	ADJ
dti-3060	81	28	bars	bar	NOUN
dti-3060	81	29	,	,	PUNCT
dti-3060	81	30	with	with	ADP
dti-3060	81	31	asterisks	asterisk	NOUN
dti-3060	81	32	*	*	PUNCT
dti-3060	81	33	(	(	PUNCT
dti-3060	81	34	p	p	X
dti-3060	81	35	<	<	X
dti-3060	81	36	0.05	0.05	NUM
dti-3060	81	37	)	)	PUNCT
dti-3060	81	38	and	and	CCONJ
dti-3060	81	39	*	*	PUNCT
dti-3060	81	40	*	*	PUNCT
dti-3060	81	41	*	*	PUNCT
dti-3060	81	42	(	(	PUNCT
dti-3060	81	43	p	p	X
dti-3060	81	44	<	<	X
dti-3060	81	45	0.0001	0.0001	NUM
dti-3060	81	46	)	)	PUNCT
dti-3060	81	47	on	on	ADP
dti-3060	81	48	the	the	DET
dti-3060	81	49	error	error	NOUN
dti-3060	81	50	bars	bar	NOUN
dti-3060	81	51	indicating	indicate	VERB
dti-3060	81	52	significant	significant	ADJ
dti-3060	81	53	differences	difference	NOUN
dti-3060	81	54	from	from	ADP
dti-3060	81	55	the	the	DET
dti-3060	81	56	absence	absence	NOUN
dti-3060	81	57	of	of	ADP
dti-3060	81	58	levofloxacin	levofloxacin	NOUN
dti-3060	81	59	in	in	ADP
dti-3060	81	60	white	white	ADJ
dti-3060	81	61	bar	bar	PROPN
dti-3060	81	62	(	(	PUNCT
dti-3060	81	63	anova	anova	PROPN
dti-3060	81	64	)	)	PUNCT
dti-3060	81	65	.	.	PUNCT
dti-3060	82	1	anova	anova	PROPN
dti-3060	83	1	=	=	PUNCT
dti-3060	83	2	analysis	analysis	NOUN
dti-3060	83	3	of	of	ADP
dti-3060	83	4	variance	variance	NOUN
dti-3060	83	5	.	.	PUNCT
dti-3060	84	1	figure	figure	NOUN
dti-3060	84	2	2	2	NUM
dti-3060	84	3	the	the	DET
dti-3060	84	4	effect	effect	NOUN
dti-3060	84	5	of	of	ADP
dti-3060	84	6	levofloxacin	levofloxacin	NOUN
dti-3060	84	7	on	on	ADP
dti-3060	84	8	glutathione	glutathione	NOUN
dti-3060	84	9	peroxidase	peroxidase	NOUN
dti-3060	84	10	activity	activity	NOUN
dti-3060	84	11	in	in	ADP
dti-3060	84	12	erythrocytes	erythrocyte	NOUN
dti-3060	84	13	exposed	expose	VERB
dti-3060	84	14	to	to	ADP
dti-3060	84	15	levofloxacin	levofloxacin	PROPN
dti-3060	84	16	(	(	PUNCT
dti-3060	84	17	measured	measure	VERB
dti-3060	84	18	in	in	ADP
dti-3060	84	19	u	u	PROPN
dti-3060	84	20	/	/	SYM
dti-3060	84	21	g	g	PROPN
dti-3060	84	22	hb	hb	PROPN
dti-3060	84	23	)	)	PUNCT
dti-3060	84	24	.	.	PUNCT
dti-3060	85	1	variations	variation	NOUN
dti-3060	85	2	in	in	ADP
dti-3060	85	3	erythrocyte	erythrocyte	ADJ
dti-3060	85	4	responses	response	NOUN
dti-3060	85	5	(	(	PUNCT
dti-3060	85	6	n	n	NOUN
dti-3060	85	7	=	=	SYM
dti-3060	85	8	15	15	NUM
dti-3060	85	9	)	)	PUNCT
dti-3060	85	10	are	be	AUX
dti-3060	85	11	visible	visible	ADJ
dti-3060	85	12	after	after	ADP
dti-3060	85	13	48	48	NUM
dti-3060	85	14	hours	hour	NOUN
dti-3060	85	15	of	of	ADP
dti-3060	85	16	incubation	incubation	NOUN
dti-3060	85	17	in	in	ADP
dti-3060	85	18	ringer	ringer	NOUN
dti-3060	85	19	’s	’s	PART
dti-3060	85	20	solution	solution	NOUN
dti-3060	85	21	with	with	ADP
dti-3060	85	22	varying	vary	VERB
dti-3060	85	23	concentrations	concentration	NOUN
dti-3060	85	24	of	of	ADP
dti-3060	85	25	levofloxacin	levofloxacin	NOUN
dti-3060	85	26	in	in	ADP
dti-3060	85	27	black	black	ADJ
dti-3060	85	28	bars	bar	NOUN
dti-3060	85	29	,	,	PUNCT
dti-3060	85	30	with	with	ADP
dti-3060	85	31	asterisks	asterisk	NOUN
dti-3060	85	32	*	*	PUNCT
dti-3060	85	33	(	(	PUNCT
dti-3060	85	34	p	p	X
dti-3060	85	35	<	<	X
dti-3060	85	36	0.05	0.05	NUM
dti-3060	85	37	)	)	PUNCT
dti-3060	85	38	and	and	CCONJ
dti-3060	85	39	*	*	PUNCT
dti-3060	85	40	*	*	PUNCT
dti-3060	85	41	*	*	PUNCT
dti-3060	85	42	(	(	PUNCT
dti-3060	85	43	p	p	X
dti-3060	85	44	<	<	X
dti-3060	85	45	0.0001	0.0001	NUM
dti-3060	85	46	)	)	PUNCT
dti-3060	85	47	on	on	ADP
dti-3060	85	48	the	the	DET
dti-3060	85	49	error	error	NOUN
dti-3060	85	50	bars	bar	NOUN
dti-3060	85	51	indicating	indicate	VERB
dti-3060	85	52	significant	significant	ADJ
dti-3060	85	53	distinctness	distinctness	NOUN
dti-3060	85	54	from	from	ADP
dti-3060	85	55	the	the	DET
dti-3060	85	56	absence	absence	NOUN
dti-3060	85	57	of	of	ADP
dti-3060	85	58	levofloxacin	levofloxacin	NOUN
dti-3060	85	59	in	in	ADP
dti-3060	85	60	white	white	ADJ
dti-3060	85	61	bar	bar	PROPN
dti-3060	85	62	(	(	PUNCT
dti-3060	85	63	anova	anova	PROPN
dti-3060	85	64	)	)	PUNCT
dti-3060	85	65	.	.	PUNCT
dti-3060	86	1	anova	anova	PROPN
dti-3060	87	1	=	=	PUNCT
dti-3060	87	2	analysis	analysis	NOUN
dti-3060	87	3	of	of	ADP
dti-3060	87	4	variance	variance	NOUN
dti-3060	87	5	.	.	PUNCT
dti-3060	88	1	aslam	aslam	PROPN
dti-3060	88	2	et	et	PROPN
dti-3060	88	3	al	al	PROPN
dti-3060	88	4	drug	drug	PROPN
dti-3060	88	5	target	target	NOUN
dti-3060	88	6	insights	insight	NOUN
dti-3060	88	7	2024	2024	NUM
dti-3060	88	8	;	;	PUNCT
dti-3060	88	9	18	18	NUM
dti-3060	88	10	:	:	SYM
dti-3060	88	11	81	81	NUM
dti-3060	88	12	©	©	ADP
dti-3060	88	13	2024	2024	NUM
dti-3060	88	14	the	the	DET
dti-3060	88	15	authors	author	NOUN
dti-3060	88	16	.	.	PUNCT
dti-3060	89	1	published	publish	VERB
dti-3060	89	2	by	by	ADP
dti-3060	89	3	aboutscience	aboutscience	NOUN
dti-3060	89	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-3060	89	5	in	in	ADP
dti-3060	89	6	accordance	accordance	NOUN
dti-3060	89	7	with	with	ADP
dti-3060	89	8	our	our	PRON
dti-3060	89	9	research	research	NOUN
dti-3060	89	10	it	it	PRON
dti-3060	89	11	was	be	AUX
dti-3060	89	12	concluded	conclude	VERB
dti-3060	89	13	that	that	SCONJ
dti-3060	89	14	therapeutic	therapeutic	ADJ
dti-3060	89	15	dosages	dosage	NOUN
dti-3060	89	16	(	(	PUNCT
dti-3060	89	17	7	7	NUM
dti-3060	89	18	,	,	PUNCT
dti-3060	89	19	14	14	NUM
dti-3060	89	20	µm	µm	NOUN
dti-3060	89	21	)	)	PUNCT
dti-3060	89	22	of	of	ADP
dti-3060	89	23	levofloxacin	levofloxacin	NOUN
dti-3060	89	24	may	may	AUX
dti-3060	89	25	elevate	elevate	VERB
dti-3060	89	26	the	the	DET
dti-3060	89	27	rate	rate	NOUN
dti-3060	89	28	of	of	ADP
dti-3060	89	29	erythrocyte	erythrocyte	ADJ
dti-3060	89	30	elimination	elimination	NOUN
dti-3060	89	31	from	from	ADP
dti-3060	89	32	the	the	DET
dti-3060	89	33	blood	blood	NOUN
dti-3060	89	34	stream	stream	NOUN
dti-3060	89	35	due	due	ADJ
dti-3060	89	36	to	to	ADP
dti-3060	89	37	oxidative	oxidative	ADJ
dti-3060	89	38	stress	stress	NOUN
dti-3060	89	39	and	and	CCONJ
dti-3060	89	40	calcium	calcium	NOUN
dti-3060	89	41	influx	influx	NOUN
dti-3060	89	42	,	,	PUNCT
dti-3060	89	43	leading	lead	VERB
dti-3060	89	44	to	to	ADP
dti-3060	89	45	eryptosis	eryptosis	NOUN
dti-3060	89	46	and	and	CCONJ
dti-3060	89	47	hemolyzing	hemolyze	VERB
dti-3060	89	48	the	the	DET
dti-3060	89	49	red	red	ADJ
dti-3060	89	50	cells	cell	NOUN
dti-3060	89	51	.	.	PUNCT
dti-3060	90	1	discussion	discussion	NOUN
dti-3060	90	2	the	the	DET
dti-3060	90	3	intent	intent	NOUN
dti-3060	90	4	of	of	ADP
dti-3060	90	5	this	this	DET
dti-3060	90	6	study	study	NOUN
dti-3060	90	7	was	be	AUX
dti-3060	90	8	to	to	PART
dti-3060	90	9	find	find	VERB
dti-3060	90	10	the	the	DET
dti-3060	90	11	impact	impact	NOUN
dti-3060	90	12	caused	cause	VERB
dti-3060	90	13	by	by	ADP
dti-3060	90	14	levofloxacin	levofloxacin	NOUN
dti-3060	90	15	on	on	ADP
dti-3060	90	16	oxidative	oxidative	ADJ
dti-3060	90	17	stress	stress	NOUN
dti-3060	90	18	status	status	NOUN
dti-3060	90	19	and	and	CCONJ
dti-3060	90	20	cell	cell	NOUN
dti-3060	90	21	death	death	NOUN
dti-3060	90	22	of	of	ADP
dti-3060	90	23	red	red	ADJ
dti-3060	90	24	blood	blood	NOUN
dti-3060	90	25	cells	cell	NOUN
dti-3060	90	26	.	.	PUNCT
dti-3060	91	1	this	this	DET
dti-3060	91	2	objective	objective	NOUN
dti-3060	91	3	of	of	ADP
dti-3060	91	4	the	the	DET
dti-3060	91	5	study	study	NOUN
dti-3060	91	6	was	be	AUX
dti-3060	91	7	achieved	achieve	VERB
dti-3060	91	8	by	by	ADP
dti-3060	91	9	investigating	investigate	VERB
dti-3060	91	10	the	the	DET
dti-3060	91	11	antioxidant	antioxidant	ADJ
dti-3060	91	12	enzymes	enzyme	NOUN
dti-3060	91	13	’	'	PUNCT
dti-3060	91	14	status	status	NOUN
dti-3060	91	15	,	,	PUNCT
dti-3060	91	16	cell	cell	NOUN
dti-3060	91	17	dimensions	dimension	NOUN
dti-3060	91	18	,	,	PUNCT
dti-3060	91	19	and	and	CCONJ
dti-3060	91	20	the	the	DET
dti-3060	91	21	role	role	NOUN
dti-3060	91	22	of	of	ADP
dti-3060	91	23	calcium	calcium	NOUN
dti-3060	91	24	in	in	ADP
dti-3060	91	25	causing	cause	VERB
dti-3060	91	26	the	the	DET
dti-3060	91	27	programmed	programmed	ADJ
dti-3060	91	28	cell	cell	NOUN
dti-3060	91	29	death	death	NOUN
dti-3060	91	30	of	of	ADP
dti-3060	91	31	red	red	ADJ
dti-3060	91	32	cells	cell	NOUN
dti-3060	91	33	.	.	PUNCT
dti-3060	92	1	the	the	DET
dti-3060	92	2	levofloxacin	levofloxacin	PROPN
dti-3060	92	3	concentrations	concentration	NOUN
dti-3060	92	4	(	(	PUNCT
dti-3060	92	5	7	7	NUM
dti-3060	92	6	,	,	PUNCT
dti-3060	92	7	14	14	NUM
dti-3060	92	8	μm	μm	NUM
dti-3060	92	9	)	)	PUNCT
dti-3060	92	10	employed	employ	VERB
dti-3060	92	11	in	in	ADP
dti-3060	92	12	this	this	DET
dti-3060	92	13	investigation	investigation	NOUN
dti-3060	92	14	were	be	AUX
dti-3060	92	15	the	the	DET
dti-3060	92	16	plasma	plasma	NOUN
dti-3060	92	17	concentration	concentration	NOUN
dti-3060	92	18	figure	figure	NOUN
dti-3060	92	19	3	3	NUM
dti-3060	92	20	the	the	DET
dti-3060	92	21	effect	effect	NOUN
dti-3060	92	22	of	of	ADP
dti-3060	92	23	levofloxacin	levofloxacin	NOUN
dti-3060	92	24	on	on	ADP
dti-3060	92	25	catalase	catalase	NOUN
dti-3060	92	26	activity	activity	NOUN
dti-3060	92	27	in	in	ADP
dti-3060	92	28	erythrocytes	erythrocyte	NOUN
dti-3060	92	29	exposed	expose	VERB
dti-3060	92	30	to	to	ADP
dti-3060	92	31	levofloxacin	levofloxacin	PROPN
dti-3060	92	32	(	(	PUNCT
dti-3060	92	33	measured	measure	VERB
dti-3060	92	34	in	in	ADP
dti-3060	92	35	u	u	PROPN
dti-3060	92	36	/	/	SYM
dti-3060	92	37	g	g	PROPN
dti-3060	92	38	hb	hb	PROPN
dti-3060	92	39	)	)	PUNCT
dti-3060	92	40	.	.	PUNCT
dti-3060	93	1	variations	variation	NOUN
dti-3060	93	2	in	in	ADP
dti-3060	93	3	erythrocyte	erythrocyte	ADJ
dti-3060	93	4	responses	response	NOUN
dti-3060	93	5	(	(	PUNCT
dti-3060	93	6	n	n	NOUN
dti-3060	93	7	=	=	SYM
dti-3060	93	8	15	15	NUM
dti-3060	93	9	)	)	PUNCT
dti-3060	93	10	are	be	AUX
dti-3060	93	11	visible	visible	ADJ
dti-3060	93	12	after	after	ADP
dti-3060	93	13	48	48	NUM
dti-3060	93	14	hours	hour	NOUN
dti-3060	93	15	of	of	ADP
dti-3060	93	16	incubation	incubation	NOUN
dti-3060	93	17	in	in	ADP
dti-3060	93	18	ringer	ringer	NOUN
dti-3060	93	19	’s	’s	PART
dti-3060	93	20	solution	solution	NOUN
dti-3060	93	21	with	with	ADP
dti-3060	93	22	varying	vary	VERB
dti-3060	93	23	concentrations	concentration	NOUN
dti-3060	93	24	of	of	ADP
dti-3060	93	25	levofloxacin	levofloxacin	NOUN
dti-3060	93	26	in	in	ADP
dti-3060	93	27	black	black	ADJ
dti-3060	93	28	bars	bar	NOUN
dti-3060	93	29	,	,	PUNCT
dti-3060	93	30	with	with	ADP
dti-3060	93	31	asterisks	asterisk	NOUN
dti-3060	93	32	*	*	PUNCT
dti-3060	93	33	*	*	PUNCT
dti-3060	93	34	(	(	PUNCT
dti-3060	93	35	p	p	X
dti-3060	93	36	<	<	X
dti-3060	93	37	0.01	0.01	NUM
dti-3060	93	38	)	)	PUNCT
dti-3060	93	39	and	and	CCONJ
dti-3060	93	40	*	*	PUNCT
dti-3060	93	41	*	*	PUNCT
dti-3060	93	42	*	*	PUNCT
dti-3060	93	43	(	(	PUNCT
dti-3060	93	44	p	p	X
dti-3060	93	45	<	<	X
dti-3060	93	46	0.0001	0.0001	NUM
dti-3060	93	47	)	)	PUNCT
dti-3060	93	48	on	on	ADP
dti-3060	93	49	the	the	DET
dti-3060	93	50	error	error	NOUN
dti-3060	93	51	bars	bar	NOUN
dti-3060	93	52	indicating	indicate	VERB
dti-3060	93	53	significant	significant	ADJ
dti-3060	93	54	differences	difference	NOUN
dti-3060	93	55	from	from	ADP
dti-3060	93	56	the	the	DET
dti-3060	93	57	absence	absence	NOUN
dti-3060	93	58	of	of	ADP
dti-3060	93	59	levofloxacin	levofloxacin	NOUN
dti-3060	93	60	in	in	ADP
dti-3060	93	61	white	white	ADJ
dti-3060	93	62	bar	bar	PROPN
dti-3060	93	63	(	(	PUNCT
dti-3060	93	64	anova	anova	PROPN
dti-3060	93	65	)	)	PUNCT
dti-3060	93	66	.	.	PUNCT
dti-3060	94	1	anova	anova	PROPN
dti-3060	95	1	=	=	PUNCT
dti-3060	95	2	analysis	analysis	NOUN
dti-3060	95	3	of	of	ADP
dti-3060	95	4	variance	variance	NOUN
dti-3060	95	5	.	.	PUNCT
dti-3060	96	1	figure	figure	VERB
dti-3060	96	2	4	4	NUM
dti-3060	96	3	the	the	DET
dti-3060	96	4	effect	effect	NOUN
dti-3060	96	5	of	of	ADP
dti-3060	96	6	levofloxacin	levofloxacin	NOUN
dti-3060	96	7	on	on	ADP
dti-3060	96	8	erythrocyte	erythrocyte	NOUN
dti-3060	96	9	mean	mean	ADJ
dti-3060	96	10	cellular	cellular	ADJ
dti-3060	96	11	volume	volume	NOUN
dti-3060	96	12	(	(	PUNCT
dti-3060	96	13	fl	fl	NOUN
dti-3060	96	14	)	)	PUNCT
dti-3060	96	15	.	.	PUNCT
dti-3060	97	1	mean	mean	NOUN
dti-3060	97	2	±	±	NUM
dti-3060	97	3	sem	sem	NOUN
dti-3060	97	4	(	(	PUNCT
dti-3060	97	5	n	n	NOUN
dti-3060	97	6	=	=	SYM
dti-3060	97	7	10	10	NUM
dti-3060	97	8	)	)	PUNCT
dti-3060	97	9	of	of	ADP
dti-3060	97	10	erythrocytes	erythrocyte	NOUN
dti-3060	97	11	incubated	incubate	VERB
dti-3060	97	12	in	in	ADP
dti-3060	97	13	ringer	ringer	NOUN
dti-3060	97	14	’s	’s	PART
dti-3060	97	15	solution	solution	NOUN
dti-3060	97	16	for	for	ADP
dti-3060	97	17	48	48	NUM
dti-3060	97	18	hours	hour	NOUN
dti-3060	97	19	without	without	ADP
dti-3060	97	20	levofloxacin	levofloxacin	NOUN
dti-3060	97	21	in	in	ADP
dti-3060	97	22	white	white	ADJ
dti-3060	97	23	bar	bar	NOUN
dti-3060	97	24	and	and	CCONJ
dti-3060	97	25	with	with	ADP
dti-3060	97	26	levofloxacin	levofloxacin	NOUN
dti-3060	97	27	concentrations	concentration	NOUN
dti-3060	97	28	(	(	PUNCT
dti-3060	97	29	7	7	NUM
dti-3060	97	30	,	,	PUNCT
dti-3060	97	31	14	14	NUM
dti-3060	97	32	µm	µm	NOUN
dti-3060	97	33	)	)	PUNCT
dti-3060	97	34	in	in	ADP
dti-3060	97	35	black	black	ADJ
dti-3060	97	36	bars	bar	NOUN
dti-3060	97	37	.	.	PUNCT
dti-3060	98	1	the	the	DET
dti-3060	98	2	y	y	NOUN
dti-3060	98	3	-	-	PUNCT
dti-3060	98	4	axis	axis	NOUN
dti-3060	98	5	represents	represent	VERB
dti-3060	98	6	±sem	±sem	NOUN
dti-3060	98	7	.	.	PUNCT
dti-3060	99	1	*	*	PUNCT
dti-3060	99	2	*	*	PUNCT
dti-3060	99	3	(	(	PUNCT
dti-3060	99	4	p	p	X
dti-3060	99	5	<	<	X
dti-3060	99	6	0.01	0.01	NUM
dti-3060	99	7	)	)	PUNCT
dti-3060	99	8	and	and	CCONJ
dti-3060	99	9	*	*	PUNCT
dti-3060	99	10	*	*	PUNCT
dti-3060	99	11	*	*	PUNCT
dti-3060	99	12	(	(	PUNCT
dti-3060	99	13	p	p	X
dti-3060	99	14	<	<	X
dti-3060	99	15	0.001	0.001	NUM
dti-3060	99	16	)	)	PUNCT
dti-3060	99	17	indicate	indicate	VERB
dti-3060	99	18	a	a	DET
dti-3060	99	19	statistically	statistically	ADV
dti-3060	99	20	significant	significant	ADJ
dti-3060	99	21	distinction	distinction	NOUN
dti-3060	99	22	in	in	ADP
dti-3060	99	23	groups	group	NOUN
dti-3060	99	24	treated	treat	VERB
dti-3060	99	25	with	with	ADP
dti-3060	99	26	levofloxacin	levofloxacin	NOUN
dti-3060	99	27	in	in	ADP
dti-3060	99	28	comparison	comparison	NOUN
dti-3060	99	29	to	to	ADP
dti-3060	99	30	the	the	DET
dti-3060	99	31	absence	absence	NOUN
dti-3060	99	32	of	of	ADP
dti-3060	99	33	levofloxacin	levofloxacin	PROPN
dti-3060	99	34	(	(	PUNCT
dti-3060	99	35	anova	anova	PROPN
dti-3060	99	36	)	)	PUNCT
dti-3060	99	37	.	.	PUNCT
dti-3060	100	1	anova	anova	PROPN
dti-3060	101	1	=	=	PUNCT
dti-3060	101	2	analysis	analysis	NOUN
dti-3060	101	3	of	of	ADP
dti-3060	101	4	variance	variance	NOUN
dti-3060	101	5	;	;	PUNCT
dti-3060	101	6	sem	sem	NOUN
dti-3060	101	7	=	=	SYM
dti-3060	101	8	standard	standard	ADJ
dti-3060	101	9	error	error	NOUN
dti-3060	101	10	of	of	ADP
dti-3060	101	11	the	the	DET
dti-3060	101	12	mean	mean	NOUN
dti-3060	101	13	.	.	PUNCT
dti-3060	102	1	figure	figure	VERB
dti-3060	102	2	5	5	NUM
dti-3060	102	3	effect	effect	NOUN
dti-3060	102	4	of	of	ADP
dti-3060	102	5	levofloxacin	levofloxacin	NOUN
dti-3060	102	6	on	on	ADP
dti-3060	102	7	phosphatidylserine	phosphatidylserine	NOUN
dti-3060	102	8	content	content	NOUN
dti-3060	102	9	following	follow	VERB
dti-3060	102	10	incubation	incubation	NOUN
dti-3060	102	11	in	in	ADP
dti-3060	102	12	ringer	ringer	NOUN
dti-3060	102	13	’s	’s	PART
dti-3060	102	14	solution	solution	NOUN
dti-3060	102	15	for	for	ADP
dti-3060	102	16	48	48	NUM
dti-3060	102	17	hours	hour	NOUN
dti-3060	102	18	in	in	ADP
dti-3060	102	19	the	the	DET
dti-3060	102	20	absence	absence	NOUN
dti-3060	102	21	(	(	PUNCT
dti-3060	102	22	control	control	NOUN
dti-3060	102	23	group	group	NOUN
dti-3060	102	24	)	)	PUNCT
dti-3060	102	25	and	and	CCONJ
dti-3060	102	26	presence	presence	NOUN
dti-3060	102	27	of	of	ADP
dti-3060	102	28	levofloxacin	levofloxacin	PROPN
dti-3060	102	29	(	(	PUNCT
dti-3060	102	30	7	7	NUM
dti-3060	102	31	,	,	PUNCT
dti-3060	102	32	14	14	NUM
dti-3060	102	33	µm	µm	NOUN
dti-3060	102	34	)	)	PUNCT
dti-3060	102	35	.	.	PUNCT
dti-3060	103	1	figure	figure	VERB
dti-3060	103	2	6	6	NUM
dti-3060	103	3	measurement	measurement	NOUN
dti-3060	103	4	of	of	ADP
dti-3060	103	5	erythrocyte	erythrocyte	NOUN
dti-3060	103	6	mean	mean	ADJ
dti-3060	103	7	cellular	cellular	ADJ
dti-3060	103	8	volume	volume	NOUN
dti-3060	103	9	in	in	ADP
dti-3060	103	10	the	the	DET
dti-3060	103	11	presence	presence	NOUN
dti-3060	103	12	and	and	CCONJ
dti-3060	103	13	absence	absence	NOUN
dti-3060	103	14	of	of	ADP
dti-3060	103	15	amlodipine	amlodipine	NOUN
dti-3060	103	16	following	follow	VERB
dti-3060	103	17	exposure	exposure	NOUN
dti-3060	103	18	to	to	ADP
dti-3060	103	19	levofloxacin	levofloxacin	PROPN
dti-3060	103	20	,	,	PUNCT
dti-3060	103	21	represented	represent	VERB
dti-3060	103	22	by	by	ADP
dti-3060	103	23	arithmetic	arithmetic	ADJ
dti-3060	103	24	mean	mean	PROPN
dti-3060	103	25	±	±	NUM
dti-3060	103	26	sem	sem	NOUN
dti-3060	103	27	(	(	PUNCT
dti-3060	103	28	n	n	NOUN
dti-3060	103	29	=	=	SYM
dti-3060	103	30	10	10	NUM
dti-3060	103	31	)	)	PUNCT
dti-3060	103	32	for	for	ADP
dti-3060	103	33	erythrocyte	erythrocyte	NOUN
dti-3060	103	34	incubated	incubate	VERB
dti-3060	103	35	in	in	ADP
dti-3060	103	36	ringer	ringer	NOUN
dti-3060	103	37	’s	’s	PART
dti-3060	103	38	solution	solution	NOUN
dti-3060	103	39	,	,	PUNCT
dti-3060	103	40	with	with	ADP
dti-3060	103	41	14	14	NUM
dti-3060	103	42	μm	μm	NOUN
dti-3060	103	43	levofloxacin	levofloxacin	NOUN
dti-3060	103	44	(	(	PUNCT
dti-3060	103	45	in	in	ADP
dti-3060	103	46	black	black	ADJ
dti-3060	103	47	bar	bar	NOUN
dti-3060	103	48	)	)	PUNCT
dti-3060	103	49	or	or	CCONJ
dti-3060	103	50	without	without	ADP
dti-3060	103	51	(	(	PUNCT
dti-3060	103	52	in	in	ADP
dti-3060	103	53	white	white	ADJ
dti-3060	103	54	bars	bar	NOUN
dti-3060	103	55	)	)	PUNCT
dti-3060	103	56	demonstrating	demonstrate	VERB
dti-3060	103	57	a	a	DET
dti-3060	103	58	decrease	decrease	NOUN
dti-3060	103	59	in	in	ADP
dti-3060	103	60	cell	cell	NOUN
dti-3060	103	61	dimensions	dimension	NOUN
dti-3060	103	62	subsequent	subsequent	ADJ
dti-3060	103	63	to	to	PART
dti-3060	103	64	amlodipine	amlodipine	VERB
dti-3060	103	65	10	10	NUM
dti-3060	103	66	μm	μm	NUM
dti-3060	103	67	treatment	treatment	NOUN
dti-3060	103	68	(	(	PUNCT
dti-3060	103	69	anova	anova	PROPN
dti-3060	103	70	)	)	PUNCT
dti-3060	103	71	as	as	SCONJ
dti-3060	103	72	indicated	indicate	VERB
dti-3060	103	73	by	by	ADP
dti-3060	103	74	*	*	PROPN
dti-3060	103	75	*	*	PUNCT
dti-3060	103	76	*	*	PUNCT
dti-3060	103	77	(	(	PUNCT
dti-3060	103	78	p	p	X
dti-3060	103	79	<	<	X
dti-3060	103	80	0.001	0.001	NUM
dti-3060	103	81	)	)	PUNCT
dti-3060	103	82	,	,	PUNCT
dti-3060	104	1	#	#	SYM
dti-3060	104	2	#	#	SYM
dti-3060	104	3	#	#	NOUN
dti-3060	104	4	(	(	PUNCT
dti-3060	104	5	p	p	X
dti-3060	104	6	<	<	X
dti-3060	104	7	0.001	0.001	NUM
dti-3060	104	8	)	)	PUNCT
dti-3060	104	9	.	.	PUNCT
dti-3060	105	1	anova	anova	PROPN
dti-3060	106	1	=	=	PUNCT
dti-3060	106	2	analysis	analysis	NOUN
dti-3060	106	3	of	of	ADP
dti-3060	106	4	variance	variance	NOUN
dti-3060	106	5	;	;	PUNCT
dti-3060	106	6	sem	sem	NOUN
dti-3060	106	7	=	=	SYM
dti-3060	106	8	standard	standard	ADJ
dti-3060	106	9	error	error	NOUN
dti-3060	106	10	of	of	ADP
dti-3060	106	11	the	the	DET
dti-3060	106	12	mean	mean	NOUN
dti-3060	106	13	.	.	PUNCT
dti-3060	107	1	membrane	membrane	NOUN
dti-3060	107	2	blebs	blebs	PROPN
dti-3060	107	3	.	.	PUNCT
dti-3060	108	1	figure	figure	NOUN
dti-3060	108	2	6	6	NUM
dti-3060	108	3	showed	show	VERB
dti-3060	108	4	noticeable	noticeable	ADJ
dti-3060	108	5	rise	rise	NOUN
dti-3060	108	6	in	in	ADP
dti-3060	108	7	erythrocyte	erythrocyte	ADJ
dti-3060	108	8	cell	cell	NOUN
dti-3060	108	9	size	size	NOUN
dti-3060	108	10	dimensions	dimension	NOUN
dti-3060	108	11	when	when	SCONJ
dti-3060	108	12	compared	compare	VERB
dti-3060	108	13	to	to	ADP
dti-3060	108	14	cells	cell	NOUN
dti-3060	108	15	that	that	PRON
dti-3060	108	16	were	be	AUX
dti-3060	108	17	free	free	ADJ
dti-3060	108	18	of	of	ADP
dti-3060	108	19	amlodipine	amlodipine	NOUN
dti-3060	108	20	,	,	PUNCT
dti-3060	108	21	which	which	PRON
dti-3060	108	22	is	be	AUX
dti-3060	108	23	most	most	ADV
dti-3060	108	24	likely	likely	ADJ
dti-3060	108	25	due	due	ADP
dti-3060	108	26	to	to	ADP
dti-3060	108	27	calcium	calcium	NOUN
dti-3060	108	28	entrance	entrance	NOUN
dti-3060	108	29	inhibition	inhibition	NOUN
dti-3060	108	30	in	in	ADP
dti-3060	108	31	the	the	DET
dti-3060	108	32	cells	cell	NOUN
dti-3060	108	33	.	.	PUNCT
dti-3060	109	1	this	this	DET
dti-3060	109	2	experiment	experiment	NOUN
dti-3060	109	3	revealed	reveal	VERB
dti-3060	109	4	no	no	DET
dti-3060	109	5	shrinkage	shrinkage	NOUN
dti-3060	109	6	in	in	ADP
dti-3060	109	7	the	the	DET
dti-3060	109	8	size	size	NOUN
dti-3060	109	9	of	of	ADP
dti-3060	109	10	erythrocytes	erythrocyte	NOUN
dti-3060	109	11	,	,	PUNCT
dti-3060	109	12	due	due	ADP
dti-3060	109	13	to	to	ADP
dti-3060	109	14	the	the	DET
dti-3060	109	15	blockade	blockade	NOUN
dti-3060	109	16	of	of	ADP
dti-3060	109	17	ca++	ca++	ADJ
dti-3060	109	18	channels	channel	NOUN
dti-3060	109	19	confirming	confirm	VERB
dti-3060	109	20	the	the	DET
dti-3060	109	21	significance	significance	NOUN
dti-3060	109	22	of	of	ADP
dti-3060	109	23	calcium	calcium	NOUN
dti-3060	109	24	in	in	ADP
dti-3060	109	25	causing	cause	VERB
dti-3060	109	26	erythrocyte	erythrocyte	NOUN
dti-3060	109	27	cell	cell	NOUN
dti-3060	109	28	death	death	NOUN
dti-3060	109	29	.	.	PUNCT
dti-3060	110	1	figure	figure	VERB
dti-3060	110	2	7	7	NUM
dti-3060	110	3	shows	show	VERB
dti-3060	110	4	the	the	DET
dti-3060	110	5	findings	finding	NOUN
dti-3060	110	6	of	of	ADP
dti-3060	110	7	%	%	NOUN
dti-3060	110	8	hemolysis	hemolysis	NOUN
dti-3060	110	9	in	in	ADP
dti-3060	110	10	levofloxacin	levofloxacin	NOUN
dti-3060	110	11	-	-	PUNCT
dti-3060	110	12	treated	treat	VERB
dti-3060	110	13	cells	cell	NOUN
dti-3060	110	14	to	to	PART
dti-3060	110	15	confirm	confirm	VERB
dti-3060	110	16	the	the	DET
dti-3060	110	17	hemolytic	hemolytic	ADJ
dti-3060	110	18	activity	activity	NOUN
dti-3060	110	19	of	of	ADP
dti-3060	110	20	levofloxacin	levofloxacin	PROPN
dti-3060	110	21	.	.	PUNCT
dti-3060	111	1	figure	figure	NOUN
dti-3060	111	2	6	6	NUM
dti-3060	111	3	shows	show	VERB
dti-3060	111	4	an	an	DET
dti-3060	111	5	increase	increase	NOUN
dti-3060	111	6	in	in	ADP
dti-3060	111	7	%	%	NOUN
dti-3060	111	8	hemolysis	hemolysis	NOUN
dti-3060	111	9	after	after	ADP
dti-3060	111	10	2	2	NUM
dti-3060	111	11	days	day	NOUN
dti-3060	111	12	of	of	ADP
dti-3060	111	13	levofloxacin	levofloxacin	NOUN
dti-3060	111	14	(	(	PUNCT
dti-3060	111	15	14	14	NUM
dti-3060	111	16	µm	µm	NOUN
dti-3060	111	17	)	)	PUNCT
dti-3060	111	18	exposure	exposure	NOUN
dti-3060	111	19	of	of	ADP
dti-3060	111	20	erythrocytes	erythrocyte	NOUN
dti-3060	111	21	.	.	PUNCT
dti-3060	112	1	levofloxacin	levofloxacin	PROPN
dti-3060	112	2	triggers	trigger	VERB
dti-3060	112	3	eryptosis	eryptosis	NOUN
dti-3060	112	4	via	via	ADP
dti-3060	112	5	oxidative	oxidative	ADJ
dti-3060	112	6	stress	stress	NOUN
dti-3060	112	7	pathways82	pathways82	NOUN
dti-3060	112	8	©	©	ADP
dti-3060	112	9	2024	2024	NUM
dti-3060	112	10	the	the	DET
dti-3060	112	11	authors	author	NOUN
dti-3060	112	12	.	.	PUNCT
dti-3060	113	1	drug	drug	NOUN
dti-3060	113	2	target	target	NOUN
dti-3060	113	3	insights	insight	NOUN
dti-3060	113	4	issn	issn	VERB
dti-3060	113	5	1177	1177	NUM
dti-3060	113	6	-	-	SYM
dti-3060	113	7	3928	3928	NUM
dti-3060	113	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-3060	113	9	reported	report	VERB
dti-3060	113	10	by	by	ADP
dti-3060	113	11	fish	fish	NOUN
dti-3060	113	12	and	and	CCONJ
dti-3060	113	13	chow	chow	PROPN
dti-3060	113	14	(	(	PUNCT
dti-3060	113	15	25	25	NUM
dti-3060	113	16	)	)	PUNCT
dti-3060	113	17	.	.	PUNCT
dti-3060	114	1	one	one	NUM
dti-3060	114	2	of	of	ADP
dti-3060	114	3	the	the	DET
dti-3060	114	4	primary	primary	ADJ
dti-3060	114	5	drivers	driver	NOUN
dti-3060	114	6	of	of	ADP
dti-3060	114	7	eryptosis	eryptosis	NOUN
dti-3060	114	8	is	be	AUX
dti-3060	114	9	oxidative	oxidative	ADJ
dti-3060	114	10	stress	stress	NOUN
dti-3060	114	11	(	(	PUNCT
dti-3060	114	12	14	14	NUM
dti-3060	114	13	)	)	PUNCT
dti-3060	114	14	,	,	PUNCT
dti-3060	114	15	and	and	CCONJ
dti-3060	114	16	increasing	increase	VERB
dti-3060	114	17	oxidative	oxidative	ADJ
dti-3060	114	18	damage	damage	NOUN
dti-3060	114	19	leads	lead	VERB
dti-3060	114	20	to	to	ADP
dti-3060	114	21	a	a	DET
dti-3060	114	22	drop	drop	NOUN
dti-3060	114	23	in	in	ADP
dti-3060	114	24	the	the	DET
dti-3060	114	25	activities	activity	NOUN
dti-3060	114	26	of	of	ADP
dti-3060	114	27	free	free	ADJ
dti-3060	114	28	radical	radical	ADJ
dti-3060	114	29	scavenger	scavenger	NOUN
dti-3060	114	30	enzymes	enzyme	NOUN
dti-3060	114	31	(	(	PUNCT
dti-3060	114	32	26	26	NUM
dti-3060	114	33	)	)	PUNCT
dti-3060	114	34	.	.	PUNCT
dti-3060	115	1	the	the	DET
dti-3060	115	2	impairment	impairment	NOUN
dti-3060	115	3	in	in	ADP
dti-3060	115	4	enzymatic	enzymatic	ADJ
dti-3060	115	5	activity	activity	NOUN
dti-3060	115	6	of	of	ADP
dti-3060	115	7	sod	sod	NOUN
dti-3060	115	8	could	could	AUX
dti-3060	115	9	be	be	AUX
dti-3060	115	10	predictive	predictive	ADJ
dti-3060	115	11	of	of	ADP
dti-3060	115	12	the	the	DET
dti-3060	115	13	heightened	heightened	ADJ
dti-3060	115	14	superoxide	superoxide	NOUN
dti-3060	115	15	radical	radical	ADJ
dti-3060	115	16	concentrations	concentration	NOUN
dti-3060	115	17	,	,	PUNCT
dti-3060	115	18	as	as	SCONJ
dti-3060	115	19	sod	sod	NOUN
dti-3060	115	20	efficiently	efficiently	ADV
dti-3060	115	21	catalyzes	catalyze	VERB
dti-3060	115	22	the	the	DET
dti-3060	115	23	conversion	conversion	NOUN
dti-3060	115	24	of	of	ADP
dti-3060	115	25	oxygen	oxygen	NOUN
dti-3060	115	26	into	into	ADP
dti-3060	115	27	h2o2	h2o2	NOUN
dti-3060	115	28	.	.	PUNCT
dti-3060	115	29	a	a	DET
dti-3060	115	30	decrease	decrease	NOUN
dti-3060	115	31	in	in	ADP
dti-3060	115	32	sod	sod	NOUN
dti-3060	115	33	activity	activity	NOUN
dti-3060	115	34	was	be	AUX
dti-3060	115	35	also	also	ADV
dti-3060	115	36	evaluated	evaluate	VERB
dti-3060	115	37	by	by	ADP
dti-3060	115	38	repeated	repeat	VERB
dti-3060	115	39	oral	oral	ADJ
dti-3060	115	40	administration	administration	NOUN
dti-3060	115	41	of	of	ADP
dti-3060	115	42	levofloxacin	levofloxacin	PROPN
dti-3060	115	43	and	and	CCONJ
dti-3060	115	44	other	other	ADJ
dti-3060	115	45	fluoroquinolones	fluoroquinolone	NOUN
dti-3060	115	46	in	in	ADP
dti-3060	115	47	rabbits	rabbit	NOUN
dti-3060	115	48	(	(	PUNCT
dti-3060	115	49	27	27	NUM
dti-3060	115	50	)	)	PUNCT
dti-3060	115	51	.	.	PUNCT
dti-3060	116	1	similar	similar	ADJ
dti-3060	116	2	effect	effect	NOUN
dti-3060	116	3	was	be	AUX
dti-3060	116	4	also	also	ADV
dti-3060	116	5	reported	report	VERB
dti-3060	116	6	on	on	ADP
dti-3060	116	7	hepatic	hepatic	ADJ
dti-3060	116	8	and	and	CCONJ
dti-3060	116	9	renal	renal	ADJ
dti-3060	116	10	tissues	tissue	NOUN
dti-3060	116	11	of	of	ADP
dti-3060	116	12	rat	rat	NOUN
dti-3060	116	13	due	due	ADP
dti-3060	116	14	to	to	ADP
dti-3060	116	15	exposure	exposure	NOUN
dti-3060	116	16	of	of	ADP
dti-3060	116	17	levofloxacin	levofloxacin	PROPN
dti-3060	116	18	(	(	PUNCT
dti-3060	116	19	28	28	NUM
dti-3060	116	20	)	)	PUNCT
dti-3060	116	21	.	.	PUNCT
dti-3060	117	1	the	the	DET
dti-3060	117	2	experiment	experiment	NOUN
dti-3060	117	3	revealed	reveal	VERB
dti-3060	117	4	a	a	DET
dti-3060	117	5	moderate	moderate	ADJ
dti-3060	117	6	(	(	PUNCT
dti-3060	117	7	at	at	ADP
dti-3060	117	8	7	7	NUM
dti-3060	117	9	µm	µm	NOUN
dti-3060	117	10	)	)	PUNCT
dti-3060	117	11	and	and	CCONJ
dti-3060	117	12	notable	notable	ADJ
dti-3060	117	13	reduction	reduction	NOUN
dti-3060	117	14	(	(	PUNCT
dti-3060	117	15	at	at	ADP
dti-3060	117	16	14	14	NUM
dti-3060	117	17	µm	µm	NOUN
dti-3060	117	18	)	)	PUNCT
dti-3060	117	19	in	in	ADP
dti-3060	117	20	gpx	gpx	NOUN
dti-3060	117	21	activity	activity	NOUN
dti-3060	117	22	,	,	PUNCT
dti-3060	117	23	which	which	PRON
dti-3060	117	24	might	might	AUX
dti-3060	117	25	be	be	AUX
dti-3060	117	26	blamed	blame	VERB
dti-3060	117	27	on	on	ADP
dti-3060	117	28	the	the	DET
dti-3060	117	29	formation	formation	NOUN
dti-3060	117	30	of	of	ADP
dti-3060	117	31	ros	ros	PROPN
dti-3060	117	32	.	.	PUNCT
dti-3060	118	1	in	in	ADP
dti-3060	118	2	a	a	DET
dti-3060	118	3	related	related	ADJ
dti-3060	118	4	research	research	NOUN
dti-3060	118	5	under	under	ADP
dti-3060	118	6	stress	stress	NOUN
dti-3060	118	7	red	red	ADJ
dti-3060	118	8	cells	cell	NOUN
dti-3060	118	9	,	,	PUNCT
dti-3060	118	10	a	a	DET
dti-3060	118	11	substantial	substantial	ADJ
dti-3060	118	12	endogenous	endogenous	ADJ
dti-3060	118	13	rate	rate	NOUN
dti-3060	118	14	of	of	ADP
dti-3060	118	15	h2o2	h2o2	NOUN
dti-3060	118	16	synthesis	synthesis	NOUN
dti-3060	118	17	from	from	ADP
dti-3060	118	18	hemoglobin	hemoglobin	NOUN
dti-3060	118	19	autoxidation	autoxidation	NOUN
dti-3060	118	20	was	be	AUX
dti-3060	118	21	observed	observe	VERB
dti-3060	118	22	.	.	PUNCT
dti-3060	119	1	gpx	gpx	PROPN
dti-3060	119	2	catalyzed	catalyze	VERB
dti-3060	119	3	a	a	DET
dti-3060	119	4	reaction	reaction	NOUN
dti-3060	119	5	by	by	ADP
dti-3060	119	6	which	which	DET
dti-3060	119	7	glutathione	glutathione	NOUN
dti-3060	119	8	is	be	AUX
dti-3060	119	9	oxidized	oxidize	VERB
dti-3060	119	10	to	to	PART
dti-3060	119	11	detoxify	detoxify	VERB
dti-3060	119	12	hydrogen	hydrogen	NOUN
dti-3060	119	13	peroxide	peroxide	NOUN
dti-3060	119	14	.	.	PUNCT
dti-3060	120	1	increasing	increase	VERB
dti-3060	120	2	oxidative	oxidative	ADJ
dti-3060	120	3	stress	stress	NOUN
dti-3060	120	4	ultimately	ultimately	ADV
dti-3060	120	5	leads	lead	VERB
dti-3060	120	6	to	to	ADP
dti-3060	120	7	demise	demise	NOUN
dti-3060	120	8	in	in	ADP
dti-3060	120	9	gpx	gpx	NOUN
dti-3060	120	10	activity	activity	NOUN
dti-3060	120	11	.	.	PUNCT
dti-3060	121	1	the	the	DET
dti-3060	121	2	reduced	reduce	VERB
dti-3060	121	3	enzyme	enzyme	NOUN
dti-3060	121	4	activity	activity	NOUN
dti-3060	121	5	is	be	AUX
dti-3060	121	6	due	due	ADJ
dti-3060	121	7	to	to	ADP
dti-3060	121	8	a	a	DET
dti-3060	121	9	decrease	decrease	NOUN
dti-3060	121	10	in	in	ADP
dti-3060	121	11	glutathione	glutathione	NOUN
dti-3060	121	12	concentration	concentration	NOUN
dti-3060	121	13	(	(	PUNCT
dti-3060	121	14	29	29	NUM
dti-3060	121	15	)	)	PUNCT
dti-3060	121	16	.	.	PUNCT
dti-3060	122	1	calderón	calderón	PROPN
dti-3060	122	2	-	-	PUNCT
dti-3060	122	3	salinas	salinas	PROPN
dti-3060	122	4	et	et	NOUN
dti-3060	122	5	al	al	PROPN
dti-3060	122	6	(	(	PUNCT
dti-3060	122	7	30	30	NUM
dti-3060	122	8	)	)	PUNCT
dti-3060	122	9	reported	report	VERB
dti-3060	122	10	that	that	SCONJ
dti-3060	122	11	oxidative	oxidative	ADJ
dti-3060	122	12	stress	stress	NOUN
dti-3060	122	13	made	make	VERB
dti-3060	122	14	the	the	DET
dti-3060	122	15	red	red	ADJ
dti-3060	122	16	cell	cell	NOUN
dti-3060	122	17	to	to	PART
dti-3060	122	18	expose	expose	VERB
dti-3060	122	19	ps	ps	PROPN
dti-3060	122	20	outside	outside	NOUN
dti-3060	122	21	,	,	PUNCT
dti-3060	122	22	which	which	PRON
dti-3060	122	23	also	also	ADV
dti-3060	122	24	decreases	decrease	VERB
dti-3060	122	25	erythrocyte	erythrocyte	ADJ
dti-3060	122	26	count	count	NOUN
dti-3060	122	27	.	.	PUNCT
dti-3060	123	1	catalase	catalase	NOUN
dti-3060	123	2	activity	activity	NOUN
dti-3060	123	3	was	be	AUX
dti-3060	123	4	also	also	ADV
dti-3060	123	5	seen	see	VERB
dti-3060	123	6	to	to	PART
dti-3060	123	7	be	be	AUX
dti-3060	123	8	declined	decline	VERB
dti-3060	123	9	in	in	ADP
dti-3060	123	10	the	the	DET
dti-3060	123	11	present	present	ADJ
dti-3060	123	12	study	study	NOUN
dti-3060	123	13	in	in	ADP
dti-3060	123	14	levofloxacin	levofloxacin	NOUN
dti-3060	123	15	-	-	PUNCT
dti-3060	123	16	treated	treat	VERB
dti-3060	123	17	erythrocytes	erythrocyte	NOUN
dti-3060	123	18	compared	compare	VERB
dti-3060	123	19	with	with	ADP
dti-3060	123	20	controlled	control	VERB
dti-3060	123	21	groups	group	NOUN
dti-3060	123	22	.	.	PUNCT
dti-3060	124	1	the	the	DET
dti-3060	124	2	decreased	decrease	VERB
dti-3060	124	3	catalase	catalase	NOUN
dti-3060	124	4	activity	activity	NOUN
dti-3060	124	5	might	might	AUX
dti-3060	124	6	be	be	AUX
dti-3060	124	7	due	due	ADJ
dti-3060	124	8	to	to	ADP
dti-3060	124	9	peroxidative	peroxidative	ADJ
dti-3060	124	10	damage	damage	NOUN
dti-3060	124	11	to	to	ADP
dti-3060	124	12	lipids	lipid	NOUN
dti-3060	124	13	and	and	CCONJ
dti-3060	124	14	injury	injury	NOUN
dti-3060	124	15	to	to	ADP
dti-3060	124	16	cellular	cellular	ADJ
dti-3060	124	17	components	component	NOUN
dti-3060	124	18	by	by	ADP
dti-3060	124	19	levofloxacin	levofloxacin	NOUN
dti-3060	124	20	-	-	PUNCT
dti-3060	124	21	induced	induce	VERB
dti-3060	124	22	oxidative	oxidative	ADJ
dti-3060	124	23	insult	insult	NOUN
dti-3060	124	24	.	.	PUNCT
dti-3060	125	1	parallel	parallel	ADJ
dti-3060	125	2	results	result	NOUN
dti-3060	125	3	were	be	AUX
dti-3060	125	4	also	also	ADV
dti-3060	125	5	reported	report	VERB
dti-3060	125	6	by	by	ADP
dti-3060	125	7	khan	khan	PROPN
dti-3060	125	8	et	et	PROPN
dti-3060	125	9	al	al	PROPN
dti-3060	125	10	(	(	PUNCT
dti-3060	125	11	27	27	NUM
dti-3060	125	12	)	)	PUNCT
dti-3060	125	13	and	and	CCONJ
dti-3060	125	14	farid	farid	PROPN
dti-3060	125	15	and	and	CCONJ
dti-3060	125	16	hegazy	hegazy	ADV
dti-3060	125	17	(	(	PUNCT
dti-3060	125	18	31	31	NUM
dti-3060	125	19	)	)	PUNCT
dti-3060	125	20	.	.	PUNCT
dti-3060	126	1	erythrocyte	erythrocyte	NOUN
dti-3060	126	2	shrinkage	shrinkage	NOUN
dti-3060	126	3	and	and	CCONJ
dti-3060	126	4	ps	ps	VERB
dti-3060	126	5	externalization	externalization	NOUN
dti-3060	126	6	on	on	ADP
dti-3060	126	7	the	the	DET
dti-3060	126	8	erythrocyte	erythrocyte	NOUN
dti-3060	126	9	membrane	membrane	NOUN
dti-3060	126	10	are	be	AUX
dti-3060	126	11	two	two	NUM
dti-3060	126	12	eryptotic	eryptotic	ADJ
dti-3060	126	13	markers	marker	NOUN
dti-3060	126	14	.	.	PUNCT
dti-3060	127	1	the	the	DET
dti-3060	127	2	high	high	ADJ
dti-3060	127	3	ps	ps	NOUN
dti-3060	127	4	exposure	exposure	NOUN
dti-3060	127	5	on	on	ADP
dti-3060	127	6	the	the	DET
dti-3060	127	7	outer	outer	ADJ
dti-3060	127	8	leaflet	leaflet	NOUN
dti-3060	127	9	of	of	ADP
dti-3060	127	10	erythrocyte	erythrocyte	PROPN
dti-3060	127	11	’s	’s	PART
dti-3060	127	12	plasma	plasma	NOUN
dti-3060	127	13	membrane	membrane	NOUN
dti-3060	127	14	in	in	ADP
dti-3060	127	15	levofloxacin	levofloxacin	NOUN
dti-3060	127	16	-	-	PUNCT
dti-3060	127	17	treated	treat	VERB
dti-3060	127	18	erythrocytes	erythrocyte	NOUN
dti-3060	127	19	indicates	indicate	VERB
dti-3060	127	20	that	that	SCONJ
dti-3060	127	21	levofloxacin	levofloxacin	PROPN
dti-3060	127	22	exposure	exposure	NOUN
dti-3060	127	23	leads	lead	VERB
dti-3060	127	24	to	to	ADP
dti-3060	127	25	increased	increase	VERB
dti-3060	127	26	eryptosis	eryptosis	NOUN
dti-3060	127	27	.	.	PUNCT
dti-3060	128	1	obtained	obtain	VERB
dti-3060	128	2	data	datum	NOUN
dti-3060	128	3	showed	show	VERB
dti-3060	128	4	significant	significant	ADJ
dti-3060	128	5	increase	increase	NOUN
dti-3060	128	6	in	in	ADP
dti-3060	128	7	ps	ps	NOUN
dti-3060	128	8	externalization	externalization	NOUN
dti-3060	128	9	in	in	ADP
dti-3060	128	10	levofloxacin	levofloxacin	NOUN
dti-3060	128	11	-	-	PUNCT
dti-3060	128	12	treated	treat	VERB
dti-3060	128	13	erythrocytes	erythrocyte	NOUN
dti-3060	128	14	while	while	SCONJ
dti-3060	128	15	control	control	NOUN
dti-3060	128	16	group	group	NOUN
dti-3060	128	17	showed	show	VERB
dti-3060	128	18	negligible	negligible	ADJ
dti-3060	128	19	ps	ps	NOUN
dti-3060	128	20	exposure	exposure	NOUN
dti-3060	128	21	.	.	PUNCT
dti-3060	129	1	thus	thus	ADV
dti-3060	129	2	,	,	PUNCT
dti-3060	129	3	increasing	increase	VERB
dti-3060	129	4	concentrations	concentration	NOUN
dti-3060	129	5	of	of	ADP
dti-3060	129	6	levofloxacin	levofloxacin	NOUN
dti-3060	129	7	lead	lead	VERB
dti-3060	129	8	to	to	ADP
dti-3060	129	9	higher	high	ADJ
dti-3060	129	10	ps	ps	NOUN
dti-3060	129	11	exposure	exposure	NOUN
dti-3060	129	12	,	,	PUNCT
dti-3060	129	13	which	which	PRON
dti-3060	129	14	is	be	AUX
dti-3060	129	15	the	the	DET
dti-3060	129	16	main	main	ADJ
dti-3060	129	17	indicator	indicator	NOUN
dti-3060	129	18	of	of	ADP
dti-3060	129	19	eryptosis	eryptosis	NOUN
dti-3060	129	20	(	(	PUNCT
dti-3060	129	21	16	16	NUM
dti-3060	129	22	)	)	PUNCT
dti-3060	129	23	.	.	PUNCT
dti-3060	130	1	a	a	DET
dti-3060	130	2	decrease	decrease	NOUN
dti-3060	130	3	in	in	ADP
dti-3060	130	4	mean	mean	ADJ
dti-3060	130	5	cell	cell	NOUN
dti-3060	130	6	volume	volume	NOUN
dti-3060	130	7	confirms	confirm	VERB
dti-3060	130	8	stimulated	stimulate	VERB
dti-3060	130	9	eryptosis	eryptosis	NOUN
dti-3060	130	10	(	(	PUNCT
dti-3060	130	11	24	24	NUM
dti-3060	130	12	)	)	PUNCT
dti-3060	130	13	.	.	PUNCT
dti-3060	131	1	the	the	DET
dti-3060	131	2	activation	activation	NOUN
dti-3060	131	3	of	of	ADP
dti-3060	131	4	a	a	DET
dti-3060	131	5	calcium	calcium	NOUN
dti-3060	131	6	influx	influx	NOUN
dti-3060	131	7	channel	channel	NOUN
dti-3060	131	8	in	in	ADP
dti-3060	131	9	red	red	ADJ
dti-3060	131	10	blood	blood	NOUN
dti-3060	131	11	cells	cell	NOUN
dti-3060	131	12	by	by	ADP
dti-3060	131	13	oxidative	oxidative	ADJ
dti-3060	131	14	stress	stress	NOUN
dti-3060	131	15	results	result	NOUN
dti-3060	131	16	in	in	ADP
dti-3060	131	17	considerable	considerable	ADJ
dti-3060	131	18	erythrocyte	erythrocyte	NOUN
dti-3060	131	19	shrinkage	shrinkage	NOUN
dti-3060	131	20	(	(	PUNCT
dti-3060	131	21	13	13	NUM
dti-3060	131	22	)	)	PUNCT
dti-3060	131	23	.	.	PUNCT
dti-3060	132	1	this	this	DET
dti-3060	132	2	action	action	NOUN
dti-3060	132	3	is	be	AUX
dti-3060	132	4	believed	believe	VERB
dti-3060	132	5	to	to	PART
dti-3060	132	6	be	be	AUX
dti-3060	132	7	triggered	trigger	VERB
dti-3060	132	8	by	by	ADP
dti-3060	132	9	ca2	ca2	PROPN
dti-3060	132	10	+	+	PROPN
dti-3060	132	11	-dependent	-dependent	ADJ
dti-3060	132	12	k+	k+	NOUN
dti-3060	132	13	channel	channel	NOUN
dti-3060	132	14	activation	activation	NOUN
dti-3060	132	15	in	in	ADP
dti-3060	132	16	the	the	DET
dti-3060	132	17	erythrocyte	erythrocyte	NOUN
dti-3060	132	18	’s	’s	PART
dti-3060	132	19	membrane	membrane	NOUN
dti-3060	132	20	,	,	PUNCT
dti-3060	132	21	which	which	PRON
dti-3060	132	22	results	result	VERB
dti-3060	132	23	in	in	ADP
dti-3060	132	24	increased	increase	VERB
dti-3060	132	25	polarization	polarization	NOUN
dti-3060	132	26	of	of	ADP
dti-3060	132	27	membrane	membrane	NOUN
dti-3060	132	28	and	and	CCONJ
dti-3060	132	29	eventual	eventual	ADJ
dti-3060	132	30	k+	k+	NOUN
dti-3060	132	31	loss	loss	NOUN
dti-3060	132	32	followed	follow	VERB
dti-3060	132	33	by	by	ADP
dti-3060	132	34	cl−	cl−	PROPN
dti-3060	132	35	in	in	ADP
dti-3060	132	36	the	the	DET
dti-3060	132	37	erythrocyte	erythrocyte	NOUN
dti-3060	132	38	(	(	PUNCT
dti-3060	132	39	32	32	NUM
dti-3060	132	40	)	)	PUNCT
dti-3060	132	41	.	.	PUNCT
dti-3060	133	1	our	our	PRON
dti-3060	133	2	results	result	NOUN
dti-3060	133	3	showed	show	VERB
dti-3060	133	4	apparent	apparent	ADJ
dti-3060	133	5	difference	difference	NOUN
dti-3060	133	6	in	in	ADP
dti-3060	133	7	cell	cell	NOUN
dti-3060	133	8	shrinkage	shrinkage	NOUN
dti-3060	133	9	in	in	ADP
dti-3060	133	10	amlodipine	amlodipine	NOUN
dti-3060	133	11	-	-	PUNCT
dti-3060	133	12	treated	treat	VERB
dti-3060	133	13	and	and	CCONJ
dti-3060	133	14	-nontreated	-nontreated	ADJ
dti-3060	133	15	erythrocytes	erythrocyte	NOUN
dti-3060	133	16	,	,	PUNCT
dti-3060	133	17	which	which	PRON
dti-3060	133	18	confirms	confirm	VERB
dti-3060	133	19	the	the	DET
dti-3060	133	20	role	role	NOUN
dti-3060	133	21	of	of	ADP
dti-3060	133	22	calcium	calcium	NOUN
dti-3060	133	23	ions	ion	NOUN
dti-3060	133	24	in	in	ADP
dti-3060	133	25	triggering	trigger	VERB
dti-3060	133	26	characteristic	characteristic	ADJ
dti-3060	133	27	cell	cell	NOUN
dti-3060	133	28	shrinking	shrinking	NOUN
dti-3060	133	29	of	of	ADP
dti-3060	133	30	eryptotic	eryptotic	ADJ
dti-3060	133	31	erythrocytes	erythrocyte	NOUN
dti-3060	133	32	.	.	PUNCT
dti-3060	134	1	eryptosis	eryptosis	NOUN
dti-3060	134	2	has	have	VERB
dti-3060	134	3	an	an	DET
dti-3060	134	4	important	important	ADJ
dti-3060	134	5	physiological	physiological	ADJ
dti-3060	134	6	influence	influence	NOUN
dti-3060	134	7	on	on	ADP
dti-3060	134	8	the	the	DET
dti-3060	134	9	disposal	disposal	NOUN
dti-3060	134	10	of	of	ADP
dti-3060	134	11	faulty	faulty	ADJ
dti-3060	134	12	erythrocytes	erythrocyte	NOUN
dti-3060	134	13	prior	prior	ADV
dti-3060	134	14	to	to	ADP
dti-3060	134	15	hemolysis	hemolysis	NOUN
dti-3060	134	16	(	(	PUNCT
dti-3060	134	17	33	33	NUM
dti-3060	134	18	)	)	PUNCT
dti-3060	134	19	.	.	PUNCT
dti-3060	135	1	hemoglobin	hemoglobin	NOUN
dti-3060	135	2	flows	flow	VERB
dti-3060	135	3	out	out	ADP
dti-3060	135	4	from	from	ADP
dti-3060	135	5	hemolyzed	hemolyze	VERB
dti-3060	135	6	cells	cell	NOUN
dti-3060	135	7	that	that	PRON
dti-3060	135	8	may	may	AUX
dti-3060	135	9	be	be	AUX
dti-3060	135	10	contrarily	contrarily	ADV
dti-3060	135	11	filtered	filter	VERB
dti-3060	135	12	in	in	ADP
dti-3060	135	13	the	the	DET
dti-3060	135	14	glomerulus	glomerulus	NOUN
dti-3060	135	15	and	and	CCONJ
dti-3060	135	16	clog	clog	VERB
dti-3060	135	17	the	the	DET
dti-3060	135	18	renal	renal	ADJ
dti-3060	135	19	tubules	tubule	NOUN
dti-3060	135	20	(	(	PUNCT
dti-3060	135	21	34	34	NUM
dti-3060	135	22	)	)	PUNCT
dti-3060	135	23	.	.	PUNCT
dti-3060	136	1	our	our	PRON
dti-3060	136	2	results	result	NOUN
dti-3060	136	3	showed	show	VERB
dti-3060	136	4	a	a	DET
dti-3060	136	5	high	high	ADJ
dti-3060	136	6	increase	increase	NOUN
dti-3060	136	7	in	in	ADP
dti-3060	136	8	%	%	NOUN
dti-3060	136	9	hemolysis	hemolysis	NOUN
dti-3060	136	10	(	(	PUNCT
dti-3060	136	11	fig	fig	NOUN
dti-3060	136	12	.	.	PUNCT
dti-3060	137	1	6	6	NUM
dti-3060	137	2	)	)	PUNCT
dti-3060	137	3	after	after	ADP
dti-3060	137	4	48	48	NUM
dti-3060	137	5	hours	hour	NOUN
dti-3060	137	6	of	of	ADP
dti-3060	137	7	levofloxacin	levofloxacin	NOUN
dti-3060	137	8	exposure	exposure	NOUN
dti-3060	137	9	to	to	ADP
dti-3060	137	10	erythrocytes	erythrocyte	NOUN
dti-3060	137	11	at	at	ADP
dti-3060	137	12	7	7	NUM
dti-3060	137	13	and	and	CCONJ
dti-3060	137	14	14	14	NUM
dti-3060	137	15	µm	µm	NOUN
dti-3060	137	16	.	.	PUNCT
dti-3060	138	1	the	the	DET
dti-3060	138	2	release	release	NOUN
dti-3060	138	3	of	of	ADP
dti-3060	138	4	erythrocyte	erythrocyte	ADJ
dti-3060	138	5	contents	content	NOUN
dti-3060	138	6	,	,	PUNCT
dti-3060	138	7	particularly	particularly	ADV
dti-3060	138	8	hemoglobin	hemoglobin	NOUN
dti-3060	138	9	,	,	PUNCT
dti-3060	138	10	during	during	ADP
dti-3060	138	11	hemolysis	hemolysis	NOUN
dti-3060	138	12	reduces	reduce	VERB
dti-3060	138	13	no	no	DET
dti-3060	138	14	bioavailability	bioavailability	NOUN
dti-3060	138	15	.	.	PUNCT
dti-3060	139	1	this	this	PRON
dti-3060	139	2	may	may	AUX
dti-3060	139	3	lead	lead	VERB
dti-3060	139	4	to	to	ADP
dti-3060	139	5	vasomotor	vasomotor	NOUN
dti-3060	139	6	instabilities	instability	NOUN
dti-3060	139	7	,	,	PUNCT
dti-3060	139	8	systemic	systemic	ADJ
dti-3060	139	9	vasoconstriction	vasoconstriction	NOUN
dti-3060	139	10	,	,	PUNCT
dti-3060	139	11	and	and	CCONJ
dti-3060	139	12	endothelial	endothelial	ADJ
dti-3060	139	13	dysfunction	dysfunction	NOUN
dti-3060	139	14	,	,	PUNCT
dti-3060	139	15	as	as	ADV
dti-3060	139	16	well	well	ADV
dti-3060	139	17	as	as	ADP
dti-3060	139	18	crucial	crucial	ADJ
dti-3060	139	19	clinical	clinical	ADJ
dti-3060	139	20	problems	problem	NOUN
dti-3060	139	21	such	such	ADJ
dti-3060	139	22	as	as	ADP
dti-3060	139	23	hypertension	hypertension	NOUN
dti-3060	139	24	,	,	PUNCT
dti-3060	139	25	respiratory	respiratory	ADJ
dti-3060	139	26	issues	issue	NOUN
dti-3060	139	27	,	,	PUNCT
dti-3060	139	28	cardiovascular	cardiovascular	ADJ
dti-3060	139	29	disorders	disorder	NOUN
dti-3060	139	30	,	,	PUNCT
dti-3060	139	31	impaired	impaired	ADJ
dti-3060	139	32	renal	renal	ADJ
dti-3060	139	33	function	function	NOUN
dti-3060	139	34	,	,	PUNCT
dti-3060	139	35	inflammation	inflammation	NOUN
dti-3060	139	36	,	,	PUNCT
dti-3060	139	37	coagulation	coagulation	NOUN
dti-3060	139	38	,	,	PUNCT
dti-3060	139	39	and	and	CCONJ
dti-3060	139	40	vulnerability	vulnerability	NOUN
dti-3060	139	41	to	to	ADP
dti-3060	139	42	infections	infection	NOUN
dti-3060	139	43	(	(	PUNCT
dti-3060	139	44	35	35	NUM
dti-3060	139	45	)	)	PUNCT
dti-3060	139	46	.	.	PUNCT
dti-3060	140	1	data	datum	NOUN
dti-3060	140	2	availability	availability	NOUN
dti-3060	140	3	statement	statement	NOUN
dti-3060	140	4	the	the	DET
dti-3060	140	5	data	datum	NOUN
dti-3060	140	6	that	that	PRON
dti-3060	140	7	support	support	VERB
dti-3060	140	8	the	the	DET
dti-3060	140	9	findings	finding	NOUN
dti-3060	140	10	of	of	ADP
dti-3060	140	11	this	this	DET
dti-3060	140	12	study	study	NOUN
dti-3060	140	13	are	be	AUX
dti-3060	140	14	available	available	ADJ
dti-3060	140	15	from	from	ADP
dti-3060	140	16	the	the	DET
dti-3060	140	17	corresponding	corresponding	ADJ
dti-3060	140	18	author	author	NOUN
dti-3060	140	19	upon	upon	SCONJ
dti-3060	140	20	reasonable	reasonable	ADJ
dti-3060	140	21	request	request	NOUN
dti-3060	140	22	.	.	PUNCT
dti-3060	141	1	acknowledgments	acknowledgment	NOUN
dti-3060	141	2	acknowledge	acknowledge	VERB
dti-3060	141	3	the	the	DET
dti-3060	141	4	support	support	NOUN
dti-3060	141	5	and	and	CCONJ
dti-3060	141	6	guidance	guidance	NOUN
dti-3060	141	7	of	of	ADP
dti-3060	141	8	the	the	DET
dti-3060	141	9	researchers	researcher	NOUN
dti-3060	141	10	and	and	CCONJ
dti-3060	141	11	mentors	mentor	NOUN
dti-3060	141	12	at	at	ADP
dti-3060	141	13	the	the	DET
dti-3060	141	14	department	department	PROPN
dti-3060	141	15	of	of	ADP
dti-3060	141	16	biochemistry	biochemistry	NOUN
dti-3060	141	17	,	,	PUNCT
dti-3060	141	18	university	university	NOUN
dti-3060	141	19	of	of	ADP
dti-3060	141	20	agriculture	agriculture	PROPN
dti-3060	141	21	faisalabad	faisalabad	PROPN
dti-3060	141	22	.	.	PUNCT
dti-3060	141	23	disclosures	disclosure	VERB
dti-3060	141	24	financial	financial	ADJ
dti-3060	141	25	support	support	NOUN
dti-3060	141	26	:	:	PUNCT
dti-3060	141	27	the	the	DET
dti-3060	141	28	author(s	author(s	NOUN
dti-3060	141	29	)	)	PUNCT
dti-3060	141	30	received	receive	VERB
dti-3060	141	31	no	no	DET
dti-3060	141	32	financial	financial	ADJ
dti-3060	141	33	support	support	NOUN
dti-3060	141	34	for	for	ADP
dti-3060	141	35	the	the	DET
dti-3060	141	36	research	research	NOUN
dti-3060	141	37	,	,	PUNCT
dti-3060	141	38	authorship	authorship	NOUN
dti-3060	141	39	,	,	PUNCT
dti-3060	141	40	and/or	and/or	CCONJ
dti-3060	141	41	publication	publication	NOUN
dti-3060	141	42	of	of	ADP
dti-3060	141	43	this	this	DET
dti-3060	141	44	article	article	NOUN
dti-3060	141	45	.	.	PUNCT
dti-3060	142	1	conflict	conflict	NOUN
dti-3060	142	2	of	of	ADP
dti-3060	142	3	interest	interest	NOUN
dti-3060	142	4	:	:	PUNCT
dti-3060	142	5	the	the	DET
dti-3060	142	6	authors	author	NOUN
dti-3060	142	7	declare	declare	VERB
dti-3060	142	8	no	no	DET
dti-3060	142	9	conflict	conflict	NOUN
dti-3060	142	10	of	of	ADP
dti-3060	142	11	interest	interest	NOUN
dti-3060	142	12	.	.	PUNCT
dti-3060	143	1	references	reference	NOUN
dti-3060	143	2	1	1	NUM
dti-3060	143	3	.	.	X
dti-3060	143	4	trespalacios	trespalacio	NOUN
dti-3060	143	5	-	-	PUNCT
dti-3060	143	6	rangél	rangél	PROPN
dti-3060	143	7	aa	aa	PROPN
dti-3060	143	8	,	,	PUNCT
dti-3060	143	9	otero	otero	PROPN
dti-3060	143	10	w	w	PROPN
dti-3060	143	11	,	,	PUNCT
dti-3060	143	12	arévalo	arévalo	NOUN
dti-3060	143	13	-	-	PUNCT
dti-3060	143	14	galvis	galvis	VERB
dti-3060	143	15	a	a	PRON
dti-3060	143	16	,	,	PUNCT
dti-3060	143	17	poutoupiñales	poutoupiñale	NOUN
dti-3060	143	18	ra	ra	PROPN
dti-3060	143	19	,	,	PUNCT
dti-3060	143	20	rimbara	rimbara	NOUN
dti-3060	143	21	e	e	PROPN
dti-3060	143	22	,	,	PUNCT
dti-3060	143	23	graham	graham	PROPN
dti-3060	143	24	dy	dy	PROPN
dti-3060	143	25	.	.	PROPN
dti-3060	144	1	surveillance	surveillance	NOUN
dti-3060	144	2	of	of	ADP
dti-3060	144	3	levofloxacin	levofloxacin	PROPN
dti-3060	144	4	resistance	resistance	NOUN
dti-3060	144	5	in	in	ADP
dti-3060	144	6	helicobacter	helicobacter	NOUN
dti-3060	144	7	pylori	pylori	NOUN
dti-3060	144	8	isolates	isolate	NOUN
dti-3060	144	9	in	in	ADP
dti-3060	144	10	bogotá	bogotá	NOUN
dti-3060	144	11	-	-	PUNCT
dti-3060	144	12	colombia	colombia	PROPN
dti-3060	144	13	(	(	PUNCT
dti-3060	144	14	2009	2009	NUM
dti-3060	144	15	-	-	SYM
dti-3060	144	16	2014	2014	NUM
dti-3060	144	17	)	)	PUNCT
dti-3060	144	18	.	.	PUNCT
dti-3060	145	1	plos	plos	PROPN
dti-3060	145	2	one	one	NUM
dti-3060	145	3	.	.	PUNCT
dti-3060	146	1	2016;11(7):e0160007	2016;11(7):e0160007	NUM
dti-3060	146	2	.	.	PUNCT
dti-3060	146	3	crossref	crossref	PROPN
dti-3060	146	4	pubmed	pubmed	PROPN
dti-3060	146	5	2	2	PROPN
dti-3060	146	6	.	.	PUNCT
dti-3060	146	7	sitovs	sitovs	PROPN
dti-3060	146	8	a	a	PRON
dti-3060	146	9	,	,	PUNCT
dti-3060	146	10	sartini	sartini	X
dti-3060	146	11	i	i	PROPN
dti-3060	146	12	,	,	PUNCT
dti-3060	146	13	giorgi	giorgi	PROPN
dti-3060	146	14	m.	m.	NOUN
dti-3060	146	15	levofloxacin	levofloxacin	PROPN
dti-3060	146	16	in	in	ADP
dti-3060	146	17	veterinary	veterinary	ADJ
dti-3060	146	18	medicine	medicine	NOUN
dti-3060	146	19	:	:	PUNCT
dti-3060	146	20	a	a	DET
dti-3060	146	21	literature	literature	NOUN
dti-3060	146	22	review	review	NOUN
dti-3060	146	23	.	.	PUNCT
dti-3060	147	1	res	res	PROPN
dti-3060	147	2	vet	vet	PROPN
dti-3060	147	3	sci	sci	PROPN
dti-3060	147	4	.	.	PUNCT
dti-3060	148	1	2021;137:111	2021;137:111	NUM
dti-3060	148	2	-	-	SYM
dti-3060	148	3	126	126	NUM
dti-3060	148	4	.	.	PUNCT
dti-3060	149	1	crossref	crossref	PROPN
dti-3060	149	2	pubmed	pubmed	PROPN
dti-3060	149	3	3	3	PROPN
dti-3060	149	4	.	.	PUNCT
dti-3060	150	1	zusso	zusso	PROPN
dti-3060	150	2	m	m	PROPN
dti-3060	150	3	,	,	PUNCT
dti-3060	150	4	lunardi	lunardi	PROPN
dti-3060	150	5	v	v	NOUN
dti-3060	150	6	,	,	PUNCT
dti-3060	150	7	franceschini	franceschini	PROPN
dti-3060	150	8	d	d	PROPN
dti-3060	150	9	,	,	PUNCT
dti-3060	150	10	et	et	PROPN
dti-3060	150	11	al	al	PROPN
dti-3060	150	12	.	.	PROPN
dti-3060	150	13	ciprofloxacin	ciprofloxacin	PROPN
dti-3060	150	14	and	and	CCONJ
dti-3060	150	15	levofloxacin	levofloxacin	NOUN
dti-3060	150	16	attenuate	attenuate	VERB
dti-3060	150	17	microglia	microglia	ADJ
dti-3060	150	18	inflammatory	inflammatory	ADJ
dti-3060	150	19	response	response	NOUN
dti-3060	150	20	via	via	ADP
dti-3060	150	21	figure	figure	NOUN
dti-3060	150	22	7	7	NUM
dti-3060	150	23	the	the	DET
dti-3060	150	24	%	%	NOUN
dti-3060	150	25	hemolysis	hemolysis	NOUN
dti-3060	150	26	effect	effect	NOUN
dti-3060	150	27	of	of	ADP
dti-3060	150	28	levofloxacin	levofloxacin	NOUN
dti-3060	150	29	in	in	ADP
dti-3060	150	30	red	red	ADJ
dti-3060	150	31	cells	cell	NOUN
dti-3060	150	32	is	be	AUX
dti-3060	150	33	shown	show	VERB
dti-3060	150	34	.	.	PUNCT
dti-3060	151	1	the	the	DET
dti-3060	151	2	arithmetic	arithmetic	ADJ
dti-3060	151	3	mean	mean	PROPN
dti-3060	151	4	±	±	NUM
dti-3060	151	5	sem	sem	NOUN
dti-3060	151	6	(	(	PUNCT
dti-3060	151	7	n	n	NOUN
dti-3060	151	8	=	=	NUM
dti-3060	151	9	12	12	NUM
dti-3060	151	10	)	)	PUNCT
dti-3060	151	11	for	for	ADP
dti-3060	151	12	erythrocytes	erythrocyte	NOUN
dti-3060	151	13	incubated	incubate	VERB
dti-3060	151	14	in	in	ADP
dti-3060	151	15	ringer	ringer	NOUN
dti-3060	151	16	’s	’s	PART
dti-3060	151	17	solution	solution	NOUN
dti-3060	151	18	with	with	ADP
dti-3060	151	19	7	7	NUM
dti-3060	151	20	and	and	CCONJ
dti-3060	151	21	14	14	NUM
dti-3060	151	22	µm	µm	NUM
dti-3060	151	23	levofloxacin	levofloxacin	NOUN
dti-3060	151	24	(	(	PUNCT
dti-3060	151	25	in	in	ADP
dti-3060	151	26	black	black	ADJ
dti-3060	151	27	bars	bar	NOUN
dti-3060	151	28	)	)	PUNCT
dti-3060	151	29	and	and	CCONJ
dti-3060	151	30	without	without	ADP
dti-3060	151	31	levofloxacin	levofloxacin	PROPN
dti-3060	151	32	(	(	PUNCT
dti-3060	151	33	in	in	ADP
dti-3060	151	34	white	white	ADJ
dti-3060	151	35	bar	bar	NOUN
dti-3060	151	36	)	)	PUNCT
dti-3060	151	37	for	for	ADP
dti-3060	151	38	48	48	NUM
dti-3060	151	39	hours	hour	NOUN
dti-3060	151	40	is	be	AUX
dti-3060	151	41	presented	present	VERB
dti-3060	151	42	,	,	PUNCT
dti-3060	151	43	with	with	ADP
dti-3060	151	44	the	the	DET
dti-3060	151	45	y	y	NOUN
dti-3060	151	46	-	-	PUNCT
dti-3060	151	47	axis	axis	NOUN
dti-3060	151	48	indicating	indicate	VERB
dti-3060	151	49	sem	sem	NOUN
dti-3060	151	50	.	.	PUNCT
dti-3060	152	1	*	*	PUNCT
dti-3060	152	2	*	*	PUNCT
dti-3060	152	3	(	(	PUNCT
dti-3060	152	4	p	p	X
dti-3060	152	5	<	<	X
dti-3060	152	6	0.01	0.01	NUM
dti-3060	152	7	)	)	PUNCT
dti-3060	152	8	and	and	CCONJ
dti-3060	152	9	*	*	PUNCT
dti-3060	153	1	*	*	PUNCT
dti-3060	153	2	*	*	PUNCT
dti-3060	153	3	(	(	PUNCT
dti-3060	153	4	p	p	X
dti-3060	153	5	<	<	X
dti-3060	153	6	0.001	0.001	NUM
dti-3060	153	7	)	)	PUNCT
dti-3060	153	8	served	serve	VERB
dti-3060	153	9	to	to	PART
dti-3060	153	10	emphasize	emphasize	VERB
dti-3060	153	11	notable	notable	ADJ
dti-3060	153	12	differences	difference	NOUN
dti-3060	153	13	in	in	ADP
dti-3060	153	14	comparison	comparison	NOUN
dti-3060	153	15	to	to	ADP
dti-3060	153	16	the	the	DET
dti-3060	153	17	absence	absence	NOUN
dti-3060	153	18	of	of	ADP
dti-3060	153	19	levofloxacin	levofloxacin	NOUN
dti-3060	153	20	at	at	ADP
dti-3060	153	21	7	7	NUM
dti-3060	153	22	and	and	CCONJ
dti-3060	153	23	14	14	NUM
dti-3060	153	24	µm	µm	NOUN
dti-3060	153	25	,	,	PUNCT
dti-3060	153	26	respectively	respectively	ADV
dti-3060	153	27	(	(	PUNCT
dti-3060	153	28	anova	anova	PROPN
dti-3060	153	29	)	)	PUNCT
dti-3060	153	30	,	,	PUNCT
dti-3060	153	31	while	while	SCONJ
dti-3060	153	32	#	#	SYM
dti-3060	153	33	#	#	NOUN
dti-3060	153	34	reflects	reflect	VERB
dti-3060	153	35	distinctions	distinction	NOUN
dti-3060	153	36	between	between	ADP
dti-3060	153	37	the	the	DET
dti-3060	153	38	%	%	NOUN
dti-3060	153	39	hemolysis	hemolysis	NOUN
dti-3060	153	40	at	at	ADP
dti-3060	153	41	7	7	NUM
dti-3060	153	42	and	and	CCONJ
dti-3060	153	43	14	14	NUM
dti-3060	153	44	µm	µm	NOUN
dti-3060	153	45	levofloxacin	levofloxacin	PROPN
dti-3060	153	46	concentration	concentration	NOUN
dti-3060	153	47	.	.	PUNCT
dti-3060	154	1	anova	anova	PROPN
dti-3060	155	1	=	=	PUNCT
dti-3060	155	2	analysis	analysis	NOUN
dti-3060	155	3	of	of	ADP
dti-3060	155	4	variance	variance	NOUN
dti-3060	155	5	;	;	PUNCT
dti-3060	155	6	sem	sem	NOUN
dti-3060	155	7	=	=	SYM
dti-3060	155	8	standard	standard	ADJ
dti-3060	155	9	error	error	NOUN
dti-3060	155	10	of	of	ADP
dti-3060	155	11	the	the	DET
dti-3060	155	12	mean	mean	NOUN
dti-3060	155	13	.	.	PUNCT
dti-3060	156	1	https://doi.org/10.1371/journal.pone.0160007	https://doi.org/10.1371/journal.pone.0160007	VERB
dti-3060	156	2	https://www.ncbi.nlm.nih.gov/pubmed/27454429	https://www.ncbi.nlm.nih.gov/pubmed/27454429	NUM
dti-3060	156	3	https://doi.org/10.1016/j.rvsc.2021.04.031	https://doi.org/10.1016/j.rvsc.2021.04.031	PROPN
dti-3060	156	4	https://www.ncbi.nlm.nih.gov/pubmed/33964616	https://www.ncbi.nlm.nih.gov/pubmed/33964616	PROPN
dti-3060	156	5	aslam	aslam	PROPN
dti-3060	156	6	et	et	PROPN
dti-3060	156	7	al	al	PROPN
dti-3060	156	8	drug	drug	PROPN
dti-3060	156	9	target	target	NOUN
dti-3060	156	10	insights	insight	NOUN
dti-3060	156	11	2024	2024	NUM
dti-3060	156	12	;	;	PUNCT
dti-3060	156	13	18	18	NUM
dti-3060	156	14	:	:	SYM
dti-3060	156	15	83	83	NUM
dti-3060	156	16	©	©	ADP
dti-3060	156	17	2024	2024	NUM
dti-3060	156	18	the	the	DET
dti-3060	156	19	authors	author	NOUN
dti-3060	156	20	.	.	PUNCT
dti-3060	157	1	published	publish	VERB
dti-3060	157	2	by	by	ADP
dti-3060	157	3	aboutscience	aboutscience	NOUN
dti-3060	157	4	www.aboutscience.eu	www.aboutscience.eu	PROPN
dti-3060	157	5	tlr4	tlr4	PROPN
dti-3060	157	6	/	/	SYM
dti-3060	157	7	nf	nf	PROPN
dti-3060	157	8	-	-	PUNCT
dti-3060	157	9	kb	kb	NOUN
dti-3060	157	10	pathway	pathway	NOUN
dti-3060	157	11	.	.	PUNCT
dti-3060	158	1	j	j	PROPN
dti-3060	158	2	neuroinflammation	neuroinflammation	PROPN
dti-3060	158	3	.	.	PUNCT
dti-3060	159	1	2019;16(1):148	2019;16(1):148	NUM
dti-3060	159	2	.	.	PUNCT
dti-3060	160	1	crossref	crossref	PROPN
dti-3060	160	2	pubmed	pubmed	PROPN
dti-3060	160	3	4	4	PROPN
dti-3060	160	4	.	.	PUNCT
dti-3060	160	5	talla	talla	PROPN
dti-3060	160	6	v	v	PROPN
dti-3060	160	7	,	,	PUNCT
dti-3060	160	8	veerareddy	veerareddy	NOUN
dti-3060	160	9	p.	p.	PROPN
dti-3060	160	10	oxidative	oxidative	ADJ
dti-3060	160	11	stress	stress	NOUN
dti-3060	160	12	induced	induce	VERB
dti-3060	160	13	by	by	ADP
dti-3060	160	14	fluoroquinolones	fluoroquinolone	NOUN
dti-3060	160	15	on	on	ADP
dti-3060	160	16	treatment	treatment	NOUN
dti-3060	160	17	for	for	ADP
dti-3060	160	18	complicated	complicated	ADJ
dti-3060	160	19	urinary	urinary	ADJ
dti-3060	160	20	tract	tract	NOUN
dti-3060	160	21	infections	infection	NOUN
dti-3060	160	22	in	in	ADP
dti-3060	160	23	indian	indian	ADJ
dti-3060	160	24	patients	patient	NOUN
dti-3060	160	25	.	.	PUNCT
dti-3060	161	1	j	j	PROPN
dti-3060	161	2	young	young	ADJ
dti-3060	161	3	pharm	pharm	NOUN
dti-3060	161	4	.	.	PUNCT
dti-3060	162	1	2011;3(4):304	2011;3(4):304	NUM
dti-3060	162	2	-	-	NUM
dti-3060	162	3	309	309	NUM
dti-3060	162	4	.	.	PUNCT
dti-3060	163	1	crossref	crossref	PROPN
dti-3060	163	2	pubmed	pubmed	PROPN
dti-3060	163	3	5	5	PROPN
dti-3060	163	4	.	.	PUNCT
dti-3060	164	1	abdullah	abdullah	PROPN
dti-3060	164	2	ra	ra	PROPN
dti-3060	164	3	,	,	PUNCT
dti-3060	164	4	taee	taee	PROPN
dti-3060	164	5	fd	fd	PROPN
dti-3060	164	6	,	,	PUNCT
dti-3060	164	7	thanoon	thanoon	PROPN
dti-3060	164	8	ia	ia	PROPN
dti-3060	164	9	.	.	PROPN
dti-3060	164	10	effect	effect	NOUN
dti-3060	164	11	of	of	ADP
dti-3060	164	12	levofloxacin	levofloxacin	NOUN
dti-3060	164	13	on	on	ADP
dti-3060	164	14	some	some	DET
dti-3060	164	15	body	body	NOUN
dti-3060	164	16	tissues	tissue	NOUN
dti-3060	164	17	in	in	ADP
dti-3060	164	18	mice	mouse	NOUN
dti-3060	164	19	.	.	PUNCT
dti-3060	165	1	iraqi	iraqi	ADJ
dti-3060	165	2	j	j	PROPN
dti-3060	165	3	vet	vet	PROPN
dti-3060	165	4	sci	sci	PROPN
dti-3060	165	5	.	.	PUNCT
dti-3060	166	1	2021;35(1):109	2021;35(1):109	NUM
dti-3060	166	2	-	-	PUNCT
dti-3060	166	3	111	111	NUM
dti-3060	166	4	.	.	PUNCT
dti-3060	167	1	crossref	crossref	PROPN
dti-3060	167	2	6	6	NUM
dti-3060	167	3	.	.	PUNCT
dti-3060	168	1	sies	sies	PROPN
dti-3060	168	2	h.	h.	PROPN
dti-3060	168	3	the	the	DET
dti-3060	168	4	concept	concept	NOUN
dti-3060	168	5	of	of	ADP
dti-3060	168	6	oxidative	oxidative	ADJ
dti-3060	168	7	stress	stress	NOUN
dti-3060	168	8	after	after	ADP
dti-3060	168	9	30	30	NUM
dti-3060	168	10	years	year	NOUN
dti-3060	168	11	.	.	PUNCT
dti-3060	169	1	in	in	ADP
dti-3060	169	2	:	:	PUNCT
dti-3060	169	3	gelpi	gelpi	NOUN
dti-3060	169	4	r	r	NOUN
dti-3060	169	5	,	,	PUNCT
dti-3060	169	6	boveris	boveris	VERB
dti-3060	169	7	a	a	PRON
dti-3060	169	8	,	,	PUNCT
dti-3060	169	9	poderoso	poderoso	PROPN
dti-3060	169	10	j	j	PROPN
dti-3060	169	11	,	,	PUNCT
dti-3060	169	12	eds	eds	PROPN
dti-3060	169	13	.	.	PUNCT
dti-3060	170	1	biochemistry	biochemistry	NOUN
dti-3060	170	2	of	of	ADP
dti-3060	170	3	oxidative	oxidative	ADJ
dti-3060	170	4	stress	stress	NOUN
dti-3060	170	5	.	.	PUNCT
dti-3060	171	1	advances	advance	NOUN
dti-3060	171	2	in	in	ADP
dti-3060	171	3	biochemistry	biochemistry	NOUN
dti-3060	171	4	in	in	ADP
dti-3060	171	5	health	health	NOUN
dti-3060	171	6	and	and	CCONJ
dti-3060	171	7	disease	disease	NOUN
dti-3060	171	8	.	.	PUNCT
dti-3060	172	1	vol	vol	NOUN
dti-3060	172	2	16	16	NUM
dti-3060	172	3	.	.	PUNCT
dti-3060	173	1	cham	cham	PROPN
dti-3060	173	2	:	:	PUNCT
dti-3060	173	3	springer	springer	NOUN
dti-3060	173	4	;	;	PUNCT
dti-3060	173	5	2016	2016	NUM
dti-3060	173	6	.	.	PUNCT
dti-3060	174	1	crossref	crossref	PROPN
dti-3060	174	2	7	7	NUM
dti-3060	174	3	.	.	PUNCT
dti-3060	175	1	haider	haider	PROPN
dti-3060	175	2	k	k	PROPN
dti-3060	175	3	,	,	PUNCT
dti-3060	175	4	haider	haider	PROPN
dti-3060	175	5	mr	mr	PROPN
dti-3060	175	6	,	,	PUNCT
dti-3060	175	7	neha	neha	NOUN
dti-3060	175	8	k	k	PROPN
dti-3060	175	9	,	,	PUNCT
dti-3060	175	10	yar	yar	PROPN
dti-3060	175	11	ms	ms	PROPN
dti-3060	175	12	.	.	PROPN
dti-3060	175	13	free	free	ADJ
dti-3060	175	14	radical	radical	ADJ
dti-3060	175	15	scavengers	scavenger	NOUN
dti-3060	175	16	:	:	PUNCT
dti-3060	175	17	an	an	DET
dti-3060	175	18	overview	overview	NOUN
dti-3060	175	19	on	on	ADP
dti-3060	175	20	heterocyclic	heterocyclic	ADJ
dti-3060	175	21	advances	advance	NOUN
dti-3060	175	22	and	and	CCONJ
dti-3060	175	23	medicinal	medicinal	ADJ
dti-3060	175	24	prospects	prospect	NOUN
dti-3060	175	25	.	.	PUNCT
dti-3060	176	1	eur	eur	PROPN
dti-3060	176	2	j	j	PROPN
dti-3060	176	3	med	med	PROPN
dti-3060	176	4	chem	chem	NOUN
dti-3060	176	5	.	.	PUNCT
dti-3060	177	1	2020;204:112607	2020;204:112607	NUM
dti-3060	177	2	.	.	PUNCT
dti-3060	178	1	pubmed	pubmed	PROPN
dti-3060	178	2	pmid:32721784	pmid:32721784	PROPN
dti-3060	178	3	crossref	crossref	PROPN
dti-3060	178	4	pubmed	pubmed	PROPN
dti-3060	178	5	8	8	PROPN
dti-3060	178	6	.	.	PUNCT
dti-3060	179	1	mani	mani	PROPN
dti-3060	179	2	s	s	PROPN
dti-3060	179	3	,	,	PUNCT
dti-3060	179	4	tyagi	tyagi	PROPN
dti-3060	179	5	s	s	PROPN
dti-3060	179	6	,	,	PUNCT
dti-3060	179	7	pal	pal	ADJ
dti-3060	179	8	kv	kv	PROPN
dti-3060	179	9	,	,	PUNCT
dti-3060	179	10	et	et	PROPN
dti-3060	179	11	al	al	PROPN
dti-3060	179	12	.	.	PROPN
dti-3060	179	13	drug	drug	NOUN
dti-3060	179	14	-	-	PUNCT
dti-3060	179	15	induced	induce	VERB
dti-3060	179	16	oxidative	oxidative	ADJ
dti-3060	179	17	stress	stress	NOUN
dti-3060	179	18	and	and	CCONJ
dti-3060	179	19	cellular	cellular	ADJ
dti-3060	179	20	toxicity	toxicity	NOUN
dti-3060	179	21	.	.	PUNCT
dti-3060	180	1	in	in	ADP
dti-3060	180	2	:	:	PUNCT
dti-3060	180	3	kesari	kesari	PROPN
dti-3060	180	4	kk	kk	PROPN
dti-3060	180	5	,	,	PUNCT
dti-3060	180	6	jha	jha	PROPN
dti-3060	180	7	nk	nk	PROPN
dti-3060	180	8	,	,	PUNCT
dti-3060	180	9	eds	eds	PROPN
dti-3060	180	10	.	.	PUNCT
dti-3060	180	11	free	free	ADJ
dti-3060	180	12	radical	radical	ADJ
dti-3060	180	13	biology	biology	NOUN
dti-3060	180	14	and	and	CCONJ
dti-3060	180	15	environmental	environmental	ADJ
dti-3060	180	16	toxicity	toxicity	NOUN
dti-3060	180	17	.	.	PUNCT
dti-3060	180	18	springer	springer	NOUN
dti-3060	180	19	;	;	PUNCT
dti-3060	180	20	2022	2022	NUM
dti-3060	180	21	:	:	PUNCT
dti-3060	180	22	73	73	NUM
dti-3060	180	23	-	-	SYM
dti-3060	180	24	113	113	NUM
dti-3060	180	25	.	.	PUNCT
dti-3060	181	1	crossref	crossref	NOUN
dti-3060	181	2	9	9	NUM
dti-3060	181	3	.	.	PUNCT
dti-3060	182	1	lang	lang	PROPN
dti-3060	182	2	f	f	PROPN
dti-3060	182	3	,	,	PUNCT
dti-3060	182	4	jilani	jilani	PROPN
dti-3060	182	5	k	k	PROPN
dti-3060	182	6	,	,	PUNCT
dti-3060	183	1	lang	lang	PROPN
dti-3060	183	2	e.	e.	PROPN
dti-3060	183	3	therapeutic	therapeutic	PROPN
dti-3060	183	4	potential	potential	NOUN
dti-3060	183	5	of	of	ADP
dti-3060	183	6	manipulating	manipulate	VERB
dti-3060	183	7	suicidal	suicidal	ADJ
dti-3060	183	8	erythrocyte	erythrocyte	NOUN
dti-3060	183	9	death	death	NOUN
dti-3060	183	10	.	.	PUNCT
dti-3060	184	1	expert	expert	NOUN
dti-3060	184	2	opin	opin	NOUN
dti-3060	184	3	ther	ther	ADJ
dti-3060	184	4	targets	target	NOUN
dti-3060	184	5	.	.	PUNCT
dti-3060	185	1	2015;19(9):1219	2015;19(9):1219	NUM
dti-3060	185	2	-	-	PUNCT
dti-3060	185	3	1227	1227	NUM
dti-3060	185	4	.	.	PUNCT
dti-3060	186	1	crossref	crossref	PROPN
dti-3060	186	2	pubmed	pubmed	PROPN
dti-3060	186	3	10	10	PROPN
dti-3060	186	4	.	.	PUNCT
dti-3060	187	1	pyrshev	pyrshev	PROPN
dti-3060	187	2	ka	ka	PROPN
dti-3060	187	3	,	,	PUNCT
dti-3060	187	4	klymchenko	klymchenko	VERB
dti-3060	187	5	as	as	ADP
dti-3060	187	6	,	,	PUNCT
dti-3060	187	7	csúcs	csúcs	PROPN
dti-3060	187	8	g	g	PROPN
dti-3060	187	9	,	,	PUNCT
dti-3060	187	10	demchenko	demchenko	VERB
dti-3060	187	11	ap	ap	PROPN
dti-3060	187	12	.	.	PUNCT
dti-3060	188	1	apoptosis	apoptosis	NOUN
dti-3060	188	2	and	and	CCONJ
dti-3060	188	3	eryptosis	eryptosis	NOUN
dti-3060	188	4	:	:	PUNCT
dti-3060	188	5	striking	strike	VERB
dti-3060	188	6	differences	difference	NOUN
dti-3060	188	7	on	on	ADP
dti-3060	188	8	biomembrane	biomembrane	ADJ
dti-3060	188	9	level	level	NOUN
dti-3060	188	10	.	.	PUNCT
dti-3060	189	1	biochim	biochim	PROPN
dti-3060	189	2	biophys	biophy	NOUN
dti-3060	189	3	acta	acta	PROPN
dti-3060	189	4	biomembr	biomembr	NOUN
dti-3060	189	5	.	.	PUNCT
dti-3060	190	1	2018;1860(6):13621371	2018;1860(6):13621371	X
dti-3060	190	2	.	.	PUNCT
dti-3060	191	1	crossref	crossref	PROPN
dti-3060	191	2	pubmed	pubmed	PROPN
dti-3060	191	3	11	11	NUM
dti-3060	191	4	.	.	PUNCT
dti-3060	192	1	dreischer	dreischer	PROPN
dti-3060	192	2	p	p	NOUN
dti-3060	192	3	,	,	PUNCT
dti-3060	192	4	duszenko	duszenko	PROPN
dti-3060	192	5	m	m	PROPN
dti-3060	192	6	,	,	PUNCT
dti-3060	192	7	stein	stein	PROPN
dti-3060	192	8	j	j	PROPN
dti-3060	192	9	,	,	PUNCT
dti-3060	192	10	wieder	wieder	NOUN
dti-3060	192	11	t.	t.	PROPN
dti-3060	192	12	eryptosis	eryptosis	PROPN
dti-3060	192	13	:	:	PUNCT
dti-3060	192	14	programmed	program	VERB
dti-3060	192	15	death	death	NOUN
dti-3060	192	16	of	of	ADP
dti-3060	192	17	nucleus	nucleus	NOUN
dti-3060	192	18	-	-	PUNCT
dti-3060	192	19	free	free	ADJ
dti-3060	192	20	,	,	PUNCT
dti-3060	192	21	iron	iron	NOUN
dti-3060	192	22	-	-	PUNCT
dti-3060	192	23	filled	fill	VERB
dti-3060	192	24	blood	blood	NOUN
dti-3060	192	25	cells	cell	NOUN
dti-3060	192	26	.	.	PUNCT
dti-3060	193	1	cells	cell	NOUN
dti-3060	193	2	.	.	PUNCT
dti-3060	194	1	2022	2022	NUM
dti-3060	194	2	feb	feb	PROPN
dti-3060	194	3	1;11(3):503	1;11(3):503	NUM
dti-3060	194	4	.	.	PUNCT
dti-3060	195	1	crossref	crossref	PROPN
dti-3060	195	2	pubmed	pubmed	PROPN
dti-3060	195	3	12	12	NUM
dti-3060	195	4	.	.	PUNCT
dti-3060	196	1	lang	lang	PROPN
dti-3060	196	2	f	f	PROPN
dti-3060	196	3	,	,	PUNCT
dti-3060	196	4	lang	lang	PROPN
dti-3060	196	5	ks	ks	PROPN
dti-3060	196	6	,	,	PUNCT
dti-3060	196	7	lang	lang	PROPN
dti-3060	196	8	pa	pa	PROPN
dti-3060	196	9	,	,	PUNCT
dti-3060	196	10	huber	huber	PROPN
dti-3060	196	11	sm	sm	PROPN
dti-3060	196	12	,	,	PUNCT
dti-3060	196	13	wieder	wieder	NOUN
dti-3060	196	14	t.	t.	NOUN
dti-3060	196	15	mechanisms	mechanism	NOUN
dti-3060	196	16	and	and	CCONJ
dti-3060	196	17	significance	significance	NOUN
dti-3060	196	18	of	of	ADP
dti-3060	196	19	eryptosis	eryptosis	NOUN
dti-3060	196	20	.	.	PUNCT
dti-3060	197	1	antioxid	antioxid	NOUN
dti-3060	197	2	redox	redox	NOUN
dti-3060	197	3	signal	signal	NOUN
dti-3060	197	4	.	.	PUNCT
dti-3060	198	1	2006	2006	NUM
dti-3060	198	2	;	;	PUNCT
dti-3060	198	3	8(7	8(7	NUM
dti-3060	198	4	-	-	PUNCT
dti-3060	198	5	8):1183	8):1183	NUM
dti-3060	198	6	-	-	PUNCT
dti-3060	198	7	1192	1192	NUM
dti-3060	198	8	.	.	PUNCT
dti-3060	199	1	crossref	crossref	PROPN
dti-3060	199	2	pubmed	pubmed	PROPN
dti-3060	199	3	13	13	NUM
dti-3060	199	4	.	.	PUNCT
dti-3060	200	1	lang	lang	PROPN
dti-3060	200	2	f	f	PROPN
dti-3060	200	3	,	,	PUNCT
dti-3060	200	4	gulbins	gulbin	NOUN
dti-3060	200	5	e	e	NOUN
dti-3060	200	6	,	,	PUNCT
dti-3060	200	7	lerche	lerche	PROPN
dti-3060	200	8	h	h	PROPN
dti-3060	200	9	,	,	PUNCT
dti-3060	200	10	huber	huber	PROPN
dti-3060	200	11	sm	sm	PROPN
dti-3060	200	12	,	,	PUNCT
dti-3060	200	13	kempe	kempe	ADJ
dti-3060	200	14	ds	ds	PROPN
dti-3060	200	15	,	,	PUNCT
dti-3060	200	16	foller	foller	NOUN
dti-3060	200	17	m.	m.	NOUN
dti-3060	200	18	eryptosis	eryptosis	PROPN
dti-3060	200	19	,	,	PUNCT
dti-3060	200	20	a	a	DET
dti-3060	200	21	window	window	NOUN
dti-3060	200	22	to	to	ADP
dti-3060	200	23	systemic	systemic	ADJ
dti-3060	200	24	disease	disease	NOUN
dti-3060	200	25	.	.	PUNCT
dti-3060	201	1	cell	cell	NOUN
dti-3060	201	2	physiol	physiol	PROPN
dti-3060	201	3	biochem	biochem	PROPN
dti-3060	201	4	.	.	PUNCT
dti-3060	202	1	2008;22(5	2008;22(5	NUM
dti-3060	202	2	-	-	PUNCT
dti-3060	202	3	6):373	6):373	PROPN
dti-3060	202	4	-	-	PUNCT
dti-3060	202	5	380	380	NUM
dti-3060	202	6	.	.	PUNCT
dti-3060	203	1	crossref	crossref	PROPN
dti-3060	203	2	pubmed	pubmed	PROPN
dti-3060	203	3	14	14	PROPN
dti-3060	203	4	.	.	PUNCT
dti-3060	204	1	pretorius	pretorius	PROPN
dti-3060	204	2	e	e	PROPN
dti-3060	204	3	,	,	PUNCT
dti-3060	204	4	du	du	PROPN
dti-3060	204	5	plooy	plooy	PROPN
dti-3060	204	6	jn	jn	PROPN
dti-3060	204	7	,	,	PUNCT
dti-3060	204	8	bester	bester	PROPN
dti-3060	204	9	j.	j.	PROPN
dti-3060	204	10	a	a	DET
dti-3060	204	11	comprehensive	comprehensive	ADJ
dti-3060	204	12	review	review	NOUN
dti-3060	204	13	on	on	ADP
dti-3060	204	14	eryptosis	eryptosis	NOUN
dti-3060	204	15	.	.	PUNCT
dti-3060	205	1	cell	cell	PROPN
dti-3060	205	2	physiol	physiol	PROPN
dti-3060	205	3	biochem	biochem	PROPN
dti-3060	205	4	.	.	PUNCT
dti-3060	206	1	2016;39(5):1977	2016;39(5):1977	PROPN
dti-3060	206	2	-	-	SYM
dti-3060	206	3	2000	2000	NUM
dti-3060	206	4	.	.	PUNCT
dti-3060	207	1	crossref	crossref	PROPN
dti-3060	207	2	pubmed	pubmed	PROPN
dti-3060	207	3	15	15	PROPN
dti-3060	207	4	.	.	PUNCT
dti-3060	208	1	fink	fink	PROPN
dti-3060	208	2	m	m	PROPN
dti-3060	208	3	,	,	PUNCT
dti-3060	208	4	al	al	PROPN
dti-3060	208	5	mamun	mamun	PROPN
dti-3060	208	6	bhuyan	bhuyan	PROPN
dti-3060	208	7	a	a	PROPN
dti-3060	208	8	,	,	PUNCT
dti-3060	208	9	zacharopoulou	zacharopoulou	PROPN
dti-3060	208	10	n	n	CCONJ
dti-3060	208	11	,	,	PUNCT
dti-3060	208	12	lang	lang	PROPN
dti-3060	208	13	f.	f.	PROPN
dti-3060	208	14	stimulation	stimulation	PROPN
dti-3060	208	15	of	of	ADP
dti-3060	208	16	eryptosis	eryptosis	NOUN
dti-3060	208	17	,	,	PUNCT
dti-3060	208	18	the	the	DET
dti-3060	208	19	suicidal	suicidal	ADJ
dti-3060	208	20	erythrocyte	erythrocyte	NOUN
dti-3060	208	21	death	death	NOUN
dti-3060	208	22	,	,	PUNCT
dti-3060	208	23	by	by	ADP
dti-3060	208	24	costunolide	costunolide	NOUN
dti-3060	208	25	.	.	PUNCT
dti-3060	209	1	cell	cell	PROPN
dti-3060	209	2	physiol	physiol	PROPN
dti-3060	209	3	biochem	biochem	PROPN
dti-3060	209	4	.	.	PUNCT
dti-3060	210	1	2018;50(6):2283	2018;50(6):2283	NUM
dti-3060	210	2	-	-	SYM
dti-3060	210	3	2295	2295	NUM
dti-3060	210	4	.	.	PUNCT
dti-3060	211	1	crossref	crossref	PROPN
dti-3060	211	2	pubmed	pubmed	PROPN
dti-3060	211	3	16	16	NUM
dti-3060	211	4	.	.	PUNCT
dti-3060	212	1	bissinger	bissing	ADJ
dti-3060	212	2	r	r	NOUN
dti-3060	212	3	,	,	PUNCT
dti-3060	212	4	malik	malik	X
dti-3060	212	5	a	a	X
dti-3060	212	6	,	,	PUNCT
dti-3060	212	7	jilani	jilani	PROPN
dti-3060	212	8	k	k	PROPN
dti-3060	212	9	,	,	PUNCT
dti-3060	212	10	lang	lang	PROPN
dti-3060	212	11	f.	f.	PROPN
dti-3060	212	12	triggering	triggering	PROPN
dti-3060	212	13	of	of	ADP
dti-3060	212	14	erythrocyte	erythrocyte	NOUN
dti-3060	212	15	cell	cell	NOUN
dti-3060	212	16	membrane	membrane	NOUN
dti-3060	212	17	scrambling	scramble	VERB
dti-3060	212	18	by	by	ADP
dti-3060	212	19	salinomycin	salinomycin	NOUN
dti-3060	212	20	.	.	PUNCT
dti-3060	213	1	basic	basic	ADJ
dti-3060	213	2	clin	clin	PROPN
dti-3060	213	3	pharmacol	pharmacol	PROPN
dti-3060	213	4	toxicol	toxicol	PROPN
dti-3060	213	5	.	.	PUNCT
dti-3060	214	1	2014;115(5):396	2014;115(5):396	NUM
dti-3060	214	2	-	-	SYM
dti-3060	214	3	402	402	NUM
dti-3060	214	4	.	.	PUNCT
dti-3060	215	1	crossref	crossref	PROPN
dti-3060	215	2	pubmed	pubmed	PROPN
dti-3060	215	3	17	17	NUM
dti-3060	215	4	.	.	PUNCT
dti-3060	216	1	naveed	naveed	PROPN
dti-3060	216	2	a	a	X
dti-3060	216	3	,	,	PUNCT
dti-3060	216	4	jilani	jilani	PROPN
dti-3060	216	5	k	k	X
dti-3060	216	6	,	,	PUNCT
dti-3060	216	7	siddique	siddique	PROPN
dti-3060	216	8	ab	ab	PROPN
dti-3060	216	9	,	,	PUNCT
dti-3060	217	1	et	et	PROPN
dti-3060	217	2	al	al	PROPN
dti-3060	217	3	.	.	PROPN
dti-3060	217	4	induction	induction	NOUN
dti-3060	217	5	of	of	ADP
dti-3060	217	6	erythrocyte	erythrocyte	PROPN
dti-3060	217	7	shrinkage	shrinkage	NOUN
dti-3060	217	8	by	by	ADP
dti-3060	217	9	omeprazole	omeprazole	NOUN
dti-3060	217	10	.	.	PUNCT
dti-3060	218	1	dose	dose	NOUN
dti-3060	218	2	response	response	NOUN
dti-3060	218	3	.	.	PUNCT
dti-3060	219	1	2020	2020	NUM
dti-3060	219	2	aug	aug	PROPN
dti-3060	219	3	3;18(3	3;18(3	NUM
dti-3060	219	4	):	):	PUNCT
dti-3060	219	5	1559325820946941	1559325820946941	NUM
dti-3060	219	6	.	.	PUNCT
dti-3060	220	1	crossref	crossref	PROPN
dti-3060	220	2	pubmed	pubmed	PROPN
dti-3060	220	3	18	18	NUM
dti-3060	220	4	.	.	PUNCT
dti-3060	221	1	sattar	sattar	PROPN
dti-3060	221	2	t	t	PROPN
dti-3060	221	3	,	,	PUNCT
dti-3060	221	4	jilani	jilani	PROPN
dti-3060	221	5	k	k	PROPN
dti-3060	221	6	,	,	PUNCT
dti-3060	221	7	parveen	parveen	PROPN
dti-3060	221	8	k	k	PROPN
dti-3060	221	9	,	,	PUNCT
dti-3060	221	10	mushataq	mushataq	PROPN
dti-3060	221	11	z	z	NOUN
dti-3060	221	12	,	,	PUNCT
dti-3060	221	13	nawaz	nawaz	ADJ
dti-3060	221	14	h	h	NOUN
dti-3060	221	15	,	,	PUNCT
dti-3060	221	16	khan	khan	PROPN
dti-3060	221	17	mab	mab	PROPN
dti-3060	221	18	.	.	PUNCT
dti-3060	222	1	induction	induction	NOUN
dti-3060	222	2	of	of	ADP
dti-3060	222	3	erythrocyte	erythrocyte	ADJ
dti-3060	222	4	membrane	membrane	NOUN
dti-3060	222	5	blebbing	blebbe	VERB
dti-3060	222	6	by	by	ADP
dti-3060	222	7	methotrexate	methotrexate	NOUN
dti-3060	222	8	-	-	PUNCT
dti-3060	222	9	induced	induce	VERB
dti-3060	222	10	oxidative	oxidative	ADJ
dti-3060	222	11	stress	stress	NOUN
dti-3060	222	12	.	.	PUNCT
dti-3060	223	1	dose	dose	NOUN
dti-3060	223	2	response	response	NOUN
dti-3060	223	3	.	.	PUNCT
dti-3060	224	1	2022	2022	NUM
dti-3060	224	2	apr	apr	NOUN
dti-3060	224	3	13;20(2):15593258221093853	13;20(2):15593258221093853	NUM
dti-3060	224	4	.	.	PUNCT
dti-3060	225	1	crossref	crossref	PROPN
dti-3060	225	2	pubmed	pubmed	PROPN
dti-3060	225	3	19	19	NUM
dti-3060	225	4	.	.	PUNCT
dti-3060	226	1	mukhtar	mukhtar	PROPN
dti-3060	226	2	f	f	PROPN
dti-3060	226	3	,	,	PUNCT
dti-3060	226	4	jilani	jilani	PROPN
dti-3060	226	5	k	k	PROPN
dti-3060	226	6	,	,	PUNCT
dti-3060	226	7	bibi	bibi	PROPN
dti-3060	226	8	i	i	PRON
dti-3060	226	9	,	,	PUNCT
dti-3060	226	10	mushataq	mushataq	PROPN
dti-3060	226	11	z	z	PROPN
dti-3060	226	12	,	,	PUNCT
dti-3060	226	13	bari	bari	PROPN
dti-3060	226	14	khan	khan	PROPN
dti-3060	226	15	ma	ma	PROPN
dti-3060	226	16	,	,	PUNCT
dti-3060	226	17	fatima	fatima	PROPN
dti-3060	226	18	m.	m.	PROPN
dti-3060	226	19	stimulation	stimulation	NOUN
dti-3060	226	20	of	of	ADP
dti-3060	226	21	erythrocyte	erythrocyte	ADJ
dti-3060	226	22	membrane	membrane	NOUN
dti-3060	226	23	blebbing	blebbe	VERB
dti-3060	226	24	by	by	ADP
dti-3060	226	25	bifenthrin	bifenthrin	NOUN
dti-3060	226	26	induced	induce	VERB
dti-3060	226	27	oxidative	oxidative	ADJ
dti-3060	226	28	stress	stress	NOUN
dti-3060	226	29	.	.	PUNCT
dti-3060	227	1	dose	dose	NOUN
dti-3060	227	2	response	response	NOUN
dti-3060	227	3	.	.	PUNCT
dti-3060	228	1	2022	2022	NUM
dti-3060	228	2	mar	mar	PROPN
dti-3060	228	3	3;20(1	3;20(1	NUM
dti-3060	228	4	):	):	PUNCT
dti-3060	228	5	15593258221076710	15593258221076710	NUM
dti-3060	228	6	.	.	PUNCT
dti-3060	229	1	crossref	crossref	PROPN
dti-3060	229	2	pubmed	pubmed	PROPN
dti-3060	229	3	20	20	PROPN
dti-3060	229	4	.	.	PUNCT
dti-3060	230	1	ilyas	ilyas	PROPN
dti-3060	230	2	s	s	PROPN
dti-3060	230	3	,	,	PUNCT
dti-3060	230	4	jilani	jilani	PROPN
dti-3060	230	5	k	k	PROPN
dti-3060	230	6	,	,	PUNCT
dti-3060	230	7	sikandar	sikandar	PROPN
dti-3060	230	8	m	m	PROPN
dti-3060	230	9	,	,	PUNCT
dti-3060	230	10	et	et	PROPN
dti-3060	230	11	al	al	PROPN
dti-3060	230	12	.	.	PROPN
dti-3060	230	13	stimulation	stimulation	NOUN
dti-3060	230	14	of	of	ADP
dti-3060	230	15	erythrocyte	erythrocyte	ADJ
dti-3060	230	16	membrane	membrane	NOUN
dti-3060	230	17	blebbing	blebbe	VERB
dti-3060	230	18	by	by	ADP
dti-3060	230	19	naproxen	naproxen	NOUN
dti-3060	230	20	sodium	sodium	NOUN
dti-3060	230	21	.	.	PUNCT
dti-3060	231	1	dose	dose	NOUN
dti-3060	231	2	response	response	NOUN
dti-3060	231	3	.	.	PUNCT
dti-3060	232	1	2020;18(1):1559325819899259	2020;18(1):1559325819899259	X
dti-3060	232	2	.	.	PUNCT
dti-3060	233	1	crossref	crossref	PROPN
dti-3060	233	2	pubmed	pubmed	PROPN
dti-3060	233	3	21	21	NUM
dti-3060	233	4	.	.	PUNCT
dti-3060	234	1	burger	burger	NOUN
dti-3060	234	2	d	d	PROPN
dti-3060	234	3	,	,	PUNCT
dti-3060	234	4	turner	turner	PROPN
dti-3060	234	5	m	m	PROPN
dti-3060	234	6	,	,	PUNCT
dti-3060	234	7	xiao	xiao	PROPN
dti-3060	234	8	f	f	PROPN
dti-3060	234	9	,	,	PUNCT
dti-3060	234	10	et	et	PROPN
dti-3060	234	11	al	al	PROPN
dti-3060	234	12	.	.	PROPN
dti-3060	234	13	high	high	ADJ
dti-3060	234	14	glucose	glucose	NOUN
dti-3060	234	15	increases	increase	VERB
dti-3060	234	16	the	the	DET
dti-3060	234	17	formation	formation	NOUN
dti-3060	234	18	and	and	CCONJ
dti-3060	234	19	pro	pro	ADJ
dti-3060	234	20	-	-	ADJ
dti-3060	234	21	oxidative	oxidative	ADJ
dti-3060	234	22	activity	activity	NOUN
dti-3060	234	23	of	of	ADP
dti-3060	234	24	endothelial	endothelial	ADJ
dti-3060	234	25	microparticles	microparticle	NOUN
dti-3060	234	26	.	.	PUNCT
dti-3060	235	1	diabetologia	diabetologia	NOUN
dti-3060	235	2	.	.	PUNCT
dti-3060	236	1	2017;60:1791	2017;60:1791	NUM
dti-3060	236	2	-	-	SYM
dti-3060	236	3	1800	1800	NUM
dti-3060	236	4	.	.	PUNCT
dti-3060	237	1	crossref	crossref	PROPN
dti-3060	237	2	22	22	NUM
dti-3060	237	3	.	.	PUNCT
dti-3060	238	1	shabir	shabir	PROPN
dti-3060	238	2	k	k	PROPN
dti-3060	238	3	,	,	PUNCT
dti-3060	238	4	jilani	jilani	PROPN
dti-3060	238	5	k	k	PROPN
dti-3060	238	6	,	,	PUNCT
dti-3060	238	7	zbidah	zbidah	PROPN
dti-3060	238	8	m	m	PROPN
dti-3060	238	9	,	,	PUNCT
dti-3060	238	10	et	et	PROPN
dti-3060	238	11	al	al	PROPN
dti-3060	238	12	.	.	PUNCT
dti-3060	239	1	triggering	trigger	VERB
dti-3060	239	2	of	of	ADP
dti-3060	239	3	erythrocyte	erythrocyte	NOUN
dti-3060	239	4	membrane	membrane	NOUN
dti-3060	239	5	blebbing	blebbe	VERB
dti-3060	239	6	by	by	ADP
dti-3060	239	7	ciprofloxacin	ciprofloxacin	PROPN
dti-3060	239	8	.	.	PUNCT
dti-3060	240	1	acta	acta	PROPN
dti-3060	240	2	pol	pol	PROPN
dti-3060	240	3	pharm	pharm	PROPN
dti-3060	240	4	.	.	PUNCT
dti-3060	241	1	2019;76(5):901	2019;76(5):901	NUM
dti-3060	241	2	-	-	PUNCT
dti-3060	241	3	906	906	NUM
dti-3060	241	4	.	.	PUNCT
dti-3060	242	1	crossref	crossref	PROPN
dti-3060	242	2	23	23	NUM
dti-3060	242	3	.	.	PUNCT
dti-3060	243	1	mischitelli	mischitelli	PROPN
dti-3060	243	2	m	m	PROPN
dti-3060	243	3	,	,	PUNCT
dti-3060	243	4	jemaà	jemaà	PROPN
dti-3060	243	5	m	m	PROPN
dti-3060	243	6	,	,	PUNCT
dti-3060	243	7	almasry	almasry	PROPN
dti-3060	243	8	m	m	PRON
dti-3060	243	9	,	,	PUNCT
dti-3060	243	10	faggio	faggio	NOUN
dti-3060	243	11	c	c	PROPN
dti-3060	243	12	,	,	PUNCT
dti-3060	243	13	lang	lang	PROPN
dti-3060	243	14	f.	f.	PROPN
dti-3060	243	15	triggering	triggering	PROPN
dti-3060	243	16	of	of	ADP
dti-3060	243	17	erythrocyte	erythrocyte	NOUN
dti-3060	243	18	cell	cell	NOUN
dti-3060	243	19	membrane	membrane	NOUN
dti-3060	243	20	scrambling	scramble	VERB
dti-3060	243	21	by	by	ADP
dti-3060	243	22	emodin	emodin	PROPN
dti-3060	243	23	.	.	PUNCT
dti-3060	244	1	cell	cell	PROPN
dti-3060	244	2	physiol	physiol	PROPN
dti-3060	244	3	biochem	biochem	PROPN
dti-3060	244	4	.	.	PUNCT
dti-3060	245	1	2016;40(1	2016;40(1	NUM
dti-3060	245	2	-	-	SYM
dti-3060	245	3	2):91	2):91	NUM
dti-3060	245	4	-	-	PUNCT
dti-3060	245	5	103	103	NUM
dti-3060	245	6	.	.	PUNCT
dti-3060	246	1	crossref	crossref	PROPN
dti-3060	246	2	pubmed	pubmed	PROPN
dti-3060	246	3	24	24	NUM
dti-3060	246	4	.	.	PUNCT
dti-3060	247	1	lupescu	lupescu	PROPN
dti-3060	247	2	a	a	PRON
dti-3060	247	3	,	,	PUNCT
dti-3060	247	4	bissinger	bissinger	ADJ
dti-3060	247	5	r	r	NOUN
dti-3060	247	6	,	,	PUNCT
dti-3060	247	7	jilani	jilani	PROPN
dti-3060	247	8	k	k	PROPN
dti-3060	247	9	,	,	PUNCT
dti-3060	247	10	lang	lang	PROPN
dti-3060	247	11	f.	f.	PROPN
dti-3060	247	12	triggering	triggering	PROPN
dti-3060	247	13	of	of	ADP
dti-3060	247	14	suicidal	suicidal	ADJ
dti-3060	247	15	erythrocyte	erythrocyte	NOUN
dti-3060	247	16	death	death	NOUN
dti-3060	247	17	by	by	ADP
dti-3060	247	18	celecoxib	celecoxib	NOUN
dti-3060	247	19	.	.	PUNCT
dti-3060	247	20	toxins	toxin	NOUN
dti-3060	247	21	.	.	PUNCT
dti-3060	248	1	2013;5(9):1543	2013;5(9):1543	NUM
dti-3060	248	2	-	-	SYM
dti-3060	248	3	1554	1554	NUM
dti-3060	248	4	.	.	PUNCT
dti-3060	249	1	crossref	crossref	PROPN
dti-3060	249	2	25	25	NUM
dti-3060	249	3	.	.	PUNCT
dti-3060	250	1	fish	fish	PROPN
dti-3060	250	2	dn	dn	PROPN
dti-3060	250	3	,	,	PUNCT
dti-3060	250	4	chow	chow	VERB
dti-3060	250	5	at	at	ADP
dti-3060	250	6	.	.	PUNCT
dti-3060	251	1	the	the	DET
dti-3060	251	2	clinical	clinical	ADJ
dti-3060	251	3	pharmacokinetics	pharmacokinetic	NOUN
dti-3060	251	4	of	of	ADP
dti-3060	251	5	levofloxacin	levofloxacin	PROPN
dti-3060	251	6	.	.	PUNCT
dti-3060	252	1	clin	clin	PROPN
dti-3060	252	2	pharmacokinet	pharmacokinet	PROPN
dti-3060	252	3	.	.	PUNCT
dti-3060	253	1	1997;32(2):101	1997;32(2):101	NUM
dti-3060	253	2	-	-	SYM
dti-3060	253	3	119	119	NUM
dti-3060	253	4	.	.	PUNCT
dti-3060	254	1	crossref	crossref	PROPN
dti-3060	254	2	pubmed	pubmed	PROPN
dti-3060	254	3	26	26	NUM
dti-3060	254	4	.	.	PUNCT
dti-3060	255	1	vaziri	vaziri	PROPN
dti-3060	255	2	nd	nd	PROPN
dti-3060	255	3	,	,	PUNCT
dti-3060	255	4	dicus	dicus	PROPN
dti-3060	255	5	m	m	PROPN
dti-3060	255	6	,	,	PUNCT
dti-3060	255	7	ho	ho	PROPN
dti-3060	255	8	nd	nd	PRON
dti-3060	255	9	,	,	PUNCT
dti-3060	255	10	boroujerdi	boroujerdi	PROPN
dti-3060	255	11	-	-	PUNCT
dti-3060	255	12	rad	rad	PROPN
dti-3060	255	13	l	l	PROPN
dti-3060	255	14	,	,	PUNCT
dti-3060	255	15	sindhu	sindhu	PROPN
dti-3060	255	16	rk	rk	PROPN
dti-3060	255	17	.	.	PROPN
dti-3060	255	18	oxidative	oxidative	ADJ
dti-3060	255	19	stress	stress	NOUN
dti-3060	255	20	and	and	CCONJ
dti-3060	255	21	dysregulation	dysregulation	NOUN
dti-3060	255	22	of	of	ADP
dti-3060	255	23	superoxide	superoxide	NOUN
dti-3060	255	24	dismutase	dismutase	NOUN
dti-3060	255	25	and	and	CCONJ
dti-3060	255	26	nadph	nadph	ADJ
dti-3060	255	27	oxidase	oxidase	NOUN
dti-3060	255	28	in	in	ADP
dti-3060	255	29	renal	renal	ADJ
dti-3060	255	30	insufficiency	insufficiency	NOUN
dti-3060	255	31	.	.	PUNCT
dti-3060	256	1	kidney	kidney	NOUN
dti-3060	256	2	int	int	NOUN
dti-3060	256	3	.	.	PUNCT
dti-3060	257	1	2003;63(1):179	2003;63(1):179	X
dti-3060	257	2	-	-	SYM
dti-3060	257	3	185	185	NUM
dti-3060	257	4	.	.	PUNCT
dti-3060	258	1	crossref	crossref	PROPN
dti-3060	258	2	pubmed	pubmed	PROPN
dti-3060	258	3	27	27	NUM
dti-3060	258	4	.	.	PUNCT
dti-3060	259	1	khan	khan	PROPN
dti-3060	259	2	am	be	AUX
dti-3060	259	3	,	,	PUNCT
dti-3060	259	4	rampal	rampal	PROPN
dti-3060	259	5	s	s	PROPN
dti-3060	259	6	,	,	PUNCT
dti-3060	259	7	sood	sood	PROPN
dti-3060	259	8	nk	nk	PROPN
dti-3060	259	9	.	.	PROPN
dti-3060	259	10	effect	effect	NOUN
dti-3060	259	11	of	of	ADP
dti-3060	259	12	repeated	repeat	VERB
dti-3060	259	13	oral	oral	ADJ
dti-3060	259	14	administration	administration	NOUN
dti-3060	259	15	of	of	ADP
dti-3060	259	16	levofloxacin	levofloxacin	PROPN
dti-3060	259	17	,	,	PUNCT
dti-3060	259	18	enrofloxacin	enrofloxacin	PROPN
dti-3060	259	19	,	,	PUNCT
dti-3060	259	20	and	and	CCONJ
dti-3060	259	21	meloxicam	meloxicam	NOUN
dti-3060	259	22	on	on	ADP
dti-3060	259	23	antioxidant	antioxidant	ADJ
dti-3060	259	24	parameters	parameter	NOUN
dti-3060	259	25	and	and	CCONJ
dti-3060	259	26	lipid	lipid	NOUN
dti-3060	259	27	peroxidation	peroxidation	NOUN
dti-3060	259	28	in	in	ADP
dti-3060	259	29	rabbits	rabbit	NOUN
dti-3060	259	30	.	.	PUNCT
dti-3060	260	1	hum	hum	VERB
dti-3060	260	2	exp	exp	NOUN
dti-3060	260	3	toxicol	toxicol	NOUN
dti-3060	260	4	.	.	PUNCT
dti-3060	261	1	2017;36(1):42	2017;36(1):42	NUM
dti-3060	261	2	-	-	SYM
dti-3060	261	3	50	50	NUM
dti-3060	261	4	.	.	PUNCT
dti-3060	262	1	crossref	crossref	PROPN
dti-3060	262	2	pubmed	pubmed	PROPN
dti-3060	262	3	28	28	PROPN
dti-3060	262	4	.	.	PUNCT
dti-3060	263	1	olayinka	olayinka	PROPN
dti-3060	263	2	et	et	PROPN
dti-3060	263	3	,	,	PUNCT
dti-3060	263	4	ore	ore	PROPN
dti-3060	263	5	a	a	NOUN
dti-3060	263	6	,	,	PUNCT
dti-3060	263	7	ola	ola	PROPN
dti-3060	263	8	os	os	PROPN
dti-3060	263	9	.	.	PUNCT
dti-3060	264	1	influence	influence	NOUN
dti-3060	264	2	of	of	ADP
dti-3060	264	3	different	different	ADJ
dti-3060	264	4	doses	dose	NOUN
dti-3060	264	5	of	of	ADP
dti-3060	264	6	levofloxacin	levofloxacin	NOUN
dti-3060	264	7	on	on	ADP
dti-3060	264	8	antioxidant	antioxidant	ADJ
dti-3060	264	9	defense	defense	NOUN
dti-3060	264	10	systems	system	NOUN
dti-3060	264	11	and	and	CCONJ
dti-3060	264	12	markers	marker	NOUN
dti-3060	264	13	of	of	ADP
dti-3060	264	14	renal	renal	ADJ
dti-3060	264	15	and	and	CCONJ
dti-3060	264	16	hepatic	hepatic	ADJ
dti-3060	264	17	dysfunctions	dysfunction	NOUN
dti-3060	264	18	in	in	ADP
dti-3060	264	19	rats	rat	NOUN
dti-3060	264	20	.	.	PUNCT
dti-3060	265	1	adv	adv	PROPN
dti-3060	265	2	toxicol	toxicol	NOUN
dti-3060	265	3	.	.	PUNCT
dti-3060	265	4	2015	2015	NUM
dti-3060	265	5	.	.	PUNCT
dti-3060	266	1	crossref	crossref	PROPN
dti-3060	266	2	29	29	NUM
dti-3060	266	3	.	.	PUNCT
dti-3060	267	1	waggiallah	waggiallah	PROPN
dti-3060	267	2	h	h	PROPN
dti-3060	267	3	,	,	PUNCT
dti-3060	267	4	alzohairy	alzohairy	NOUN
dti-3060	267	5	m.	m.	NOUN
dti-3060	267	6	the	the	DET
dti-3060	267	7	effect	effect	NOUN
dti-3060	267	8	of	of	ADP
dti-3060	267	9	oxidative	oxidative	ADJ
dti-3060	267	10	stress	stress	NOUN
dti-3060	267	11	on	on	ADP
dti-3060	267	12	human	human	ADJ
dti-3060	267	13	red	red	ADJ
dti-3060	267	14	cells	cell	NOUN
dti-3060	267	15	glutathione	glutathione	NOUN
dti-3060	267	16	peroxidase	peroxidase	NOUN
dti-3060	267	17	,	,	PUNCT
dti-3060	267	18	glutathione	glutathione	NOUN
dti-3060	267	19	reductase	reductase	NOUN
dti-3060	267	20	level	level	NOUN
dti-3060	267	21	,	,	PUNCT
dti-3060	267	22	and	and	CCONJ
dti-3060	267	23	prevalence	prevalence	NOUN
dti-3060	267	24	of	of	ADP
dti-3060	267	25	anemia	anemia	NOUN
dti-3060	267	26	among	among	ADP
dti-3060	267	27	diabetics	diabetic	NOUN
dti-3060	267	28	.	.	PUNCT
dti-3060	268	1	n	n	PRON
dti-3060	268	2	am	be	AUX
dti-3060	268	3	j	j	PROPN
dti-3060	268	4	med	med	PROPN
dti-3060	268	5	sci	sci	PROPN
dti-3060	268	6	.	.	PROPN
dti-3060	269	1	2011;3(7):344	2011;3(7):344	NUM
dti-3060	269	2	-	-	PUNCT
dti-3060	269	3	347	347	NUM
dti-3060	269	4	.	.	PUNCT
dti-3060	270	1	crossref	crossref	NOUN
dti-3060	270	2	30	30	NUM
dti-3060	270	3	.	.	PUNCT
dti-3060	271	1	calderón	calderón	PROPN
dti-3060	271	2	-	-	PUNCT
dti-3060	271	3	salinas	salina	NOUN
dti-3060	271	4	jv	jv	PROPN
dti-3060	271	5	,	,	PUNCT
dti-3060	271	6	muñoz	muñoz	PROPN
dti-3060	271	7	-	-	PUNCT
dti-3060	271	8	reyes	reyes	PROPN
dti-3060	271	9	eg	eg	PROPN
dti-3060	271	10	,	,	PUNCT
dti-3060	271	11	guerrero	guerrero	PROPN
dti-3060	271	12	-	-	PUNCT
dti-3060	271	13	romero	romero	PROPN
dti-3060	271	14	jf	jf	PROPN
dti-3060	271	15	,	,	PUNCT
dti-3060	271	16	et	et	PROPN
dti-3060	271	17	al	al	PROPN
dti-3060	271	18	.	.	PROPN
dti-3060	271	19	eryptosis	eryptosis	NOUN
dti-3060	271	20	and	and	CCONJ
dti-3060	271	21	oxidative	oxidative	ADJ
dti-3060	271	22	damage	damage	NOUN
dti-3060	271	23	in	in	ADP
dti-3060	271	24	type	type	NOUN
dti-3060	271	25	2	2	NUM
dti-3060	271	26	diabetic	diabetic	ADJ
dti-3060	271	27	mellitus	mellitus	NOUN
dti-3060	271	28	patients	patient	NOUN
dti-3060	271	29	with	with	ADP
dti-3060	271	30	chronic	chronic	ADJ
dti-3060	271	31	kidney	kidney	NOUN
dti-3060	271	32	disease	disease	NOUN
dti-3060	271	33	.	.	PUNCT
dti-3060	272	1	mol	mol	ADP
dti-3060	272	2	cell	cell	NOUN
dti-3060	272	3	biochem	biochem	PROPN
dti-3060	272	4	.	.	PUNCT
dti-3060	273	1	2011;357(1	2011;357(1	NUM
dti-3060	273	2	-	-	PUNCT
dti-3060	273	3	2):171	2):171	NUM
dti-3060	273	4	-	-	PUNCT
dti-3060	273	5	179	179	NUM
dti-3060	273	6	.	.	PUNCT
dti-3060	274	1	crossref	crossref	PROPN
dti-3060	274	2	pubmed	pubmed	PROPN
dti-3060	274	3	31	31	NUM
dti-3060	274	4	.	.	PUNCT
dti-3060	275	1	farid	farid	PROPN
dti-3060	275	2	as	as	ADP
dti-3060	275	3	,	,	PUNCT
dti-3060	275	4	hegazy	hegazy	ADV
dti-3060	275	5	am	be	AUX
dti-3060	275	6	.	.	PUNCT
dti-3060	276	1	ameliorative	ameliorative	ADJ
dti-3060	276	2	effects	effect	NOUN
dti-3060	276	3	of	of	ADP
dti-3060	276	4	moringa	moringa	NOUN
dti-3060	276	5	oleifera	oleifera	NOUN
dti-3060	276	6	leaf	leaf	NOUN
dti-3060	276	7	extract	extract	NOUN
dti-3060	276	8	on	on	ADP
dti-3060	276	9	levofloxacin	levofloxacin	NOUN
dti-3060	276	10	-	-	PUNCT
dti-3060	276	11	induced	induce	VERB
dti-3060	276	12	hepatic	hepatic	ADJ
dti-3060	276	13	toxicity	toxicity	NOUN
dti-3060	276	14	in	in	ADP
dti-3060	276	15	rats	rat	NOUN
dti-3060	276	16	.	.	PUNCT
dti-3060	277	1	drug	drug	NOUN
dti-3060	277	2	chem	chem	NOUN
dti-3060	277	3	toxicol	toxicol	NOUN
dti-3060	277	4	.	.	PUNCT
dti-3060	278	1	2020;43(6):616	2020;43(6):616	NUM
dti-3060	278	2	-	-	SYM
dti-3060	278	3	622	622	NUM
dti-3060	278	4	.	.	PUNCT
dti-3060	279	1	crossref	crossref	PROPN
dti-3060	279	2	pubmed	pubmed	PROPN
dti-3060	279	3	32	32	NUM
dti-3060	279	4	.	.	PUNCT
dti-3060	280	1	lang	lang	PROPN
dti-3060	280	2	ks	ks	PROPN
dti-3060	280	3	,	,	PUNCT
dti-3060	280	4	duranton	duranton	PROPN
dti-3060	280	5	c	c	PROPN
dti-3060	280	6	,	,	PUNCT
dti-3060	280	7	poehlmann	poehlmann	PROPN
dti-3060	280	8	h	h	NOUN
dti-3060	280	9	,	,	PUNCT
dti-3060	280	10	et	et	PROPN
dti-3060	280	11	al	al	PROPN
dti-3060	280	12	.	.	PROPN
dti-3060	280	13	cation	cation	NOUN
dti-3060	280	14	channels	channel	NOUN
dti-3060	280	15	trigger	trigger	VERB
dti-3060	280	16	apoptotic	apoptotic	ADJ
dti-3060	280	17	death	death	NOUN
dti-3060	280	18	of	of	ADP
dti-3060	280	19	erythrocytes	erythrocyte	NOUN
dti-3060	280	20	.	.	PUNCT
dti-3060	281	1	cell	cell	NOUN
dti-3060	281	2	death	death	NOUN
dti-3060	281	3	differ	differ	VERB
dti-3060	281	4	.	.	PUNCT
dti-3060	282	1	2003;10(2):249	2003;10(2):249	NUM
dti-3060	282	2	-	-	SYM
dti-3060	282	3	256	256	NUM
dti-3060	282	4	.	.	PUNCT
dti-3060	283	1	crossref	crossref	PROPN
dti-3060	283	2	pubmed	pubmed	PROPN
dti-3060	283	3	33	33	NUM
dti-3060	283	4	.	.	PUNCT
dti-3060	284	1	charras	charras	PROPN
dti-3060	284	2	gt	gt	PROPN
dti-3060	284	3	,	,	PUNCT
dti-3060	284	4	coughlin	coughlin	PROPN
dti-3060	284	5	m	m	PROPN
dti-3060	284	6	,	,	PUNCT
dti-3060	284	7	mitchison	mitchison	PROPN
dti-3060	284	8	tj	tj	PROPN
dti-3060	284	9	,	,	PUNCT
dti-3060	284	10	mahadevan	mahadevan	PROPN
dti-3060	284	11	l.	l.	PROPN
dti-3060	284	12	life	life	PROPN
dti-3060	284	13	and	and	CCONJ
dti-3060	284	14	times	time	NOUN
dti-3060	284	15	of	of	ADP
dti-3060	284	16	a	a	DET
dti-3060	284	17	cellular	cellular	ADJ
dti-3060	284	18	bleb	bleb	NOUN
dti-3060	284	19	.	.	PUNCT
dti-3060	285	1	biophys	biophys	PROPN
dti-3060	285	2	j.	j.	PROPN
dti-3060	285	3	2008	2008	NUM
dti-3060	285	4	mar	mar	PROPN
dti-3060	285	5	1;94(5):18361853	1;94(5):18361853	NOUN
dti-3060	285	6	.	.	PUNCT
dti-3060	286	1	crossref	crossref	PROPN
dti-3060	286	2	pubmed	pubmed	PROPN
dti-3060	286	3	34	34	NUM
dti-3060	286	4	.	.	PUNCT
dti-3060	287	1	harrison	harrison	PROPN
dti-3060	287	2	he	he	PROPN
dti-3060	287	3	,	,	PUNCT
dti-3060	287	4	bunting	bunting	NOUN
dti-3060	287	5	h	h	NOUN
dti-3060	287	6	,	,	PUNCT
dti-3060	287	7	ordway	ordway	PROPN
dti-3060	287	8	nk	nk	PROPN
dti-3060	287	9	,	,	PUNCT
dti-3060	287	10	albrink	albrink	VERB
dti-3060	287	11	ws	ws	NOUN
dti-3060	287	12	.	.	PUNCT
dti-3060	288	1	the	the	DET
dti-3060	288	2	pathogenesis	pathogenesis	NOUN
dti-3060	288	3	of	of	ADP
dti-3060	288	4	the	the	DET
dti-3060	288	5	renal	renal	ADJ
dti-3060	288	6	injury	injury	NOUN
dti-3060	288	7	produced	produce	VERB
dti-3060	288	8	in	in	ADP
dti-3060	288	9	the	the	DET
dti-3060	288	10	dog	dog	NOUN
dti-3060	288	11	by	by	ADP
dti-3060	288	12	hemoglobin	hemoglobin	NOUN
dti-3060	288	13	or	or	CCONJ
dti-3060	288	14	methemoglobin	methemoglobin	NOUN
dti-3060	288	15	.	.	PUNCT
dti-3060	289	1	j	j	PROPN
dti-3060	289	2	exp	exp	NOUN
dti-3060	289	3	med	med	PROPN
dti-3060	289	4	.	.	PUNCT
dti-3060	290	1	1947;86(4):339	1947;86(4):339	NUM
dti-3060	290	2	-	-	PUNCT
dti-3060	290	3	356	356	NUM
dti-3060	290	4	.	.	PUNCT
dti-3060	291	1	crossref	crossref	PROPN
dti-3060	291	2	pubmed	pubmed	PROPN
dti-3060	291	3	35	35	NUM
dti-3060	291	4	.	.	PUNCT
dti-3060	292	1	rapido	rapido	PROPN
dti-3060	292	2	f.	f.	PROPN
dti-3060	292	3	the	the	DET
dti-3060	292	4	potential	potential	ADJ
dti-3060	292	5	adverse	adverse	ADJ
dti-3060	292	6	effects	effect	NOUN
dti-3060	292	7	of	of	ADP
dti-3060	292	8	haemolysis	haemolysis	NOUN
dti-3060	292	9	.	.	PUNCT
dti-3060	293	1	blood	blood	NOUN
dti-3060	293	2	transfus	transfus	PROPN
dti-3060	293	3	.	.	PUNCT
dti-3060	294	1	2017	2017	NUM
dti-3060	294	2	may;15(3):218	may;15(3):218	NOUN
dti-3060	294	3	-	-	PUNCT
dti-3060	294	4	221	221	NUM
dti-3060	294	5	.	.	PUNCT
dti-3060	295	1	crossref	crossref	PROPN
dti-3060	295	2	pubmed	pubmed	PROPN
dti-3060	295	3	https://doi.org/10.1186/s12974-019-1538-9	https://doi.org/10.1186/s12974-019-1538-9	PROPN
dti-3060	295	4	https://www.ncbi.nlm.nih.gov/pubmed/31319868	https://www.ncbi.nlm.nih.gov/pubmed/31319868	NUM
dti-3060	295	5	https://doi.org/10.4103/0975-1483.90242	https://doi.org/10.4103/0975-1483.90242	PROPN
dti-3060	295	6	https://www.ncbi.nlm.nih.gov/pubmed/22224037	https://www.ncbi.nlm.nih.gov/pubmed/22224037	NUM
dti-3060	295	7	https://doi.org/10.33899/ijvs.2020.126416.1316	https://doi.org/10.33899/ijvs.2020.126416.1316	PROPN
dti-3060	295	8	https://doi.org/10.1007/978-3-319-45865-6_1	https://doi.org/10.1007/978-3-319-45865-6_1	NOUN
dti-3060	295	9	https://doi.org/10.1016/j.ejmech.2020.112607	https://doi.org/10.1016/j.ejmech.2020.112607	PROPN
dti-3060	295	10	https://www.ncbi.nlm.nih.gov/pubmed/32721784	https://www.ncbi.nlm.nih.gov/pubmed/32721784	NOUN
dti-3060	295	11	https://doi.org/10.1007/978-3-030-83446-3_4	https://doi.org/10.1007/978-3-030-83446-3_4	PUNCT
dti-3060	295	12	https://doi.org/10.1517/14728222.2015.1051306	https://doi.org/10.1517/14728222.2015.1051306	PROPN
dti-3060	295	13	https://www.ncbi.nlm.nih.gov/pubmed/26013571	https://www.ncbi.nlm.nih.gov/pubmed/26013571	PROPN
dti-3060	295	14	https://doi.org/10.1016/j.bbamem.2018.03.019	https://doi.org/10.1016/j.bbamem.2018.03.019	PROPN
dti-3060	295	15	https://www.ncbi.nlm.nih.gov/pubmed/29573990	https://www.ncbi.nlm.nih.gov/pubmed/29573990	PRON
dti-3060	295	16	https://doi.org/10.3390/cells11030503	https://doi.org/10.3390/cells11030503	VERB
dti-3060	296	1	https://www.ncbi.nlm.nih.gov/pubmed/35159312	https://www.ncbi.nlm.nih.gov/pubmed/35159312	ADJ
dti-3060	296	2	https://doi.org/10.1089/ars.2006.8.1183	https://doi.org/10.1089/ars.2006.8.1183	ADJ
dti-3060	296	3	https://www.ncbi.nlm.nih.gov/pubmed/16910766	https://www.ncbi.nlm.nih.gov/pubmed/16910766	X
dti-3060	296	4	https://doi.org/10.1159/000185448	https://doi.org/10.1159/000185448	NOUN
dti-3060	296	5	https://pubmed.ncbi.nlm.nih.gov/19088418/	https://pubmed.ncbi.nlm.nih.gov/19088418/	PROPN
dti-3060	296	6	https://doi.org/10.1159/000447895	https://doi.org/10.1159/000447895	PROPN
dti-3060	296	7	https://www.ncbi.nlm.nih.gov/pubmed/27771701	https://www.ncbi.nlm.nih.gov/pubmed/27771701	X
dti-3060	296	8	https://doi.org/10.1159/000495088	https://doi.org/10.1159/000495088	PROPN
dti-3060	296	9	https://www.ncbi.nlm.nih.gov/pubmed/30423572	https://www.ncbi.nlm.nih.gov/pubmed/30423572	X
dti-3060	296	10	https://doi.org/10.1111/bcpt.12250	https://doi.org/10.1111/bcpt.12250	PROPN
dti-3060	296	11	https://www.ncbi.nlm.nih.gov/pubmed/24717091	https://www.ncbi.nlm.nih.gov/pubmed/24717091	NUM
dti-3060	296	12	https://doi.org/10.1177/1559325820946941	https://doi.org/10.1177/1559325820946941	PUNCT
dti-3060	297	1	https://pubmed.ncbi.nlm.nih.gov/32863802/	https://pubmed.ncbi.nlm.nih.gov/32863802/	ADJ
dti-3060	297	2	https://doi.org/10.1177/15593258221093853	https://doi.org/10.1177/15593258221093853	NOUN
dti-3060	297	3	https://pubmed.ncbi.nlm.nih.gov/35449724/	https://pubmed.ncbi.nlm.nih.gov/35449724/	PROPN
dti-3060	297	4	https://doi.org/10.1177/15593258221076710	https://doi.org/10.1177/15593258221076710	PRON
dti-3060	297	5	https://pubmed.ncbi.nlm.nih.gov/35645655/	https://pubmed.ncbi.nlm.nih.gov/35645655/	PROPN
dti-3060	297	6	https://doi.org/10.1177/1559325819899259	https://doi.org/10.1177/1559325819899259	VERB
dti-3060	297	7	https://www.ncbi.nlm.nih.gov/pubmed/31983907	https://www.ncbi.nlm.nih.gov/pubmed/31983907	PRON
dti-3060	297	8	https://doi.org/10.1007/s00125-017-4331-2	https://doi.org/10.1007/s00125-017-4331-2	NUM
dti-3060	298	1	https://doi.org/10.32383/appdr/110772	https://doi.org/10.32383/appdr/110772	INTJ
dti-3060	298	2	https://doi.org/10.1159/000452527	https://doi.org/10.1159/000452527	PRON
dti-3060	298	3	https://www.ncbi.nlm.nih.gov/pubmed/27855368	https://www.ncbi.nlm.nih.gov/pubmed/27855368	NUM
dti-3060	298	4	https://doi.org/10.3390/toxins5091543	https://doi.org/10.3390/toxins5091543	PROPN
dti-3060	298	5	https://doi.org/10.2165/00003088-199732020-00002	https://doi.org/10.2165/00003088-199732020-00002	NOUN
dti-3060	298	6	https://www.ncbi.nlm.nih.gov/pubmed/9068926	https://www.ncbi.nlm.nih.gov/pubmed/9068926	PART
dti-3060	298	7	https://doi.org/10.1046/j.1523-1755.2003.00702.x	https://doi.org/10.1046/j.1523-1755.2003.00702.x	NOUN
dti-3060	298	8	https://www.ncbi.nlm.nih.gov/pubmed/12472781	https://www.ncbi.nlm.nih.gov/pubmed/12472781	NUM
dti-3060	298	9	https://doi.org/10.1177/0960327116637111	https://doi.org/10.1177/0960327116637111	NOUN
dti-3060	298	10	https://www.ncbi.nlm.nih.gov/pubmed/26962111	https://www.ncbi.nlm.nih.gov/pubmed/26962111	X
dti-3060	298	11	https://doi.org/10.1155/2015%2f385023	https://doi.org/10.1155/2015%2f385023	NOUN
dti-3060	298	12	https://doi.org/10.4297/najms.2011.3344	https://doi.org/10.4297/najms.2011.3344	PROPN
dti-3060	298	13	https://doi.org/10.1007/s11010-011-0887-1	https://doi.org/10.1007/s11010-011-0887-1	PROPN
dti-3060	298	14	https://www.ncbi.nlm.nih.gov/pubmed/21625956	https://www.ncbi.nlm.nih.gov/pubmed/21625956	PROPN
dti-3060	298	15	https://doi.org/10.1080/01480545.2019.1574811	https://doi.org/10.1080/01480545.2019.1574811	PROPN
dti-3060	298	16	https://www.ncbi.nlm.nih.gov/pubmed/30782023	https://www.ncbi.nlm.nih.gov/pubmed/30782023	NUM
dti-3060	298	17	https://doi.org/10.1038/sj.cdd.4401144	https://doi.org/10.1038/sj.cdd.4401144	NOUN
dti-3060	298	18	https://www.ncbi.nlm.nih.gov/pubmed/12700653	https://www.ncbi.nlm.nih.gov/pubmed/12700653	NUM
dti-3060	298	19	https://doi.org/10.1529/biophysj.107.113605	https://doi.org/10.1529/biophysj.107.113605	PROPN
dti-3060	298	20	https://pubmed.ncbi.nlm.nih.gov/17921219/	https://pubmed.ncbi.nlm.nih.gov/17921219/	PROPN
dti-3060	298	21	https://doi.org/10.1084/jem.86.4.339	https://doi.org/10.1084/jem.86.4.339	VERB
dti-3060	298	22	https://pubmed.ncbi.nlm.nih.gov/19871682/	https://pubmed.ncbi.nlm.nih.gov/19871682/	PROPN
dti-3060	298	23	https://doi.org/10.2450/2017.0311-16	https://doi.org/10.2450/2017.0311-16	PROPN
dti-3060	298	24	https://pubmed.ncbi.nlm.nih.gov/28518048/	https://pubmed.ncbi.nlm.nih.gov/28518048/	PROPN